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ABSTRACT 	  Eukaryotic	   genomes	   must	   be,	   on	   the	   one	   hand,	   highly	   compacted	   by	   wrapping	  their	  DNA	  around	  histones	   to	   form	  nucleosomes	  while	   on	   the	  other,	   still	   remain	  accessible	   to	   the	   transcriptional	   machinery	   in	   a	   developmental	   and	   cell-­‐type	  specific	  manner.	  Various	  epigenetic-­‐based	  mechanisms	  exist	  that	  can	  regulate	  DNA	  accessibility	  ensuring	  the	  proper	  regulation	  of	  gene	  transcription.	  One	  epigenetic	  modification	   in	   particular	   that	   impacts	   all	   aspects	   of	   genome	   function	   and	  organization	   is	   the	   replacement	   of	   canonical	   histones	   with	   their	   variant	   forms.	  Among	  the	  histone	  variants	  that	  are	  most	  extensively	  studied	  is	  the	  essential	  and	  evolutionary	  conserved	  variant,	  H2A.Z.	  Recent	  studies	  have	  revealed	  many	  layers	  of	   regulation	   and	   complex	   functions	   of	   H2A.Z	   in	   modulating	   gene	   expression.	  Notably,	   H2A.Z	   has	   the	   ability	   to	   both	   activate	   and	   repress	   transcription	   but	   it	  remains	  unresolved	  how	  H2A.Z	  affects	  gene	  expression	  in	  these	  opposing	  ways.	  At	  a	   genome-­‐wide	   level,	   H2A.Z	   is	   found	   at	   active	   transcription	   start	   sites,	   inactive	  promoters	   and	   of	   relevance	   to	   this	   thesis,	   it	   is	   also	   found	   at	   satellite	   repeats	  including	   those	   present	   at	   constitutive	   heterochromatin	   and	   the	   centromere.	   To	  gain	   new	   insights	   into	   the	   function	   of	   H2A.Z	   and	   how	   it	   can	   perform	   these	  opposing	   roles,	   this	   thesis	   has	   examined	   the	   transcriptional	   role	   of	   H2A.Z	   in	  regulating	   two	   different	   types	   of	   RNAPII	   transcribed	   elements:	   the	  retrotransposon,	  LINE-­‐1	  and	  a	  coding	  gene	  important	  for	  T-­‐cell	  development,	  Cd69.	  	  Long	  Interspersed	  Nucleotide	  Element-­‐1	  (LINE-­‐1)	  is	  one	  of	  most	  impactful	  and	  still	  active	  transposable	  elements	  (TEs)	  that	  occupy	  18%-­‐20%	  of	  mammalian	  genomes.	  Given	   that	   H2A.Z	   is	   targeted	   to	   repetitive	   mouse	   DNA	   sequences	   found	   at	  heterochromatin	   and	   the	   centromere,	   which	   is	   necessary	   for	   chromatin	  compaction,	   I	  wondered	  whether	   this	   role	  might	   extend	   to	   other	   repetitive	  DNA	  elements.	  Specifically,	  I	  explored	  the	  role	  of	  H2A.Z	  in	  LINE-­‐1	  transcription	  in	  four	  different	   cell	   types	   that	   were	   undifferentiated	   (mouse	   trophoblast	   stem	   cells	  (TSCs)),	  differentiated	  (trophoblast	  giant	  cells	  (TGCs)	  and	  mouse	  L929	  cells)	  and	  committed	  (mouse	  embryonic	  fibroblasts	  (MEFs)).	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The	   results	   showed	   significant	   variability	   in	  H2A.Z	   occupancy	   relative	   to	  H2A	   at	  LINE-­‐1s	   in	   these	   different	   cell	   types.	   Moreover,	   the	   enrichment	   of	   H2A.Z	   was	  inversely	  correlated	  with	  LINE-­‐1	  RNA	  expression.	  	  Specifically,	  relative	  high	  levels	  of	  LINE-­‐1	  transcripts	  were	  observed	  in	  TSCs	  compared	  to	  MEFs	  and	  L929	  cells	  and	  this	  was	  correlated	  with	  a	  lower	  level	  of	  H2A.Z	  in	  the	  promoter	  and	  coding	  region	  of	   the	  LINE-­‐1	  element.	  Furthermore,	  when	  TSCs	  were	  differentiated	   into	  TGCs	   in	  
vitro,	  there	  was	  a	  dramatic	  reduction	  in	  LINE-­‐1	  expression	  and	  this	  repression	  was	  positively	   correlated	   with	   a	   gain	   of	   H2A.Z	   on	   LINE-­‐1s.	   These	   observations	  suggested	  that	  H2A.Z	  was	  a	  repressor	  of	  LINE-­‐1	  transcription.	  	  To	   directly	   test	   this	   hypothesis,	   a	   H2A.Z	   knockdown	   system	   was	   successfully	  established	   in	   both	   L929	   and	   TSCs.	   Indeed,	   the	   loss	   of	   H2A.Z	   activated	   LINE-­‐1	  transcription	  in	  both	  L929	  cells	  and	  TGCs	  following	   its	  differentiation	  from	  TSCs.	  These	   data	   shows	  unequivocally	   that	  H2A.Z	   is	   a	   repressor	   of	   LINE-­‐1	   expression.	  	  Unexpectedly	  though,	  the	  inhibition	  of	  H2A.Z	  expression	  in	  TSCs	  decreased	  LINE-­‐1	  expression	  rather	  than	  increasing	  it.	  Further	  investigations	  revealed	  that	  the	  level	  of	  acetylated	  H2A.Z	  (acH2A.Z)	  at	  the	  promoter	  region	  of	  LINE-­‐1s	  differed	  between	  TSCs	   and	   TGCs.	   Significantly,	   there	   was	   a	   higher	   level	   of	   acH2A.Z	   at	   LINE-­‐1s	   in	  TSCs	   compared	   to	   TGCs	   consistent	   with	   acH2A.Z	   being	   a	   mark	   of	   active	  transcription	   and	   the	   higher	   level	   of	   transcription	   seen	   in	   TSCs.	   These	   results	  demonstrate	  for	  the	  first	  time	  that	  H2A.Z	  is	  a	  regulator	  of	  LINE-­‐1	  transcription	  and	  whether	  it	  activates	  or	  represses	  these	  repetitive	  elements	  is	  dependent	  upon	  the	  abundance	  and	  the	  acetylation	  state	  of	  H2A.Z.	  	  To	  further	  explore	  the	  role	  of	  H2A.Z	  in	  the	  regulation	  of	  gene	  transcription,	  I	  chose	  to	   study	   the	   activation	   of	   the	   Cd69	   promoter	   during	   T-­‐cell	   development.	   The	  advantage	   of	   studying	   T-­‐cell	   development	   is	   that	   it	   is	   possible	   to	   obtain	   a	   pure	  population	   of	   T-­‐cells	   at	   different	   stages	   of	   development.	   The	   Cd69	   gene	   was	   of	  interest	  because	   it	   is	  a	   surface	  marker	   that	  accompanies	   induction	  or	   repression	  through	  different	  stages	  of	  thymocyte	  development.	  	  This	  enabled	  an	  investigation	  of	   when	   during	   development	   H2A.Z	   is	   recruited	   to	   the	   Cd69	   promoter,	   and	   the	  relationship	  between	  this	  recruitment	  with	  gene	  activation	  and	  the	  engagement	  of	  RNA	  polymerase	  II	  (RNAPII).	  Surprisingly,	  the	  data	  demonstrated	  that	  H2A.Z	  was	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present	  on	  the	  Cd69	  promoter	  early	  in	  development	  when	  it	  is	  inactive	  and	  prior	  to	  the	   recruitment	   of	   RNAPII.	   Furthermore,	   H2A.Z	  was	   subsequently	   removed	   at	   a	  developmental	   stage	   prior	   to	   the	   binding	   of	   RNAPII	   suggesting	   again	   that	  H2A.Z	  may	  be	  a	  repressor	  of	  gene	  transcription	  during	  development.	   In	  conclusion,	   this	  thesis	  has	  revealed	  new	  unexpected	  functions	  for	  H2A.Z	  in	  the	  regulation	  of	  LINE-­‐1	  and	  Cd69	  transcription.	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ABBREVIATIONS 	  
Abbreviation	   Full	  name/term	  Cdx2	   Caudal	  type	  homeobox	  transcription	  factor	  2	  ChIP	   Chromatin	  Immunoprecipitation	  CpG	   Cytosine	  nucleotide	  occurs	  next	  to	  a	  guanine	  nucleotede	  DDR	   DNA	  damage	  response	  DNA	   Deoxyribonucleic	  acid	  EMT	   Epithelial-­‐mesenchymal	  transition	  Eomes	   eomesodermin	  Esrrβ	   Estrogen-­‐related	  receptor-­‐β	  FGF4	   Fibroblast	  growth	  factor	  4	  Fgfr2	   Fibroblast	  growth	  factor	  receptor	  2	  GFP	   Green	  fluorescent	  protein	  ICM	   Inner	  cell	  mass	  LINE	   Long	  Interspersed	  Nucleotide	  Element	  LTR	   Long	  terminal	  repeats	  MEFs	   Mouse	  Embryonic	  Fibrobalsts	  NFR	   Nucleosome-­‐free	  region	  ORF	   Open	  reading	  frames	  PCR	   Polymerase	  chain	  reaction	  PI	   Propidium	  iodide	  PL-­‐1	   Placental	  lactogen-­‐1	  Pol1	   DNA	  polymerase	  isoform	  1	  PTMs	   Posttranslational	  modifications	  RNA	   Ribonucleic	  acid	  RNAPII	   RNA	  Polymerase	  II	  RPLP0	   Large	  ribosomal	  protein	  RFP	   Red	  fluorescent	  protein	  SINE	   Short	  Interspersed	  Nucleotide	  Element	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TEs	   Transposable	  Elements	  TGC	   Trophoblast	  giant	  cell	  TSC	   Trophoblast	  stem	  cell	  TSS	   Transcriptional	  start	  site	  UTR	   Untranslated	  region	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Chapter	  1	  Introduction	  
	  2	  
1.1	  Chromatin	  and	  the	  control	  of	  gene	  expression	  
1.1.1 Chromatin structure The	  genetic	  material	  of	  eukaryotic	  cells	  is	  organised	  into	  a	  highly	  regulated	  DNA–protein	  structure	  called	  chromatin.	  The	  basic	  structural	  unit	  of	  chromatin,	  the	  nucleosome,	  is	  composed	  of	  147	  base	  pairs	  (bp)	  of	  DNA	  wrapped	  1.7	  times	  around	  an	  octamer	  containing	  two	  copies	  of	  each	  of	  the	  core	  histones	  H2A,	  H2B,	  H3	  and	  H4	  (Davey	  et	  al.,	  2002,	  Polo	  and	  Almouzni,	  2006).	  There	  are	  two	  steps	  in	  chromatin	  assembly.	  First,	  a	  core	  (H3-­‐H4)2	  tetramer	  is	  assembled,	  and	  then	  two	  H2A-­‐H2B	  dimers	  associate	  separately	  with	  the	  tetramer	  to	  form	  the	  histone	  octamer	  (Ramakrishnan,	  1997)	  (Figure	  1.1).	  In	  addition	  to	  the	  four	  core	  histones	  present	  in	  the	  nucleosomal	  octamer,	  a	  fifth	  histone,	  linker	  histone	  (H1),	  is	  bound	  to	  the	  DNA	  as	  it	  enters	  each	  nucleosome	  core	  particle.	  This	  forms	  a	  chromatin	  subunit	  known	  as	  a	  chromatosome,	  which	  consists	  of	  166	  bp	  of	  DNA	  wrapped	  around	  the	  histone	  core	  and	  held	  in	  place	  by	  histone	  H1.	  Nucleosome	  arrays	  are	  assembled	  into	  10	  nm	  chromatin	  fibres.	  In	  an	  electron	  microscope	  image,	  this	  10	  nm	  fibre	  has	  a	  beaded	  appearance,	  like	  “beads	  on	  a	  string”	  (Olins	  and	  Olins,	  2003).	  This	  chromatin	  template	  can	  be	  further	  condensed	  by	  coiling	  into	  chromatin	  fibres	  with	  a	  diameter	  of	  30	  nm	  in	  the	  presence	  of	  cations,	  which	  is	  stabilised	  by	  histone	  H1.	  However,	  recent	  studies	  argue	  that	  such	  30	  nm	  chromation	  fiber	  might	  only	  exist	  in	  vitro	  but	  not	  in	  vivo	  (Maeshima	  et	  al.,	  2014).	  This	  30	  nm	  fibre	  can	  then	  be	  fold	  into	  higher	  order	  configurations	  and	  the	  extent	  of	  chromatin	  compacting	  depends	  on	  a	  variety	  of	  factors	  including	  the	  stage	  of	  the	  cell	  cycle,	  the	  nature	  of	  the	  underlying	  DNA	  sequence	  and	  whether	  this	  DNA	  is	  expressed	  or	  not.	  	  The	  extent	  of	  chromatin	  condensation	  can	  be	  classified	  as	  euchromatin	  or	  heterochromatin,	  based	  on	  the	  density	  of	  nucleic	  acid	  staining	  in	  micrographs	  (Trojer	  and	  Reinberg,	  2007).	  Heterochromatin	  is	  highly	  condensed,	  gene	  poor	  and	  transcriptionally	  silent,	  whereas	  euchromatin	  is	  less	  condensed,	  gene	  rich	  and	  more	  easily	  transcribed	  (Huisinga	  et	  al.,	  2006).	  An	  important	  feature	  of	  heterochromatin	  is	  its	  propensity	  to	  “spread”	  to	  adjacent	  regions	  of	  chromatin	  (Hines	  et	  al.,	  2009,	  Liaw	  and	  Lustig,	  2006).	  Heterochromatin	  can	  be	  further	  divided	  into	  constitutive	  heterochromatin	  and	  facultative	  heterochromatin.	  Facultative	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heterochromatin	  is	  condensed,	  transcriptionally	  silent	  chromatin	  that	  can	  transit	  to	  a	  more	  open	  structure	  and	  allow	  transcription	  within	  temporal,	  spatial	  or	  parental/heritable	  contexts.	  Conversely,	  constitutive	  heterochromatin	  is	  always	  compacted,	  and	  tends	  to	  be	  enriched	  with	  repetitive	  and	  late-­‐replicating	  DNA	  sequences	  (Trojer	  and	  Reinberg,	  2007).	  It	  has	  been	  thought	  for	  a	  long	  time	  that	  structurally	  different	  chromatin	  (i.e.	  heterochromatin	  vs.	  euchromatin)	  has	  a	  very	  different	  expression	  profile.	  	  
	  
Figure 1.1 Nucleosome structure and its stepwise assembly.  (i)	  Crystal	  structure	  of	  the	  nucleosome	  core	  particle	  (NCBI	  Protein	  Data	  Bank	  structure	  1KX5;	  adapted	  from	  (Luger	  et	  al.,	  1997)).	  A	  histone	  (H3-­‐H4)2	  tetramer	  is	  flanked	  by	  two	  easily	  exchangeable	  dimers	  of	  H2A-­‐H2B	  to	  form	  an	  octamer.	  Around	  this	  octamer	  is	  wrapped	  147	  bp	  of	  DNA	  to	  form	  the	  nucleosome	  core	  particle.	  The	  amino-­‐terminal	  tails	  of	  histones	  protrude	  out	  of	  the	  nucleosome,	  and	  are	  therefore	  accessible	  for	  modification	  by	  histone	  modifiers.	  (ii)	  Cartoon	  representation	  of	  the	  nucleosome	  core	  particle	  (Corpet	  and	  Almouzni,	  2009).	  	  As	  pointed	  out	  above,	  organisation	  of	  the	  genome	  into	  chromatin	  can	  limit	  its	  accessibility,	  thereby	  providing	  a	  means	  to	  modulate	  gene	  expression.	  Indeed,	  it	  is	  difficult	  to	  explain	  how	  genes	  are	  expressed	  differently	  at	  different	  times	  during	  development	  without	  the	  modulation	  of	  DNA	  packaging.	  Compared	  to	  higher-­‐order	  structures,	  more	  is	  known	  about	  chromatin	  organisation	  at	  the	  level	  of	  nucleosome	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arrays.	  Hence,	  a	  question	  that	  can	  be	  asked	  is	  how	  alterations	  to	  chromatin	  structure	  specifically	  at	  the	  level	  of	  the	  nucleosome	  contribute	  to	  the	  control	  of	  gene	  expression.	  	  
1.1.2 The role of histone chaperones and chromatin 
remodelers in establishing chromatin organisation Histones,	  the	  key	  protein	  component	  of	  nucleosomes,	  must	  be	  assembled,	  replaced	  or	  exchanged	  to	  preserve	  or	  change	  chromatin	  organisation	  according	  to	  cellular	  needs.	  How	  does	  the	  cell	  ensure	  the	  formation	  of	  well-­‐defined	  nucleosomes?	  When	  histones	  are	  not	  associated	  with	  DNA,	  they	  are	  bound	  to	  proteins	  called	  histone	  chaperones	  (Loyola	  and	  Almouzni,	  2004).	  Histone	  chaperones	  were	  originally	  thought	  to	  be	  histone	  carriers.	  However,	  ongoing	  study	  of	  these	  proteins	  revealed	  that	  they	  are	  important	  players	  at	  all	  stages	  of	  histone	  existence.	  Chaperones	  associate	  with	  histones	  upon	  their	  synthesis,	  escort	  them	  into	  the	  nucleus,	  prevent	  unintended	  interactions	  of	  histones	  with	  other	  factors,	  and	  help	  to	  control	  histone	  supply	  and	  incorporation	  into	  chromatin.	  They	  are	  crucial	  in	  fundamental	  processes	  such	  as	  transcription,	  DNA	  replication	  and	  DNA	  repair.	  Furthermore,	  it	  now	  appears	  that	  they	  modulate,	  directly	  or	  indirectly,	  histone	  post-­‐translational	  modifications.	  	  Histone	  chaperones,	  by	  acting	  as	  histone	  acceptors	  and	  donors,	  assist	  in	  the	  disruption	  and	  reassembly	  of	  nucleosomes.	  Most	  histone	  chaperones	  bind	  either	  to	  H3-­‐H4	  or	  to	  H2A-­‐H2B	  oligomers	  (Bowman	  et	  al.,	  2011,	  English	  et	  al.,	  2006,	  Hondele	  et	  al.,	  2013).	  They	  control	  histone	  provision	  locally	  and	  exhibit	  specificity	  for	  particular	  histones	  and	  histone	  variants	  (De	  Koning	  et	  al.,	  2007).	  Interestingly,	  most	  histone	  chaperones	  bind	  to	  regions	  on	  histones	  that	  are	  essential	  for	  nucleosome	  formation	  (Su	  et	  al.,	  2012,	  Hondele	  et	  al.,	  2013).	  	  In	  addition	  to	  histone	  chaperones,	  multi-­‐subunit	  remodelling	  complexes	  built	  around	  a	  large	  motor	  ATPase	  also	  regulate	  chromatin	  organisation.	  Four	  major	  ATPase	  families	  –	  the	  SWI/SNF,	  ISWI	  (imitation	  switch),	  CHD	  (chromodomain-­‐helicase-­‐DNA-­‐binding	  protein)	  and	  INO80	  (inositol-­‐requiring	  protein	  80)	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complexes	  –	  have	  been	  shown	  to	  play	  an	  important	  role	  in	  chromatin	  assembly	  in	  eukaryotes	  (Clapier	  and	  Cairns,	  2009).	  However,	  in	  the	  context	  of	  transcription,	  only	  three	  of	  these	  complexes	  are	  known	  to	  regulate	  this	  process.	  ISWI	  remodelers,	  consisting	  of	  two	  to	  four	  subunits,	  were	  initially	  purified	  from	  Drosophila	  
melanogaster.	  Although	  certain	  complexes,	  such	  as	  NURF,	  can	  randomise	  nucleosome	  spacing	  and	  assist	  in	  RNA	  polymerase	  II	  activation,	  many	  ISWI	  family	  complexes	  (e.g.	  ACF,	  CHRAC)	  optimise	  nucleosome	  spacing	  to	  promote	  chromatin	  assembly	  and	  the	  repression	  of	  transcription	  (Corona	  and	  Tamkun,	  2004).	  	  The	  CHD	  remodelers,	  consisting	  of	  one	  to	  ten	  subunits,	  were	  originally	  purified	  from	  the	  frog	  Xenopus	  laevis.	  The	  catalytic	  subunit	  is	  monomeric	  in	  lower	  eukaryotes,	  but	  can	  form	  large	  complexes	  in	  vertebrates.	  Certain	  CHD	  remodelers	  slide	  or	  eject	  nucleosomes	  to	  promote	  transcription,	  while	  others	  have	  repressive	  roles.	  Its	  variability	  may	  rely,	  in	  part,	  on	  chromodomain	  diversity	  (Marfella	  and	  Imbalzano,	  2007).	  The	  INO80	  remodelers	  contain	  more	  than	  10	  subunits.	  They	  have	  a	  “split”	  ATPase	  domain,	  with	  a	  long	  insertion	  in	  the	  middle	  of	  the	  ATPase	  domain.	  INO80	  has	  diverse	  functions,	  including	  promoting	  transcriptional	  activation	  and	  DNA	  repair.	  SWR1	  is	  highly	  related	  to	  INO80,	  but	  it	  can	  restructure	  nucleosomes	  by	  removing	  canonical	  H2A-­‐H2B	  dimers	  and	  replacing	  them	  with	  H2A.Z-­‐H2B	  dimers,	  thereby	  inserting	  the	  histone	  variant	  H2A.Z	  (see	  below)	  (Bao	  and	  Shen,	  2007).	  	  
1.1.3 Histone modifications in chromatin Histone	  modifications	  have	  been	  of	  great	  interest	  in	  the	  last	  twenty	  years.	  Amino-­‐terminal	  histone	  tails	  can	  be	  altered	  by	  covalent	  modifications	  such	  as	  acetylation,	  methylation,	  ubiquitination,	  sumoylation	  and/or	  phosphorylation	  (Lee	  et	  al.,	  2010).	  These	  modifications	  can	  work	  together	  to	  regulate	  chromatin	  structure,	  thus	  affecting	  biological	  processes	  including	  gene	  expression	  (Ramakrishnan,	  1997,	  Luger	  et	  al.,	  1997).	  	  Hyperacetylated	  histones	  are	  most	  often	  associated	  with	  actively	  transcribed	  genes,	  indicating	  a	  role	  for	  histone	  acetylation	  in	  facilitating	  transcription.	  Indeed,	  acetylation	  can	  increase	  the	  accessibility	  of	  DNA	  to	  the	  transcriptional	  machinery	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by	  neutralising	  the	  positive	  charge	  of	  lysine	  residues,	  thus	  weakening	  charge-­‐dependent	  interactions	  between	  the	  histone	  and	  nucleosomal	  DNA,	  linker	  DNA	  or	  adjacent	  histones.	  For	  example,	  acetylation	  of	  histone	  H3	  lysines	  9	  and	  14	  (H3K9,14ac)	  occurs	  in	  promoter-­‐associated	  nucleosomes	  at	  actively	  transcribed	  genes	  (Pokholok	  et	  al.,	  2005,	  Bernstein	  et	  al.,	  2005).	  Acetylation	  of	  histone	  tails	  can	  also	  regulate	  transcription	  by	  directly	  recruiting	  reader	  proteins	  (e.g.	  bromodomain-­‐containing	  proteins)	  (Sanchez	  and	  Zhou,	  2009).	  
Histone	  methylation,	  on	  the	  other	  hand,	  is	  thought	  to	  be	  less	  directly	  involved	  in	  nucleosome	  dynamics	  than	  acetylation,	  since	  mono-­‐,	  di-­‐	  or	  trimethylation	  of	  lysine	  residues	  does	  not	  affect	  the	  positive	  charge	  of	  histones.	  One	  well-­‐studied	  histone	  modification	  is	  the	  methylation	  of	  histone	  H3	  lysine	  4	  (H3K4me),	  which	  is	  associated	  with	  transcriptionally	  active	  genes	  and	  acts	  as	  a	  binding	  site	  for	  a	  variety	  of	  factors,	  including	  those	  with	  histone	  modifying	  and	  remodelling	  activities	  (Shilatifard,	  2006).	  The	  histone	  H3	  lysine	  36	  trimethyl	  (H3K36me3)	  modification	  occurs	  at	  nucleosomes	  in	  the	  3ʹ′	  end	  of	  the	  transcribed	  region	  of	  actively	  transcribed	  genes	  (Pokholok	  et	  al.,	  2005,	  Bernstein	  et	  al.,	  2005).	  In	  contrast,	  H3K9me3	  correlates	  with	  repressed	  genes	  when	  found	  at	  the	  promoter	  (Mikkelsen	  et	  al.,	  2007,	  Barski	  et	  al.,	  2007).	  However,	  H3K9me3	  enrichment	  within	  the	  body	  of	  a	  gene	  can	  also	  correlate	  with	  gene	  expression	  with	  a	  potential	  role	  in	  pre-­‐	  mRNA	  splicing	  (Brinkman	  et	  al.,	  2006,	  Vakoc	  et	  al.,	  2005).	  
Histones	  are	  the	  most	  abundant	  ubiquitinated	  proteins	  in	  cells,	  and	  the	  dominant	  form	  of	  ubiquitinated	  histones	  are	  monoubiquitinated	  H2A	  (H2Aub)	  and	  H2B	  (H2Bub).	  H2Aub	  is	  correlated	  with	  gene	  silencing,	  while	  H2Bub	  is	  mostly	  associated	  with	  transcriptional	  activation	  (Minsky	  et	  al.,	  2008,	  Shema	  et	  al.,	  2008,	  Zhu	  et	  al.,	  2007).	  Ubiquitination	  of	  H2A	  inhibited	  transcriptional	  elongation	  of	  certain	  genes	  by	  blocking	  the	  recruitment	  of	  FACT	  (Zhou	  et	  al.,	  2008).	  Furthermore,	  H2Aub	  was	  shown	  to	  repress	  transcriptional	  initiation	  and	  to	  inhibit	  the	  formation	  of	  markers	  of	  transcriptional	  activity,	  dimethylated	  and	  trimethylated	  histone	  H3K4	  (H3K4me2	  and	  H3K4me3)	  (Nakagawa	  et	  al.,	  2008).	  In	  contrast	  to	  H2Aub,	  histone	  H2B	  monoubiquitination	  (H2Bub1)	  affects	  transcription	  by	  stimulating	  histone	  H3K4	  di-­‐	  and	  trimethylation	  (Shahbazian	  et	  al.,	  2005,	  Dehe	  et	  al.,	  2005,	  Sun	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and	  Allis,	  2002).	  The	  H2B	  ubiquitination	  machinery,	  FACT	  chaperone	  and	  Paf1	  elongation	  complex	  are	  all	  required	  to	  enhance	  the	  rate	  of	  transcriptional	  elongation	  from	  chromatin	  templates	  (Pavri	  et	  al.,	  2006).	  Ubiquitination	  of	  H2B	  depends	  greatly	  on	  FACT,	  and	  in	  turn	  promotes	  retention	  of	  the	  chaperone	  at	  the	  coding	  region	  of	  active	  genes	  (Fleming	  et	  al.,	  2008).	  
Similar	  to	  ubiquitination,	  small	  ubiquitin-­‐related	  modifier	  (SUMO)	  proteins	  are	  a	  family	  of	  ubiquitin-­‐like	  proteins	  that	  resemble	  ubiquitin	  in	  both	  structure	  and	  their	  mechanism	  of	  ligation	  to	  substrates.	  There	  are	  three	  members	  of	  the	  SUMO	  family	  in	  mammals:	  SUMO-­‐1,	  SUMO-­‐2	  and	  SUMO-­‐3	  (Saitoh	  and	  Hinchey,	  2000,	  Tatham	  et	  al.,	  2001).	  Histone	  H4	  sumoylation	  mediates	  transcriptional	  repression	  through	  the	  recruitment	  of	  histone	  deacetylases	  and	  heterochromatin	  protein	  1	  (HP1)	  (Shiio	  and	  Eisenman,	  2003).	  
Phosphorylation	  imparts	  a	  negative	  charge	  to	  its	  modified	  residue.	  Considering	  that	  the	  phosphates	  of	  the	  DNA	  backbone	  are	  negatively	  charged,	  phosphorylation	  of	  histones	  would	  create	  charge	  repulsion	  between	  the	  histones	  and	  DNA,	  thus	  loosening	  the	  association	  of	  DNA	  with	  histones.	  This	  suggests	  that	  histone	  phosphorylation	  has	  a	  similar	  role	  to	  acetylation	  in	  modulating	  nucleosome	  dynamics	  (Banerjee	  and	  Chakravarti,	  2011).	  Several	  studies	  indicate	  that	  a	  number	  of	  phosphorylated	  histone	  residues	  are	  mitosis-­‐specific	  and	  may	  associate	  with	  regulation	  of	  gene	  expression,	  especially	  the	  proliferative	  genes.	  For	  example,	  phosphorylation	  of	  H3	  serines	  10	  and	  28	  (H3S10,S28ph)	  and	  H2B	  serine	  32	  (H2BS32ph)	  has	  been	  associated	  with	  the	  regulation	  of	  epidermal	  growth	  factor-­‐responsive	  gene	  transcription	  (Chadee	  et	  al.,	  1999,	  Choi	  et	  al.,	  2005,	  Lau	  et	  al.,	  2011).	  Furthermore,	  H3S10ph	  and	  H2BS30ph	  were	  correlated	  with	  the	  expression	  of	  proto-­‐oncogenes	  such	  as	  c-­‐Myc,	  c-­‐Jun	  and	  c-­‐Fos,	  while	  H3S28ph	  is	  targeted	  to	  the	  promoters	  of	  c-­‐Fos	  and	  α-­‐globin,	  and	  controls	  their	  activation	  (Lau	  and	  Cheung,	  2011).	  
Histone	  modifications	  regulate	  gene	  transcription	  via	  a	  number	  of	  different	  mechanisms.	  First,	  with	  the	  exception	  of	  methylation,	  histone	  modifications	  can	  change	  the	  net	  charge	  of	  nucleosomes,	  which	  in	  turn	  loosens	  inter-­‐	  or	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intranucleosomal	  DNA–histone	  interactions	  (Hassan	  et	  al.,	  2006,	  Chandy	  et	  al.,	  2006,	  Zhao	  et	  al.,	  2005).	  Second,	  because	  of	  the	  diversity	  of	  covalent	  modifications,	  individual	  histone	  modifications	  or	  modification	  patterns	  may	  be	  read	  by	  other	  proteins	  that	  affect	  chromatin	  dynamics	  and	  function	  (Jenuwein	  and	  Allis,	  2001,	  Turner,	  2000,	  Strahl	  and	  Allis,	  2000).	  Third,	  some	  modifications	  directly	  affect	  higher-­‐order	  chromatin	  structure.	  For	  instance,	  acetylation	  of	  H4K16	  inhibits	  the	  formation	  of	  compact	  30	  nm	  fibres	  (Shogren-­‐Knaak	  et	  al.,	  2006).	  
1.1.4 Histone variants and gene transcription While	  research	  on	  chromatin	  states	  has	  focused	  primarily	  on	  histone	  modifications,	  an	  alternative	  means	  of	  regulating	  gene	  expression	  and	  other	  DNA-­‐dependent	  cellular	  processes	  is	  to	  replace	  canonical	  histones	  with	  non-­‐allelic	  histone	  variants	  (Table	  1.1)	  (Li	  et	  al.,	  2007).	  Histone	  variants	  are	  separately	  encoded	  and	  differ	  in	  sequence	  from	  canonical	  histones.	  These	  variants	  can	  contain	  minor	  sequence	  differences	  (e.g.	  the	  canonical	  histones	  H3.1	  and	  H3.2,	  and	  the	  variant	  H3.3)	  or	  significant	  structure	  dissimilarities	  (e.g.	  macroH2A,	  the	  centromere-­‐specific	  protein	  CENP-­‐A)	  (Rogakou	  and	  Sekeri-­‐Pataryas,	  1999).	  In	  contrast	  to	  canonical	  histones,	  histone	  variants	  are	  expressed	  outside	  of	  S	  phase	  and	  are	  incorporated	  into	  chromatin	  in	  a	  DNA	  replication-­‐independent	  manner.	  
Chapter	  1	  General	  Introduction	  
	  9	  
Table 1.1 Histone variants involved in transcriptional regulation	  




Localisation	   Structural	  features	   Functions	  
H2A	   H2A.Z	   Transcriptional	  activation/	  repression	  
Promoters	  Enhancers	  Insulators	  Heterochromatin	  
Disfavours	  formation	  of	  hybrid	  nucleosomes	  Carboxyl	  terminus	  is	  essential	  for	  recognition	  Loop	  1	  differs	  from	  H2A	  
Regulates	  +1	  nucleosome	  and	  RNA	  polymerase	  II	  progression	  Affects	  nucleosome	  mobility	  and	  positioning	  Facilitates	  TBP	  binding	  Required	  for	  constitutive	  heterochromatin	  and	  chromosome	  stability	  macroH2A	   Repression	  or	  activation?	   X	  chromosome	   Amino-­‐terminal	  non-­‐histone-­‐like	  region	  is	  responsible	  for	  most	  of	  functions	  Prefers	  to	  form	  heterotypic	  nucleosomes	  
Interferes	  with	  transcription	  factor	  binding	  Inhibition	  of	  ATP-­‐dependent	  nucleosome	  remodelling	  Interferes	  with	  histone	  acetylation	  by	  p300	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H2A.Bbd	   Activation	   Strongly	  expressed	  in	  testis,	  more	  weakly	  in	  brain	  
Lacks	  carboxyl-­‐terminal	  tail	  and	  part	  of	  the	  docking	  domain	  Lacks	  an	  acidic	  patch	  
Creates	  a	  specific	  chromatin	  landscape	  at	  the	  promoters	  of	  active	  genes	  Associated	  with	  actively	  transcribed	  chromatin	  Associated	  with	  mRNA	  splicing	  H3	   H3.3	   Activation	   Transcribing	  regions	  Enhancers	  Promoters	  
Different	  from	  canonical	  H3	  in	  only	  four	  amino	  acids	   Active	  transcription	  triggers	  deposition	  and	  removal	  
H3.Y	   Activation?	   Primate-­‐specifc	  histone	  variant,	  	  Transcriptional	  start	  sites	  of	  actively	  transcribed	  genes	  
Different	  from	  H3.3	  and	  H3.1	  in	  26	  and	  30	  amino	  acid	  residues	  respectively	  
Forms	  a	  relaxed	  chromatin	  configuration	  Binds	  linker	  histone	  H1	  less	  efficiently	  Very	  stable	  in	  vitro	  and	  in	  vivo	  Preferentially	  accumulates	  on	  the	  transcriptional	  start	  sites	  of	  actively	  transcribed	  genes	  	  Table	  adapted	  from	  Li	  et	  al.	  (2007).	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The	  histone	  variant	  H3.3	  is	  specifically	  incorporated	  into	  transcribed	  genes	  and	  regulatory	  sequences	  (Henikoff,	  2008).	  Its	  incorporation	  takes	  place	  on	  induction	  of	  transcription	  and	  is	  associated	  with	  transcriptional	  elongation	  (Sutcliffe	  et	  al.,	  2009,	  Schwartz	  and	  Ahmad,	  2005).	  H3.3	  is	  highly	  enriched	  relative	  to	  canonical	  H3	  in	  several	  modifications	  associated	  with	  transcription,	  suggesting	  that	  deposition	  context	  is	  important	  in	  determining	  post-­‐translational	  modification	  of	  variants	  (Hake	  and	  Allis,	  2006,	  Hake	  et	  al.,	  2006).	  H3.3	  is	  assembled	  in	  the	  pericentric	  heterochromatin	  of	  the	  paternal	  pronucleus	  before	  the	  first	  mitosis	  following	  fertilisation	  (Orsi	  et	  al.,	  2009).	  In	  mammalian	  male	  meiosis,	  its	  deposition	  is	  accompanied	  by	  the	  initial	  depletion	  and	  the	  later	  acquisition	  of	  post-­‐translational	  modifications	  required	  for	  meiotic	  silencing	  of	  unsynapsed	  chromatin	  and	  meiotic	  sex	  chromosome	  inactivation	  (van	  der	  Heijden	  et	  al.,	  2007).	  In	  nuclear	  transplantation	  experiments	  in	  X.	  laevis,	  H3.3	  mediated	  the	  epigenetic	  memory	  of	  an	  activated	  gene	  state	  via	  lysine	  4	  (H3.3K4)	  (Ng	  and	  Gurdon,	  2008).	  Nucleosomes	  containing	  H3.3	  and	  another	  histone	  variant,	  H2A.Z	  (see	  below),	  appeared	  to	  be	  less	  stable	  and	  were	  therefore	  easier	  to	  displace	  from	  DNA	  than	  canonical	  nucleosomes	  (Jin	  and	  Felsenfeld,	  2007).	  
In	  addition	  to	  histone	  variants	  H3.3	  and	  H2A.Z,	  which	  have	  been	  extensively	  studied,	  more	  and	  more	  research	  is	  focusing	  on	  other	  variants	  such	  as	  H2A.Bbd,	  macroH2A	  and	  H2A.X.	  H2A.Bbd	  is	  strongly	  expressed	  in	  testis	  (Chadwick	  and	  Willard,	  2001b,	  Ishibashi	  et	  al.,	  2010,	  Soboleva	  et	  al.,	  2012),	  and	  to	  a	  much	  lesser	  extent	  in	  brain	  (Soboleva	  et	  al.,	  2012).	  H2A.Bbd	  is	  involved	  in	  creating	  a	  specific	  chromatin	  landscape	  at	  the	  promoters	  of	  active	  genes.	  H2A.Z	  occupies	  the	  −2	  nucleosome	  and	  H2A.Bbd	  the	  −1	  nucleosome,	  with	  respect	  to	  the	  transcription	  start	  site	  (TSS),	  of	  active	  genes	  during	  spermatogenesis	  (Soboleva	  et	  al.,	  2012).	  However,	  in	  contrast	  to	  endogenous	  mouse	  H2A.Bbd,	  ectopically	  expressed,	  epitope-­‐tagged	  human	  H2A.Bbd	  is	  depleted	  at	  the	  TSS	  but	  enriched	  in	  gene	  bodies	  (Tolstorukov	  et	  al.,	  2012).	  Interestingly,	  several	  in	  vitro	  studies	  showed	  different	  results.	  Only	  mild	  effects	  on	  transcription	  were	  observed	  on	  a	  H2A.Bbd	  chromatin	  template	  compared	  with	  canonical	  H2A	  (Angelov	  et	  al.,	  2004,	  Bao	  et	  al.,	  2004),	  while	  another	  study	  found	  transcription	  to	  be	  ~5-­‐fold	  more	  efficient	  on	  a	  H2A.Bbd	  template	  (Zhou	  et	  al.,	  2007).	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While	  H2A.Bbd	  seems	  to	  be	  associated	  with	  active	  chromatin,	  being	  deficient	  on	  inactive	  X	  chromosomes	  in	  fibroblasts	  (Chadwick	  and	  Willard,	  2001b),	  macroH2A	  is	  enriched	  on	  the	  inactive	  X	  chromosome	  of	  female	  mammals,	  suggesting	  a	  role	  in	  transcriptional	  silencing	  (Costanzi	  and	  Pehrson,	  2001,	  Chadwick	  and	  Willard,	  2001a).	  It	  has	  been	  proposed	  that	  macroH2A	  acts	  on	  at	  least	  two	  distinct	  levels	  to	  repress	  transcription.	  Firstly,	  it	  can	  interfere	  with	  transcription	  factor	  binding	  if	  the	  binding	  site	  is	  close	  to	  the	  nucleosome	  dyad	  axis,	  the	  region	  that	  shows	  the	  strongest	  alteration	  in	  DNase	  I	  digestion	  pattern	  compared	  to	  canonical	  H2A.	  Secondly,	  it	  can	  inhibit	  ATP-­‐dependent	  nucleosome	  remodelling	  (Angelov	  et	  al.,	  2003).	  The	  SWI/SNF	  chromatin	  remodelling	  complex	  binds	  preferentially	  to	  canonical	  H2A	  over	  macroH2A	  nucleosomes;	  however,	  macroH2A	  is	  still	  an	  excellent	  substrate	  for	  SWI/SNF	  ATP-­‐dependent	  nucleosome	  remodelling	  (Chang	  et	  al.,	  2008).	  H2A.X	  is	  involved	  in	  the	  DNA	  damage	  response.	  However,	  a	  study	  demonstrated	  a	  striking	  increase	  in	  H2A.X	  chromatin	  incorporation,	  rather	  than	  canonical	  H2A,	  H2A.Z	  or	  macroH2A,	  after	  fertilisation	  (Nashun	  et	  al.,	  2010),	  suggesting	  a	  novel	  role	  for	  H2A.X	  in	  chromatin	  structure	  outside	  of	  the	  DNA	  damage	  response.	  	  Although	  extensive	  studies	  have	  provided	  a	  detailed	  view	  of	  the	  chromatin	  landscape	  in	  which	  particular	  histone	  variants	  or	  histone	  modifications	  occur,	  knowledge	  of	  how	  the	  chromatin	  landscape	  was	  created	  lags	  behind.	  Further	  investigation	  of	  dynamic	  chromatin	  processes	  is	  likely	  to	  require	  a	  better	  understanding	  of	  the	  functions,	  contexts	  and	  substrates	  of	  the	  chromatin	  remodelers	  and	  histone	  chaperones	  that	  position	  histones,	  and	  of	  the	  enzymes	  that	  modify	  them.	  	  H2A.Z	  is	  a	  highly	  conserved	  histone	  variant,	  which	  evolved	  early	  and	  only	  once	  in	  evolution	  (Thatcher	  and	  Gorovsky,	  1994).	  However,	  H2A.Z	  has	  apparently	  contradictory	  roles	  in	  transcriptional	  regulation,	  nucleosome	  turnover,	  DNA	  repair	  (Zlatanova	  and	  Thakar,	  2008),	  embryonic	  stem	  cell	  differentiation	  (Creyghton	  et	  al.,	  2008),	  and	  antagonising	  DNA	  methylation	  in	  plants	  (Zilberman	  et	  al.,	  2008).	  These	  roles	  will	  be	  discussed	  in	  the	  next	  section.	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1.2	  Histone	  variant	  H2A.Z	  and	  its	  biological	  
functions	  
1.2.1 H2A.Z structure and biophysical effects on 
nucleosome structure The	  histone	  H2A	  family	  has	  the	  greatest	  number	  of	  variants	  among	  the	  core	  histones.	  Among	  them,	  H2A.Z	  is	  one	  of	  the	  most	  comprehensively	  studied	  histone	  variants,	  yet	  its	  function	  is	  far	  from	  being	  understood.	  H2A.Z	  has	  been	  highly	  conserved	  during	  evolution.	  It	  is	  found	  in	  organisms	  as	  diverse	  as	  the	  malaria-­‐causing	  protozoan	  parasite	  Plasmodium	  falciparum,	  the	  yeast	  Saccharomyces	  
cerevisiae,	  and	  Homo	  sapiens,	  with	  protein	  sequence	  conservation	  of	  ~90%	  (Iouzalen	  et	  al.,	  1996).	  Phylogenetic	  analysis	  showed	  that	  H2A.Z	  is	  only	  ~60%	  identical	  to	  canonical	  H2A	  within	  the	  same	  species	  (Zlatanova	  and	  Thakar,	  2008).	  For	  example,	  Figure	  1.2A	  shows	  the	  differences	  in	  primary	  sequence	  of	  yeast	  and	  human	  H2A.Z,	  compared	  to	  the	  respective	  canonical	  H2A.	  Figure	  1.2B	  highlights	  the	  regions	  of	  considerable	  divergence	  between	  H2A.Z	  and	  H2A.	  Despite	  significant	  sequence	  divergence,	  the	  H2A.Z	  nucleosome	  crystal	  structure	  (Figure	  1.2C)	  (Suto	  et	  al.,	  2000)	  revealed	  a	  strong	  similarity	  to	  the	  canonical	  structure	  (Luger	  et	  al.,	  1997).	  However,	  the	  differences,	  such	  as	  divergent	  regions	  in	  the	  amino-­‐	  and	  carboxyl-­‐terminal	  domains	  as	  well	  as	  the	  L1	  loop	  region	  within	  the	  histone	  fold,	  suggest	  that	  H2A.Z	  incorporation	  could	  alter	  the	  biophysical	  properties	  of	  chromatin.	  Furthermore,	  H2A.Z	  has	  two	  distinct	  isoforms,	  H2A.Z.1	  and	  H2A.Z.2,	  two	  non-­‐allelic	  genes	  that	  have	  been	  identified	  in	  the	  vertebrate	  genome	  (Dryhurst	  et	  al.,	  2009).	  In	  addition,	  an	  unusual	  alternative	  splice	  form	  of	  H2A.Z,	  H2A.Z.2.2,	  was	  identified	  and	  structural	  characterized	  in	  human	  cells	  (Bonisch	  et	  al.,	  2012).	  	  The	  H2A.Z	  carboxyl-­‐terminal	  acidic	  patch	  is	  different	  from	  that	  of	  H2A;	  specifically,	  the	  substitution	  of	  H2A	  residues	  Asn89,	  Asn94	  and	  Lys95	  for	  Gly92,	  Asp97	  and	  Ser98.	  These	  three	  divergent	  residues	  form	  an	  acidic	  patch	  that	  extends	  across	  the	  surface	  of	  the	  H2A.Z	  octamer,	  resulting	  in	  a	  solvent-­‐exposed	  cavity	  in	  the	  centre	  of	  the	  nucleosome	  (Suto	  et	  al.,	  2000).	  Many	  biophysical	  studies	  have	  been	  performed	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to	  understand	  the	  properties	  of	  H2A.Z-­‐containing	  nucleosomes.	  Some	  studies	  found	  nucleosome	  stabilisation	  (Thambirajah	  et	  al.,	  2006,	  Park	  et	  al.,	  2004,	  Li	  et	  al.,	  1993),	  whereas	  others	  observed	  destabilisation	  compared	  to	  canonical	  nucleosomes	  (Zhang	  et	  al.,	  2005,	  Abbott	  et	  al.,	  2001).	  In	  agreement	  with	  the	  destabilising	  role	  of	  H2A.Z,	  nucleosomal	  H2A.Z	  was	  more	  unstable	  and	  susceptible	  to	  loss	  in	  high	  salt	  conditions	  compared	  to	  H3	  or	  H2A	  using	  purified	  yeast	  chromatin	  (Zhang	  et	  al.,	  2005).	  Meanwhile,	  another	  study	  described	  a	  subtle	  stabilisation	  of	  H2A.Z	  that	  was	  dependent	  on	  core	  histone	  acetylation,	  while	  the	  H2A.Z-­‐H2B	  dimer	  itself	  has	  reduced	  stability	  compared	  to	  H2A-­‐H2B	  (Thambirajah	  et	  al.,	  2006).	  The	  Felsenfeld	  laboratory	  reported	  that	  H2A.Z	  severely	  destabilises	  nucleosomes	  if	  present	  with	  H3.3	  in	  the	  same	  nucleosome	  (Jin	  and	  Felsenfeld,	  2007).	  They	  also	  showed	  that	  H3.3-­‐H2A.Z-­‐containing	  double-­‐variant	  nucleosomes	  mark	  the	  nucleosome-­‐free	  regions	  (NFRs)	  of	  active	  promoters,	  enhancers	  and	  insulator	  regions,	  and	  are	  highly	  unstable	  (Jin	  et	  al.,	  2009).	  Furthermore,	  H2A.Z.2.2	  has	  been	  found	  to	  cause	  major	  structural	  changes	  and	  significantly	  destabilizes	  nucleosomes	  (Bonisch	  et	  al.,	  2012).	  These	  features	  result	  in	  unstable	  H2A.Z-­‐containing	  nucleosomes,	  which	  contribute	  to	  its	  role	  in	  transcriptional	  activation.	   	  




Figure 1.2 Primary protein sequence of H2A.Z, and regions of 
considerable divergence from H2A in the secondary structure and the 
nucleosome core particle structure.  
(A)	  The	  amino	  acid	  sequences	  of	  H2A.Z	  (S.	  cerevisiae	  versus	  human;	  H.s.)	  and	  S.	  
cerevisiae	  H2A	  versus	  S.	  cerevisiae	  H2A.Z	  are	  aligned	  (differences	  are	  presented	  in	  red).	  (B)	  Schematic	  representation	  of	  the	  secondary	  structure	  of	  histones	  H2A	  and	  H2A.Z,	  showing	  the	  five	  α-­‐helices	  (blue	  rectangles).	  Brackets	  encompass	  the	  canonical	  histone	  fold	  (helices	  1,	  2	  and	  3)	  and	  the	  docking	  domain;	  loops	  1	  and	  2	  are	  also	  marked.	  Pink	  ovals	  denote	  segments	  with	  considerable	  sequence	  divergence	  from	  H2A.	  Numbers	  refer	  to	  the	  amino	  acid	  residues	  of	  H2A.Z.	  (C)	  Representation	  of	  a	  portion	  of	  the	  crystal	  structure	  of	  the	  nucleosome	  core	  particle	  containing,	  for	  clarity,	  only	  the	  nucleosomal	  DNA	  and	  two	  molecules	  of	  H2A.Z.	  The	  major	  regions	  of	  divergence	  are	  circled	  in	  yellow	  and	  pink.	  This	  representation	  was	  created	  using	  existing	  crystal	  structure	  coordinates	  from	  the	  NCBI	  Protein	  Data	  Bank	  structure	  1F66,	  with	  the	  help	  of	  UCSF	  Chimera	  (Zlatanova	  and	  Thakar,	  2008).	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In	  contrast,	  other	  in	  vitro	  studies	  showed	  that	  H2A.Z	  incorporation	  stabilises	  the	  dimer–tetramer	  interface,	  and	  strongly	  favours	  the	  formation	  of	  30	  nm	  fibres	  over	  the	  formation	  of	  higher-­‐order	  chromatin	  structures	  (that	  require	  fibre–fibre	  interactions),	  compared	  to	  canonical	  H2A	  (Abbott	  et	  al.,	  2001,	  Park	  et	  al.,	  2004,	  Park	  and	  Luger,	  2008).	  Fluorescence	  resonance	  energy	  transfer	  measurements	  detected	  only	  subtle	  effects	  on	  stability	  in	  vitro	  (Goujon	  et	  al.,	  2010,	  Hoch	  et	  al.,	  2007).	  Earlier	  results	  from	  the	  laboratory	  of	  Jim	  Davie	  showed	  that	  H2A.Z	  eluted	  from	  hydroxyapatite-­‐absorbed	  chromatin	  at	  much	  higher	  salt	  concentrations	  than	  the	  canonical	  H2A-­‐H2B	  dimer	  (Li	  et	  al.,	  1993).	  Therefore,	  these	  properties	  of	  the	  H2A.Z	  nucleosome	  suggest	  that	  it	  may	  play	  a	  role	  in	  transcriptional	  repression	  and/or	  stable	  H2A.Z-­‐containing	  nucleosomes	  have	  a	  role	  in	  regulating	  active	  transcription	  (e.g.	  the	  +1	  nucleosome,	  see	  below).	  	  	  This	  contradictory	  data	  may	  be	  explained	  in	  a	  number	  of	  different	  ways.	  For	  example,	  these	  studies	  were	  carried	  out	  in	  different	  organisms,	  using	  different	  sources	  of	  chromatin	  (recombinant	  versus	  native	  chromatin)	  and	  even	  using	  different	  experimental	  systems.	  Moreover,	  the	  H2A.Z-­‐containing	  nucleosome	  may	  have	  increased	  or	  decreased	  stability	  depending	  on	  pre-­‐existing	  histone	  modifications	  on	  H2A.Z	  itself	  or	  the	  other	  nucleosomal	  histones	  (Babiarz	  et	  al.,	  2006,	  Ishibashi	  et	  al.,	  2009,	  Keogh	  et	  al.,	  2006).	  Studies	  have	  identified	  two	  different	  forms	  of	  H2A.Z-­‐containing	  octamers:	  one	  with	  two	  copies	  of	  H2A.Z-­‐H2B	  dimers,	  called	  the	  homotypic	  state	  (ZZ);	  the	  other	  with	  only	  one	  copy,	  along	  with	  a	  canonical	  H2A-­‐H2B	  dimer,	  called	  the	  heterotypic	  state	  (AZ)	  (Luk	  et	  al.,	  2010,	  Weber	  et	  al.,	  2010b,	  Nekrasov	  et	  al.,	  2012)The	  relative	  distribution	  of	  these	  nucleosome	  configurations	  was	  calculated	  as	  35%	  and	  65%,	  respectively	  (Luk	  et	  al.,	  2010).	  Based	  on	  the	  crystal	  structure	  of	  H2A.Z,	  it	  is	  possible	  that	  ZZ	  nucleosomes	  have	  increased	  stability,	  because	  of	  more	  extensive	  interactions	  in	  the	  L1	  region,	  and	  may	  also	  have	  a	  reduced	  interface	  with	  H3,	  due	  to	  the	  loss	  of	  interactions	  in	  this	  area	  (Bonisch	  and	  Hake,	  2012).	  	  Thus,	  determining	  the	  features	  of	  H2A.Z	  that	  distinguish	  it	  from	  core	  H2A	  is	  essential	  to	  understanding	  its	  functional	  specialisation,	  and	  may	  provide	  new	  insights	  into	  the	  essential	  role	  of	  this	  variant	  in	  transcriptional	  regulation.	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1.2.2 Genome localisation of H2A.Z In	  addition	  to	  its	  biophysical	  properties,	  the	  localisation	  of	  H2A.Z	  in	  the	  genome	  is	  another	  important	  factor	  in	  transcriptional	  regulation.	  A	  number	  of	  yeast	  studies	  showed	  that	  H2A.Z	  is	  distributed	  mostly	  at	  RNA	  polymerase	  II	  promoters,	  both	  active	  and	  inactive,	  at	  one	  nucleosome	  upstream	  (nucleosome	  −1)	  and	  one	  downstream	  (nucleosome	  +1)	  of	  the	  transcriptional	  start	  site	  (TSS)	  (Zhang	  et	  al.,	  2005,	  Guillemette	  et	  al.,	  2005,	  Raisner	  et	  al.,	  2005,	  Albert	  et	  al.,	  2007).	  For	  example,	  one	  study	  estimated	  that	  ~75%	  of	  all	  H2A.Z	  loci	  are	  within	  the	  promoter	  regions	  of	  annotated	  genes	  (Guillemette	  et	  al.,	  2005),	  while	  another	  study	  reported	  increased	  prevalence	  of	  H2A.Z	  in	  TATA-­‐less	  promoters	  (Zhang	  et	  al.,	  2005).	  However,	  not	  all	  promoters	  are	  decorated	  with	  H2A.Z;	  a	  significant	  portion	  (~37%)	  do	  not	  contain	  H2A.Z	  loci	  (Guillemette	  et	  al.,	  2005).	  NFRs	  are	  an	  ~150	  bp	  regions	  devoid	  of	  stable	  nucleosomes	  and	  are	  located	  within	  transcriptional	  regulatory	  regions,	  in	  particular	  the	  5’	  and	  3’	  ends	  of	  genes	  associated	  with	  transcriptional	  initiation	  and	  termination,	  respectively.	  The	  TSS	  is	  located	  within	  a	  NFR	  (Yuan	  et	  al.,	  2005).	  H2A.Z	  chromatin	  immunoprecipitation	  (ChIP)–microarray	  analysis	  showed	  that	  H2A.Z,	  as	  noted	  above,	  is	  specifically	  found	  in	  the	  nucleosomes	  that	  flank	  one	  or	  both	  sides	  of	  an	  NFR	  (the	  -­‐1	  and	  +1	  nucleosome,	  respectively)	  (Raisner	  et	  al.,	  2005).	  	  As	  mentioned	  in	  section	  1.2.1,	  H2A.Z-­‐containing	  nucleosomes	  can	  exist	  as	  either	  the	  AZ	  or	  ZZ	  form,	  as	  detected	  by	  in	  vitro	  nucleosome	  reconstitution	  (Suto	  et	  al.,	  2000,	  Chakravarthy	  et	  al.,	  2004).	  It	  was	  observed	  that	  both	  heterotypic	  and	  homotypic	  H2A.Z	  nucleosomes	  are	  similarly	  enriched	  at	  gene	  promoters	  in	  yeast	  (Luk	  et	  al.,	  2010).	  In	  contrast,	  only	  homotypic	  H2A.Z	  nucleosomes	  are	  present	  in	  active	  promoters	  in	  Drosophila	  (Weber	  et	  al.,	  2010b).	  Whether	  H2A.Z-­‐containing	  nucleosomes	  are	  homotypic	  or	  heterotypic	  also	  depends	  upon	  the	  stage	  of	  the	  cell	  cycle	  (Nekrasov	  et	  al.,	  2012).	  Finally,	  H2A.Z	  preferentially	  associated	  with	  inducible	  genes	  under	  repressed	  or	  basal	  expression	  conditions	  (Guillemette	  et	  al.,	  2005,	  Li	  et	  al.,	  2005).	  Deletion	  of	  the	  yeast	  H2A.Z	  gene	  led	  to	  reduced	  transcription	  of	  inducible	  genes	  under	  inducing	  conditions	  instead	  of	  derepression,	  suggesting	  that	  H2A.Z	  may	  help	  in	  the	  activation	  process	  by	  poising	  the	  chromatin	  structure.	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In	  mammalian	  cells,	  H2A.Z	  enrichment	  has	  also	  been	  observed	  around	  gene	  promoters	  (Barski	  et	  al.,	  2007,	  John	  et	  al.,	  2008).	  However,	  H2A.Z	  deposition	  is	  not	  restricted	  to	  the	  nucleosomes	  flanking	  the	  NFR;	  instead,	  it	  is	  preferentially	  located	  in	  gene	  regulatory	  regions	  such	  as	  promoters,	  insulators	  and	  enhancers.	  This	  suggests	  a	  role	  in	  the	  regulation	  of	  gene	  expression	  (Bruce	  et	  al.,	  2005,	  Barski	  et	  al.,	  2007).	  Promoter	  enrichment	  of	  H2A.Z	  was	  correlated	  with	  gene	  activity	  in	  human	  T	  cells	  (Barski	  et	  al.,	  2007).	  Similarly,	  in	  U2OS	  osteosarcoma	  cells,	  H2A.Z	  was	  enriched	  in	  the	  promoter	  of	  the	  p53-­‐regulated	  p21	  gene	  and	  was	  targeted	  to	  p53	  binding	  sites	  (Gevry	  et	  al.,	  2007).	  Whether	  H2A.Z	  represses	  or	  facilitates	  transcription	  depends	  on	  the	  positioning	  of	  the	  H2A.Z	  nucleosome	  relative	  to	  transcriptional	  factor	  binding	  sites.	  	  Numerous	  studies	  document	  the	  enrichment	  of	  H2A.Z	  and	  H3.3	  histones	  at	  both	  active	  and	  poised	  enhancer	  and	  promoter	  regions	  of	  multiple	  cell	  types,	  including	  embryonic	  stem	  cells	  (ESCs)	  (Creyghton	  et	  al.,	  2010,	  Hu	  et	  al.,	  2013,	  Jin	  and	  Felsenfeld,	  2007,	  John	  et	  al.,	  2008,	  Ku	  et	  al.,	  2012).	  During	  mouse	  ESC	  differentiation	  to	  endoderm/hepatic	  progenitor	  cells,	  a	  subset	  of	  H2A.Z-­‐occupied	  regions	  is	  targeted	  for	  nucleosomal	  depletion	  (Li	  et	  al.,	  2012).	  Knockdown	  of	  H2A.Z	  in	  mouse	  ESCs	  leads	  to	  increased	  nucleosomal	  occupancy,	  concomitant	  decrease	  in	  the	  Oct4	  binding,	  and	  diminished	  association	  of	  the	  MLL	  and	  PRC2	  methyltransferase	  complexes	  with	  active	  and	  poised	  enhancers	  and	  promoters	  (Hu	  et	  al.,	  2013).	  H2A.Z	  knockdown	  in	  ESCs	  also	  resulted	  in	  misregulation	  of	  both	  pluripotency	  and	  developmental	  genes,	  thereby	  impairing	  self-­‐renewal	  and	  differentiation	  (Creyghton	  et	  al.,	  2008,	  Hu	  et	  al.,	  2013).	  	  What	  determines	  the	  deposition	  of	  H2A.Z	  at	  these	  sites?	  As	  mentioned	  in	  section	  1.1.1,	  histone	  chaperones	  and	  chromatin	  remodelers	  are	  important	  modulators	  of	  chromatin	  organisation.	  Various	  chaperones	  have	  been	  shown	  to	  interact	  with	  H2A.Z-­‐H2B	  dimers	  in	  vivo	  (Mahapatra	  et	  al.,	  2011,	  Luk	  et	  al.,	  2007,	  Mizuguchi	  et	  al.,	  2004).	  Nucleosome	  assembly	  protein	  (Nap1)	  interacts	  with	  the	  variant	  H2A.Z-­‐H2B	  dimer,	  in	  addition	  to	  binding	  canonical	  H2A-­‐H2B	  histones	  (Mizuguchi	  et	  al.,	  2004).	  Nap1	  imports	  the	  variant	  histone	  dimer	  into	  the	  nucleus	  (Straube	  et	  al.,	  2010)	  and	  escorts	  it	  to	  the	  SWR1-­‐related	  complexes	  responsible	  for	  its	  incorporation	  into	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chromatin	  (Mizuguchi	  et	  al.,	  2004).	  Furthermore,	  Chz1,	  a	  H2A.Z-­‐H2B-­‐specific	  chaperone,	  is	  important	  in	  transcriptional	  control	  of	  telomere-­‐proximal	  genes	  (Wan	  et	  al.,	  2010).	  	  Three	  different	  mechanisms	  of	  H2A.Z	  deposition	  have	  been	  proposed	  in	  various	  organisms:	  H2A.Z	  deposition	  is	  provided	  by	  the	  NFR	  nucleotide	  sequence	  itself	  in	  yeast;	  H2A.Z	  can	  be	  incorporated	  randomly	  and	  removed	  from	  specific	  targets	  in	  certain	  conditions	  (Hardy	  and	  Robert,	  2010);	  and	  differential	  stabilities	  between	  homotypic	  H2A.Z	  nucleosomes	  and	  heterotypic	  ones	  can	  explain	  H2A.Z	  localisation	  in	  Drosophila	  (Weber	  et	  al.,	  2010b).	  In	  the	  first	  mechanism,	  the	  SWR-­‐1	  chromatin	  remodelling	  complex	  specifically	  removes	  H2A-­‐H2B	  dimers	  from	  the	  nucleosome	  and	  replaces	  them	  with	  H2A.Z-­‐H2B	  dimers	  (Kobor	  et	  al.,	  2004,	  Krogan	  et	  al.,	  2003,	  Luk	  et	  al.,	  2010,	  Mizuguchi	  et	  al.,	  2004).	  Raisner	  and	  colleagues	  demonstrated	  that	  the	  insertion	  of	  a	  DNA	  sequence	  containing	  common	  yeast	  promoter	  elements	  into	  an	  inactive	  gene	  is	  sufficient	  to	  induce	  a	  typical	  feature	  of	  S.	  cerevisiae	  promoters:	  an	  NFR	  flanked	  by	  two	  H2A.Z-­‐containing	  nucleosomes	  (Raisner	  et	  al.,	  2005).	  Moreover,	  H2A.Z-­‐specific	  deposition	  vehicle	  SWR1	  may	  be	  partly	  targeted	  to	  promoter	  regions	  by	  acetylated	  histone	  tails	  (Zhang	  et	  al.,	  2005,	  Raisner	  et	  al.,	  2005).	  In	  mammals,	  the	  p400/NuA4/TIP60	  (E1A	  binding	  protein	  p400/nucleosomal	  acetyltransferase	  of	  H4/Tat-­‐interactive	  protein	  60	  kDa)	  complex,	  and	  the	  p400	  and	  SRCAP	  (SNF2-­‐related	  CBP	  activator	  protein)	  complex	  are	  homologous	  to	  the	  SWR1	  complex	  (Billon	  and	  Cote,	  2013).	  Both	  complexes	  can	  catalyse	  the	  exchange	  of	  nucleosomal	  H2A-­‐H2B	  for	  free	  H2A.Z-­‐H2B,	  but	  they	  may	  be	  involved	  in	  different	  types	  of	  H2A.Z	  exchange,	  depending	  on	  cellular	  stimuli	  and	  chromatin	  context.	  	  In	  support	  of	  the	  second	  mechanism,	  the	  INO80	  remodelling	  complex	  actively	  exchanged	  nucleosomal	  H2A.Z-­‐H2B	  for	  free	  H2A-­‐H2B	  (Papamichos-­‐Chronakis	  et	  al.,	  2011).	  Furthermore,	  this	  study	  showed	  that	  H2A.Z	  was	  evicted	  by	  INO80	  in	  vivo	  after	  transcriptional	  induction,	  and	  loss	  of	  INO80	  led	  to	  mislocalisation	  of	  unacetylated	  H2A.Z,	  concomitant	  with	  genome	  instability.	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The	  third	  mechanism	  was	  proposed	  by	  Weber	  and	  colleagues	  (Weber	  et	  al.,	  2010b),	  after	  they	  showed	  that	  only	  homotypic	  H2A.Z	  nucleosomes	  are	  enriched	  in	  
Drosophila	  genes.	  In	  their	  model,	  RNA	  polymerase	  II	  transit	  leads	  to	  the	  loss	  of	  a	  H2A-­‐H2B	  dimer	  from	  the	  nucleosome	  during	  transcription,	  which	  can	  be	  replaced	  by	  either	  H2A-­‐H2B	  or	  H2A.Z-­‐H2B.	  Based	  on	  the	  assumption	  that	  homotypic	  H2A.Z	  nucleosomes	  are	  more	  stable	  than	  heterotypic	  or	  canonical	  ones,	  as	  discussed	  in	  section	  1.2.1,	  homotypic	  H2A.Z	  nucleosomes	  are	  disrupted	  less	  often	  than	  heterotypic	  or	  canonical	  ones,	  and	  hence	  become	  enriched	  after	  several	  round	  of	  transcription.	  Supporting	  this	  model,	  the	  Tremethick	  laboratory	  observed	  a	  H2A.Z-­‐containing	  nucleosome	  occupying	  the	  TSS	  of	  genes	  active	  in	  the	  G1	  phase	  of	  the	  cell	  cycle	  in	  trophoblast	  stem	  cells.	  Notably,	  this	  H2A.Z-­‐containing	  nucleosome	  was	  different	  from	  other	  promoter-­‐specific	  H2A.Z	  nucleosomes	  by	  being	  heterotypic	  rather	  than	  homotypic	  (Nekrasov	  et	  al.,	  2012).	  	  
1.2.3 Activation or repression? The	  biophysical	  properties	  and	  localisation	  of	  H2A.Z	  have	  been	  discussed	  in	  relation	  to	  transcriptional	  regulation.	  However,	  the	  effect	  of	  H2A.Z	  on	  transcription	  remains	  contradictory.	  In	  the	  protozoan	  Tetrahymena,	  H2A.Z	  (formerly	  called	  hv1)	  was	  only	  present	  in	  the	  transcriptionally	  active	  macronucleus,	  but	  not	  in	  the	  inactive	  micronucleus	  (Allis	  et	  al.,	  1986).	  Since	  then,	  conflicting	  results	  have	  been	  observed	  in	  different	  organisms,	  suggesting	  a	  positive	  or	  a	  negative	  role	  in	  transcription.	  In	  yeast,	  H2A.Z	  enrichment	  is	  inversely	  correlated	  with	  transcription	  (Millar	  et	  al.,	  2006,	  Zhang	  et	  al.,	  2005,	  Guillemette	  et	  al.,	  2005,	  Li	  et	  al.,	  2005),	  while	  most	  studies	  in	  animals	  report	  that	  H2A.Z	  is	  positively	  correlated	  with	  transcription	  (Hardy	  et	  al.,	  2009,	  Whittle	  et	  al.,	  2008,	  Jin	  and	  Felsenfeld,	  2007).	  Human	  cells	  generally	  show	  a	  positive	  correlation	  between	  the	  levels	  of	  H2A.Z	  and	  RNA	  polymerase	  II	  at	  promoters	  (Hardy	  et	  al.,	  2009),	  suggesting	  that	  H2A.Z	  changes	  the	  local	  chromatin	  structure	  at	  poised	  promoters,	  leading	  to	  the	  recruitment	  of	  transcriptional	  activators	  and	  the	  stimulation	  of	  transcription	  (Adam	  et	  al.,	  2001,	  Gligoris	  et	  al.,	  2007,	  Lemieux	  et	  al.,	  2008).	  However,	  at	  higher	  levels	  of	  transcription,	  H2A.Z	  is	  lost	  and	  negatively	  correlated	  with	  transcription	  like	  yeast	  (Soboleva	  et	  al.,	  2014).	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Similar	  to	  other	  histones,	  H2A.Z	  can	  be	  post-­‐translationally	  modified,	  including	  multiple	  amino-­‐terminal	  acetylation	  (Bruce	  et	  al.,	  2005,	  Millar	  et	  al.,	  2006,	  Ren	  and	  Gorovsky,	  2001).	  In	  yeast,	  H2A.Z	  acetylation	  is	  required	  for	  the	  induction	  of	  gene	  transcription	  (Halley	  et	  al.,	  2010).	  The	  hyperacetylated	  form	  of	  H2A.Z	  (K4,	  K7	  and	  K11)	  was	  also	  enriched	  at	  the	  TSS	  of	  active	  genes	  in	  chicken	  erythroblast	  cells	  (Bruce	  et	  al.,	  2005).	  In	  addition,	  a	  study	  using	  human	  cancer	  cells	  found	  that	  increased	  H2A.Z	  acetylation	  at	  TSSs	  coincided	  with	  an	  overall	  decrease	  of	  H2A.Z	  levels,	  in	  concert	  with	  oncogene	  activation	  (Valdes-­‐Mora	  et	  al.,	  2012).	  Therefore,	  in	  addition	  to	  the	  specific	  positioning	  of	  H2A.Z-­‐containing	  nucleosomes,	  its	  modification	  status	  might	  also	  reconcile	  whether	  it	  has	  an	  activating	  or	  repressing	  role.	  	  However,	  some	  studies	  suggest	  a	  more	  complex	  relationship.	  In	  ESCs,	  genes	  with	  H2A.Z	  enrichment	  are	  overrepresented	  for	  silent	  developmental	  genes	  that	  are	  required	  in	  later	  cell	  types	  during	  ESC	  differentiation	  (Creyghton	  et	  al.,	  2008).	  Another	  study	  reported	  that	  H2A.Z	  is	  present	  at	  silent	  retinoic	  acid	  response	  genes	  in	  mouse	  ESCs,	  and	  that	  it	  is	  removed	  upon	  the	  transcriptional	  activation	  of	  these	  genes	  by	  retinoic	  acid	  (Amat	  and	  Gudas,	  2011).	  Promoter	  H2A.Z	  enrichment	  and	  transcription	  displayed	  a	  roughly	  parabolic	  relationship	  in	  the	  plant	  Arabidopsis	  
thaliana,	  with	  H2A.Z	  at	  its	  highest	  levels	  in	  moderately	  transcribed	  genes	  (Zilberman	  et	  al.,	  2008).	  It	  was	  proposed	  that	  H2A.Z	  incorporation	  at	  the	  +1	  nucleosome	  regulates	  productive	  elongation	  by	  facilitating	  H2A.Z-­‐H2B	  dimer	  loss	  without	  depletion	  of	  (H3-­‐H4)2	  tetramers.	  H2A.Z	  incorporation	  at	  the	  +1	  nucleosome	  regulates	  transcriptional	  output	  by	  modulating	  RNA	  polymerase	  II	  kinetics	  and	  transcriptional	  elongation	  (Figure	  1.3)	  (Subramanian	  et	  al.,	  2015).	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Figure 1.3 Model demonstrating how H2A.Z nucleosome composition at 
promoters affects nucleosome stability and transcriptional state.  (A)	  The	  transition	  from	  homotypic	  to	  heterotypic	  H2A.Z	  nucleosomes	  can	  regulate	  gene	  activation	  through	  the	  regulation	  of	  transcriptional	  elongation.	  (B)	  H2A.Z	  nucleosomes	  decrease	  the	  stability	  of	  the	  +1	  nucleosome	  and	  thereby	  promote	  RNA	  polymerase	  II	  (RNAPII)	  progression.	  Figure	  adapted	  from	  Subramanian	  et	  al.	  (2015).	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Most	  research	  on	  H2A.Z	  has	  focused	  on	  the	  H2A.Z	  5ʹ′	  peak	  at	  the	  TSS	  of	  genes,	  but	  a	  recent	  re-­‐examination	  of	  the	  available	  genome-­‐wide	  mapping	  data	  from	  animals	  and	  fungi	  showed	  a	  substantial	  presence	  of	  H2A.Z	  within	  gene	  bodies	  (Fujimoto	  et	  al.,	  2012).	  Tolstorukov	  and	  colleagues	  suggested	  that	  as	  much	  as	  40%	  of	  all	  H2A.Z-­‐containing	  nucleosomes	  may	  reside	  downstream	  of	  the	  promoter	  in	  human	  genes	  (Tolstorukov	  et	  al.,	  2009).	  In	  A.	  thaliana,	  in	  addition	  to	  H2A.Z	  enrichment	  at	  the	  TSS,	  many	  genes	  exhibited	  considerable	  H2A.Z	  across	  their	  coding	  regions.	  Interestingly,	  the	  lowest	  expressed	  genes	  had	  the	  greatest	  gene	  body	  enrichment	  of	  H2A.Z	  (Coleman-­‐Derr	  and	  Zilberman,	  2012,	  Zilberman	  et	  al.,	  2008).	  Several	  animal	  studies	  have	  also	  noted	  that,	  unlike	  promoter	  enrichment	  of	  H2A.Z,	  the	  presence	  of	  H2A.Z	  within	  gene	  bodies	  is	  negatively	  correlated	  with	  transcription	  (Barski	  et	  al.,	  2007,	  Hardy	  and	  Robert,	  2010,	  Zemach	  et	  al.,	  2010).	  	  
1.2.4 H2A.Z functions beyond the regulation of gene 
expression As	  mentioned	  previously,	  H2A.Z	  protein	  is	  only	  ~60%	  identical	  to	  canonical	  H2A	  within	  the	  same	  species,	  but	  is	  more	  highly	  conserved	  between	  different	  species	  (~80%	  identity	  between	  most	  organisms)	  (Zlatanova	  and	  Thakar,	  2008).	  This	  suggests	  that	  H2A.Z	  has	  specific	  and	  unique	  functions	  that	  cannot	  be	  carried	  out	  by	  other	  H2A	  variants.	  Besides	  gene	  transcription,	  H2A.Z	  has	  been	  implicated	  in	  diverse	  biological	  processes,	  such	  as	  chromosome	  segregation	  and	  stability,	  heterochromatin	  silencing,	  progression	  through	  the	  cell	  cycle,	  DNA	  repair,	  cancer	  progression	  and	  ESC	  lineage	  commitment.	  	  H2A.Z	  is	  essential	  for	  development	  and	  viability	  in	  many	  organisms.	  In	  Drosophila,	  the	  lethality	  of	  the	  H2A.Z	  (called	  H2Av)	  null	  can	  be	  rescued	  with	  the	  injection	  of	  H2A.Z	  in	  early	  larval	  stages	  (Clarkson	  et	  al.,	  1999).	  In	  Tetrahymena,	  the	  HTA3	  gene,	  which	  encodes	  H2A.Z	  and	  is	  a	  H2A.F/Z	  type	  variant,	  cannot	  be	  inactivated	  by	  gene	  disruption,	  indicating	  that	  H2A.F/Z	  type	  variants	  are	  essential	  for	  survival	  (Liu	  et	  al.,	  1996).	  In	  S.	  cerevisiae,	  disruption	  of	  the	  H2A.Z	  gene	  HTZ1	  resulted	  in	  slow	  growth	  and	  formamide	  sensitivity	  (Jackson	  and	  Gorovsky,	  2000).	  Deletion	  of	  H2A.Z	  in	  X.	  laevis	  perturbed	  gastrulation,	  leading	  to	  embryos	  with	  malformed,	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short	  trunks;	  overexpression	  slowed	  down	  development	  after	  gastrulation	  (Ridgway	  et	  al.,	  2004).	  No	  homozygous	  H2A.Z	  knockout	  mice	  could	  be	  obtained;	  the	  mutant	  embryos	  failed	  at	  the	  stage	  of	  rapid	  proliferation	  and	  differentiation	  (Faast	  et	  al.,	  2001).	  	  H2A.Z	  is	  involved	  in	  chromosome	  segregation	  and	  integrity	  in	  mammals	  (Rangasamy	  et	  al.,	  2004),	  budding	  yeast	  (Guillemette	  and	  Gaudreau,	  2006,	  Krogan	  et	  al.,	  2004)	  and	  fission	  yeast	  (Ahmed	  et	  al.,	  2007,	  Carr	  et	  al.,	  1994).	  S.	  cerevisiae	  H2A.Z	  mutants	  have	  increased	  rates	  of	  chromosomal	  loss	  (Venkatasubrahmanyam	  et	  al.,	  2007).	  H2A.Z	  is	  also	  involved	  in	  the	  integrity	  of	  centromeres	  (Greaves	  et	  al.,	  2007,	  Carr	  et	  al.,	  1994)	  and	  telomeres	  (Martins-­‐Taylor	  et	  al.,	  2011,	  Shia	  et	  al.,	  2006).	  In	  fission	  yeast,	  Msc1,	  a	  regulatory	  subunit	  of	  Swr1C,	  can	  prevent	  H2A.Z	  occupancy	  in	  the	  inner	  centromere	  and	  subtelomeric	  regions	  (Qiu	  et	  al.,	  2010,	  Buchanan	  et	  al.,	  2009).	  	  Research	  from	  the	  Tremethick	  laboratory	  demonstrated	  that	  this	  variant	  plays	  a	  critical	  role	  in	  heterochromatin	  formation	  during	  embryonic	  development.	  At	  the	  blastocyst	  stage	  of	  development,	  H2A.Z	  is	  not	  expressed	  in	  the	  cells	  of	  the	  inner	  cell	  mass.	  As	  cells	  located	  at	  the	  outer	  edge	  of	  the	  inner	  cell	  mass	  differentiate,	  H2A.Z	  accumulates	  at	  sites	  of	  pericentric	  heterochromatin	  and	  at	  other	  nuclear	  sites.	  While	  H2A.Z	  was	  enriched	  in	  constitutive	  pericentric	  heterochromatin,	  the	  inactive	  X	  chromosome,	  another	  genomic	  region	  of	  constitutive	  heterochromatin,	  was	  depleted	  of	  H2A.Z	  (Rangasamy	  et	  al.,	  2003).	  Cells	  lacking	  H2A.Z	  exhibited	  poor	  HP1α	  (which	  is	  required	  for	  heterochromatin	  formation	  and	  maintenance)	  binding	  to	  heterochromatin	  and	  defects	  in	  chromosome	  segregation	  (Rangasamy	  et	  al.,	  2004).	  In	  fact,	  the	  incorporation	  of	  H2A.Z	  can	  itself	  promote	  the	  folding	  of	  chromatin	  and	  HP1α-­‐mediated	  chromatin	  folding,	  to	  form	  a	  more	  compact	  structure	  (Fan	  et	  al.,	  2004,	  Fan	  et	  al.,	  2002).	  	  The	  role	  of	  histone	  H2A.Z	  in	  cell	  cycle	  progression	  was	  explored	  in	  yeast	  (Dhillon	  et	  al.,	  2006).	  H2A.Z	  mutants	  had	  defects	  in	  progression	  through	  S	  phase	  and	  were	  delayed	  in	  the	  initiation	  of	  DNA	  replication.	  H2A.Z	  was	  also	  required	  for	  the	  efficient	  and	  timely	  transcriptional	  induction	  of	  cell	  cycle	  regulatory	  proteins	  
Chapter	  1	  General	  Introduction	  
	  25	  
(Dhillon	  et	  al.,	  2006).	  Another	  yeast	  study	  showed	  a	  physical	  interaction	  between	  H2A.Z	  and	  the	  replication	  protein	  ORC1,	  and	  genetic	  interactions	  with	  other	  replication	  factors	  including	  ORC5	  and	  PCNA,	  supporting	  a	  role	  in	  DNA	  replication	  (Muller	  et	  al.,	  2010).	  In	  A.	  thaliana,	  H2A.Z	  colocalised	  with	  replication	  origins	  (Costas	  et	  al.,	  2011),	  and	  a	  H2A.Z	  mutant	  was	  sensitive	  to	  DNA	  damaging	  agents	  during	  DNA	  replication	  (Mizuguchi	  et	  al.,	  2004,	  Kobor	  et	  al.,	  2004).	  	  The	  involvement	  of	  H2A.Z	  in	  double-­‐strand	  break	  (DSB)	  repair	  was	  studied	  in	  yeast,	  showing	  that	  loss	  of	  H2A.Z	  leads	  to	  increased	  sensitivity	  to	  DNA	  damaging	  agents	  (Papamichos-­‐Chronakis	  et	  al.,	  2011,	  Morillo-­‐Huesca	  et	  al.,	  2010)	  and	  defective	  repair	  of	  DSBs	  (Kalocsay	  et	  al.,	  2009).	  In	  mammalian	  cells,	  the	  NuA4	  complex	  promotes	  not	  only	  H4	  acetylation	  by	  the	  Tip60	  subunit,	  but	  also	  the	  rapid	  exchange	  of	  H2A	  for	  H2A.Z	  at	  DSBs.	  Cells	  lacking	  H2A.Z	  or	  components	  of	  NuA4	  were	  hypersensitive	  to	  ionising	  radiation,	  and	  had	  defects	  in	  both	  non-­‐homologous	  end	  joining	  and	  homologous	  recombination	  repair	  (Xu	  et	  al.,	  2012,	  Xu	  et	  al.,	  2010,	  Murr	  et	  al.,	  2006,	  Downs	  et	  al.,	  2004,	  Ikura	  et	  al.,	  2000).	  In	  addition,	  cells	  underwent	  unrestricted	  end	  resection	  when	  H2A.Z	  exchange	  at	  DSBs	  was	  inhibited,	  leading	  to	  the	  accumulation	  of	  excessive	  single-­‐stranded	  DNA	  and	  the	  loss	  of	  Ku70/80	  binding	  (Xu	  et	  al.,	  2012).	  In	  contrast	  to	  these	  findings,	  a	  recent	  study	  showed	  that	  while	  H2A.Z	  was	  crucial	  for	  cell	  proliferation,	  viability	  and	  cell	  cycle	  regulation,	  no	  incorporation	  was	  seen	  at	  DSBs,	  as	  tested	  by	  immunofluorescence	  and	  chromatin	  immunoprecipitation	  (Taty-­‐Taty	  et	  al.,	  2014).	  	  	  Work	  in	  Arabidopsis	  has	  demonstrated	  the	  mutual	  antagonism	  between	  DNA	  methylation	  and	  H2A.Z	  occupancy,	  with	  this	  pattern	  also	  observed	  in	  normal	  mammalian	  cells	  and	  during	  tumorigenesis	  (Conerly	  et	  al.,	  2010,	  Zilberman	  et	  al.,	  2008).	  Indeed,	  there	  was	  significant	  overexpression	  of	  H2A.Z	  in	  several	  types	  of	  human	  malignancies,	  especially	  at	  the	  metastatic	  stage	  (Zucchi	  et	  al.,	  2004,	  Rhodes	  et	  al.,	  2004,	  Dunican	  et	  al.,	  2002).	  Genome-­‐wide	  analysis	  of	  transcription	  factors,	  ER-­‐α	  and	  Myc	  binding	  sites,	  combined	  with	  estrogen-­‐stimulated	  gene	  expression	  arrays,	  identified	  overexpression	  of	  H2A.Z	  protein	  in	  primary	  breast	  tumour	  samples	  collected	  from	  over	  500	  patients.	  The	  elevated	  H2A.Z	  expression	  was	  significantly	  associated	  with	  cancer	  spread	  to	  lymph	  nodes,	  metastasis	  and	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decreased	  patient	  survival	  (Hua	  et	  al.,	  2008).	  H2A.Z	  expression	  was	  significantly	  depleted	  in	  chromosomal	  instability	  types	  of	  colorectal	  cancer	  (Dunican	  et	  al.,	  2002).	  H2A.Z.2,	  an	  isoform	  of	  H2A.Z,	  was	  highly	  expressed	  in	  metastatic	  melanoma;	  correlateds	  with	  decreased	  patient	  survival	  and	  is	  a	  mediator	  of	  cell	  proliferation	  and	  drug	  sensitivity	  (Vardabasso	  et	  al.,	  2015).	  In	  ESCs,	  H2A.Z	  localised	  exclusively	  at	  polycomb	  complex	  target	  genes,	  and	  mediated	  the	  targeting	  of	  PRC2	  and	  repression	  of	  the	  target	  genes,	  but	  was	  not	  required	  for	  ESC	  self-­‐renewal	  (Creyghton	  et	  al.,	  2008).	  Another	  study	  reported	  the	  differential	  roles	  of	  H2A.Z	  at	  active	  and	  repressed	  genes	  in	  the	  self-­‐renewal	  and	  differentiation	  of	  ESCs	  (Hu	  et	  al.,	  2013).	  	  In	  summary,	  the	  importance	  of	  H2A.Z	  in	  transcriptional	  regulation	  has	  been	  well	  established.	  However,	  its	  mechanism	  of	  action	  is	  not	  entirely	  understood.	  Investigation	  of	  chromatin	  structural	  alterations	  and	  the	  histone	  domains	  involved	  has	  revealed	  the	  functional	  significance	  of	  H2A.Z	  in	  modulating	  gene	  expression,	  and	  the	  importance	  of	  its	  acidic	  patch,	  L1	  loop	  and	  carboxyl-­‐terminal	  tail	  domains.	  Moreover,	  the	  genomic	  localisation	  and	  the	  modification	  status	  of	  H2A.Z	  further	  explain	  its	  contrasting	  effects	  on	  transcription.	  Although	  a	  lot	  of	  progress	  has	  been	  made	  in	  the	  past	  decade,	  we	  are	  still	  far	  from	  understanding	  all	  the	  H2A.Z	  functions	  in	  the	  genome,	  especially	  on	  transposable	  elements,	  which	  occupy	  nearly	  half	  of	  the	  human	  genome.	  It	  will	  be	  of	  particular	  interest	  to	  analyse	  H2A.Z	  functions	  in	  those	  regions,	  given	  that	  H2A.Z	  is	  present	  at	  constitutive	  heterochromatin,	  which	  is	  also	  comprised	  of	  DNA	  repeats.	  	  
1.3	  Transposable	  element	  control	  in	  host	  genomes	  
1.3.1 Transposable element classification Most	  of	  the	  studies	  investigating	  the	  roles	  of	  histones	  in	  regulating	  transcription	  are	  focused	  on	  protein-­‐coding	  genes,	  which	  only	  comprise	  1.5%	  of	  the	  human	  genome.	  However,	  the	  transcriptional	  regulation	  of	  other	  genetic	  elements,	  such	  as	  transposable	  elements	  (TEs),	  has	  received	  surprisingly	  little	  attention.	  	  
Chapter	  1	  General	  Introduction	  
	  27	  
TEs	  were	  first	  discovered	  by	  Barbara	  McClintock	  in	  maize;	  they	  were	  able	  to	  move	  from	  one	  chromosome	  locus	  to	  another	  and	  could	  change	  the	  expression	  pattern	  of	  nearby	  genes	  (Mc,	  1950).	  It	  is	  now	  clear	  that	  TEs	  are	  repeated	  and	  mobile	  DNA	  sequences,	  with	  the	  ability	  to	  invade	  genomes.	  Genome	  sequencing	  has	  revealed	  that	  TEs	  constitute	  a	  substantial	  fraction	  of	  most	  eukaryotic	  genomes,	  though	  the	  proportion	  of	  the	  genome	  varies	  depending	  on	  the	  species,	  and	  they	  have	  been	  active	  in	  mammalian	  genomes	  for	  hundreds	  of	  millions	  of	  years	  (de	  Koning	  et	  al.,	  2011,	  Schnable	  et	  al.,	  2009,	  Zuccolo	  et	  al.,	  2007,	  Biemont	  and	  Vieira,	  2006,	  Bennetzen,	  2005,	  Lonnig	  and	  Saedler,	  2002,	  Kidwell,	  2002,	  Lander	  et	  al.,	  2001).	  	  In	  contrast	  to	  tandem	  repeats,	  TEs	  have	  a	  defined	  structure:	  they	  have	  a	  specific	  size,	  are	  flanked	  by	  short	  or	  long	  tandem	  repeats,	  and	  often	  encode	  a	  unique	  set	  of	  proteins.	  Based	  on	  the	  type	  of	  nucleic	  acid	  intermediate	  that	  is	  used	  for	  transposition,	  TEs	  can	  be	  divided	  into	  RNA	  transposons	  (also	  called	  retrotransposons)	  and	  DNA	  transposons	  (Figure	  1.4).	  RNA	  transposons	  move	  in	  a	  “copy	  and	  paste”	  manner,	  involving	  reverse	  transcription	  of	  an	  RNA	  intermediate	  and	  insertion	  of	  the	  resulting	  cDNA	  copy	  at	  a	  new	  site	  in	  the	  genome.	  DNA	  transposons	  travel	  as	  a	  DNA	  molecule	  using	  a	  “cut	  and	  paste”	  mechanism,	  involving	  the	  excision	  and	  reinsertion	  of	  the	  DNA	  of	  the	  element,	  or	  by	  using	  a	  rolling	  circle	  process	  (Chenais	  et	  al.,	  2012).	  DNA	  transposons,	  which	  comprise	  about	  3%	  of	  the	  human	  genome,	  have	  no	  transposable	  activity	  in	  mammals	  (Lander	  et	  al.,	  2001).	  In	  this	  thesis,	  the	  retrotransposons	  will	  be	  reviewed,	  as	  they	  are	  still	  active	  in	  the	  human	  genome.	  	  Retrotransposons	  can	  be	  further	  subdivided	  into	  autonomous	  or	  non-­‐autonomous	  types.	  Autonomous	  retrotransposons	  express	  all	  of	  the	  proteins	  necessary	  for	  retrotransposition,	  while	  non-­‐autonomous	  retrotransposons	  express	  only	  part	  of	  this	  machinery	  or	  none	  at	  all	  and	  they	  depends	  on	  the	  enzymatic	  machinery	  expressed	  by	  other	  superfamily	  members.	  The	  two	  major	  types	  of	  autonomous	  retrotransposons	  are	  LTR	  (long	  terminal	  repeat)	  and	  non-­‐LTR	  retrotransposons,	  which	  are	  characterised	  by	  whether	  they	  have	  long	  terminal	  repeats	  at	  the	  5ʹ′	  and	  3ʹ′	  ends	  (Ostertag	  and	  Kazazian,	  2001).	  LTR	  retrotransposons	  include	  endogenous	  retroviruses	  (ERV),	  and	  some	  of	  them	  are	  transcriptionally	  active,	  such	  as	  ERV-­‐I,	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ERV-­‐II	  and	  ERV-­‐K	  in	  humans,	  and	  the	  intracisternal	  A-­‐particle	  (IAP)	  retrotransposon	  in	  mice.	  Within	  the	  non-­‐LTR	  retrotransposons,	  long	  interspersed	  nuclear	  elements	  (LINEs)	  remain	  active	  in	  the	  human	  and	  mouse	  genomes.	  There	  are	  approximately	  80–100	  and	  3000	  LINE-­‐1s	  in	  human	  and	  mouse,	  respectively,	  that	  are	  retrotransposition-­‐competent,	  while	  most	  LINE-­‐1	  insertions	  are	  inactive	  due	  to	  point	  mutations,	  rearrangements	  or	  truncations	  (Cordaux	  and	  Batzer,	  2009,	  Goodier	  et	  al.,	  2001).	  	  In	  addition	  to	  the	  autonomous	  retrotransposons,	  there	  is	  a	  large	  number	  of	  non-­‐autonomous	  retrotransposons	  in	  mammalian	  genomes,	  such	  as	  short	  interspersed	  nuclear	  elements	  (SINEs).	  These	  elements	  do	  not	  encode	  protein;	  consequently,	  they	  require	  activities	  encoded	  by	  other	  retrotransposons	  for	  their	  propagation.	  As	  many	  SINEs	  share	  3ʹ′-­‐end	  homology	  with	  a	  LINE	  family	  member	  from	  the	  same	  genome,	  a	  SINE	  sequence	  presumably	  binds	  to	  a	  homologous	  LINE-­‐encoded	  protein	  to	  foster	  retrotransposition	  (Ohshima	  and	  Okada,	  2005).	  	  A	  procedure	  for	  an	  automatic	  classification	  of	  DNA	  sequences	  was	  proposed	  that	  could	  also	  be	  applied	  to	  transposable	  element	  families,	  which	  include	  a	  large	  number	  of	  both	  full-­‐length	  and	  truncated	  copies.	  This	  method	  was	  tested	  on	  the	  mariner	  family	  of	  class	  II	  TEs.	  The	  classification	  obtained	  using	  both	  complete	  and	  incomplete	  DNA	  sequences	  not	  only	  matched	  the	  subfamilies	  already	  defined	  from	  phylogenetic	  analyses	  of	  the	  transposase	  protein	  sequences,	  but	  also	  allowed	  the	  identification	  of	  new	  subgroups	  (Rouault	  et	  al.,	  2009).	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Figure 1.4 Schematic overview of transposable element classification.  The	  classification	  is	  mainly	  based	  on	  the	  transcriptional	  mechanism	  used,	  which	  is	  briefly	  described	  below	  the	  element	  drawing.	  The	  presence	  and	  orientation	  of	  DNA	  repeats	  are	  indicated	  by	  arrows	  (DR,	  direct	  repeat;	  TIR,	  terminal	  inverted	  repeat).	  Grey	  arrows	  indicate	  a	  repeated	  sequence	  or	  palindrome	  within	  the	  DNA.	  In	  the	  SINE	  sequence,	  the	  A	  and	  B	  boxes	  represent	  the	  internal	  promoter	  stretch.	  ORF,	  open	  reading	  frame;	  RT,	  reverse	  transcription;	  TSD,	  target	  site	  duplication.	  Figure	  adapted	  from	  Chenais	  et	  al.	  (2012).	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1.3.2 Transposable element effects on the mammalian 
genome Although	  most	  TEs	  have	  no	  known	  function	  in	  gene	  regulation,	  some	  TE	  copies	  play	  a	  role	  in	  the	  regulation	  of	  gene	  expression	  through	  various	  processes.	  As	  a	  consequence,	  it	  has	  long	  been	  believed	  that	  TE	  insertions	  can	  have	  deleterious	  effects	  on	  host	  genomes	  by	  disrupting	  genes	  (Callinan	  and	  Batzer,	  2006,	  Mc,	  1951)	  and	  causing	  gene	  expression	  interference	  (Maksakova	  et	  al.,	  2006).	  However,	  recent	  data	  demonstrate	  that	  these	  elements	  can	  also	  contribute	  to	  gene	  imprinting	  in	  early	  development	  (Peaston	  et	  al.,	  2004).	  	  
1.3.2.1 TE insertion and gene expression TEs	  can	  provoke	  specific	  alterations	  of	  gene	  expression	  by	  being	  captured	  and	  incorporated	  directly	  into	  coding	  sequences.	  It	  is	  estimated	  that	  4%	  of	  human	  protein	  coding	  regions	  contained	  TE	  sequences	  (mostly	  LINE-­‐1	  and	  Alu)	  (Nekrutenko	  and	  Li,	  2001),	  while	  another	  study	  claimed	  0.1%	  (Gotea	  and	  Makalowski,	  2006).	  For	  example,	  the	  carboxyl-­‐terminal	  exon	  of	  the	  human	  leptin	  receptor	  isoform	  219.1	  is	  a	  new	  exon	  derived	  from	  a	  TE	  that	  has	  functional	  importance.	  A	  unique	  peptide	  sequence	  of	  67	  amino	  acids	  at	  the	  carboxyl	  terminus	  of	  this	  isoform	  was	  found	  to	  be	  homologous	  to	  the	  HERV-­‐K-­‐derived	  part	  of	  the	  SINE-­‐R/SVA	  family	  (Bennett	  et	  al.,	  1996,	  Cioffi	  et	  al.,	  1996,	  Damert	  et	  al.,	  2004).	  Excitingly,	  the	  single-­‐cell	  retrotransposon	  capture	  sequencing	  (RC-­‐seq)	  on	  individual	  human	  hippocampal	  neurons	  and	  glia	  demonstrated	  that	  LINE-­‐1	  insertions	  were	  preferentially	  located	  in	  protein-­‐coding	  genes	  highly	  transcribed	  in	  the	  hippocampus	  (Upton	  et	  al.,	  2015).	  	  Transposition	  events	  can	  also	  regulate	  gene	  expression	  through	  the	  introduction	  of	  functional	  regulatory	  elements	  such	  as	  promoters	  or	  enhancers	  (Bourque	  et	  al.,	  2008,	  Cohen	  et	  al.,	  2009,	  Teng	  et	  al.,	  2011,	  Wang	  et	  al.,	  2007).	  In	  mice	  and	  humans,	  18.1%	  and	  31.4%	  of	  total	  TSSs,	  respectively,	  are	  located	  within	  TE	  sequences	  and	  are	  often	  found	  to	  be	  tissue	  specific	  (Faulkner	  et	  al.,	  2009).	  In	  human	  ESCs,	  enhancers	  are	  significantly	  enriched	  in	  TE-­‐derived	  sequences,	  probably	  due	  to	  the	  generally	  relaxed	  epigenetic	  state	  and	  the	  increased	  activity	  of	  TEs	  in	  these	  cells	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(Teng	  et	  al.,	  2011).	  In	  addition,	  numerous	  transcription	  factor	  DNA	  binding	  motifs	  were	  enriched	  in	  various	  classes	  of	  repeats,	  such	  as	  L2,	  Alu	  and	  other	  SINEs	  (Laperriere	  et	  al.,	  2007,	  Polak	  and	  Domany,	  2006,	  Santangelo	  et	  al.,	  2007).	  For	  example,	  the	  transcription	  factor	  binding	  sites	  of	  mouse	  α-­‐fetoprotein	  are	  located	  within	  a	  300	  bp	  region	  lacking	  DNA	  methylation,	  due	  to	  the	  insertion	  of	  two	  TEs	  in	  which	  CpG	  sequences	  are	  underrepresented.	  The	  transcription	  factor	  Foxa1	  first	  binds	  to	  the	  unmethylated	  TE	  sequence,	  which	  allows	  secondary	  transcription	  factors	  such	  as	  p53	  and	  SMAD	  to	  have	  access	  to	  the	  promoter	  region,	  leading	  to	  α-­‐fetoprotein	  gene	  expression	  (Taube	  et	  al.,	  2010).	  	  Retrotransposons	  can	  also	  introduce	  genetic	  information	  that	  originates	  from	  sequences	  outside	  of	  the	  retrotransposon.	  This	  process,	  known	  as	  LINE-­‐1	  3ʹ′	  transduction,	  makes	  the	  transcriptional	  machinery	  bypass	  the	  LINE-­‐1	  polyadenylation	  signal	  and	  instead	  use	  a	  downstream	  polyadenylation	  signal,	  thus	  introducing	  an	  adjacent	  coding	  region.	  This	  event	  was	  found	  in	  ~25%	  of	  analysed	  cancer	  samples	  (Tubio	  et	  al.,	  2014).	  In	  addition,	  transposons	  can	  express	  outward-­‐reading	  antisense	  transcripts.	  The	  mouse	  IAP	  LTR	  retrotransposon	  produces	  an	  antisense	  transcript	  using	  an	  outward-­‐reading	  promoter	  from	  its	  5ʹ′	  LTR	  and	  reads	  into	  neighbouring	  genes,	  altering	  their	  regulation	  (Slotkin	  and	  Martienssen,	  2007).	  For	  example,	  a	  naturally	  occurring	  IAP	  insertion	  has	  generated	  the	  Avy	  allele	  at	  the	  mouse	  agouti	  locus,	  which	  confers	  a	  different	  coat	  colour	  from	  the	  wild-­‐type	  allele,	  as	  well	  as	  increased	  susceptibility	  to	  obesity,	  diabetes	  and	  tumours	  (Morgan	  et	  al.,	  1999).	  	  In	  addition	  to	  the	  effect	  of	  TEs	  on	  gene	  expression	  through	  direct	  insertional	  interference,	  some	  TE	  integration	  events	  can	  also	  alter	  gene	  expression	  through	  indirect	  mechanisms,	  such	  as	  regulation	  of	  microRNA	  (miRNA)	  expression.	  MicroRNAs	  function	  by	  pairing	  with	  mRNA,	  triggering	  assembly	  of	  the	  RNA-­‐induced	  silencing	  complex	  (RISC)	  that	  degrades	  the	  mRNA,	  resulting	  in	  reduced	  expression	  or	  gene	  silencing	  (Valencia-­‐Sanchez	  et	  al.,	  2006).	  Bioinformatic	  analysis	  showed	  that	  55	  experimentally	  validated	  human	  miRNA	  sequences	  were	  derived	  from	  TEs,	  and	  an	  additional	  85	  novel	  miRNAs	  were	  predicted	  to	  originate	  from	  TEs	  (Piriyapongsa	  et	  al.,	  2007).	  In	  humans,	  miRNAs	  can	  be	  expressed	  from	  an	  RNA	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polymerase	  III	  promoter	  found	  in	  Alu	  sequences	  (Borchert	  et	  al.,	  2006).	  In	  mammalian	  cells,	  two	  noncoding	  RNAs,	  mouse	  B2	  RNA	  and	  human	  Alu	  RNA,	  have	  been	  shown	  to	  repress	  general	  mRNA	  transcription	  by	  RNA	  polymerase	  II	  in	  response	  to	  heat	  shock	  (Yakovchuk	  et	  al.,	  2009).	  	  Since	  TE	  distribution	  in	  the	  human	  genome	  is	  far	  from	  being	  random	  (Lander	  et	  al.,	  2001,	  Medstrand	  et	  al.,	  2002),	  TE	  modification	  of	  gene	  expression	  may	  be	  responsible	  for	  genetic	  differences	  among	  species	  and	  may	  even	  drive	  evolutionary	  change.	  This	  is	  exemplified	  by	  the	  tissue-­‐specific	  expression	  of	  the	  
FMO1	  (flavin-­‐containing	  monooxygenase	  1)	  LINE-­‐1	  gene,	  which	  differs	  between	  humans	  and	  mice.	  LINE-­‐1	  sequence	  near	  one	  of	  the	  three	  alternative	  promoters	  in	  the	  human	  FMO1	  gene	  is	  responsible	  for	  the	  species-­‐dependent,	  tissue-­‐specific	  differences	  (Shephard	  et	  al.,	  2007).	  It	  is	  interesting	  that	  simultaneous	  bursts	  of	  Alu	  and	  processed	  pseudogene	  amplifications	  40	  to	  50	  million	  years	  ago	  are	  coincident	  with	  the	  radiation	  of	  higher	  primates,	  and	  are	  possibly	  linked	  with	  the	  activity	  of	  several	  LINE-­‐1	  subfamilies	  (Ohshima	  et	  al.,	  2003).	  Meanwhile,	  additional	  pseudogene	  peaks	  occurred	  38	  million	  years	  ago,	  a	  time	  when	  hominoid	  species	  started	  to	  appear	  (Devor	  and	  Moffat-­‐Wilson,	  2003).	  These	  findings	  suggest	  that	  evolutionary	  forces	  acting	  upon	  TE	  integration	  events	  have	  a	  profound	  effect	  on	  TE	  distribution	  profiles	  in	  the	  genome.	  	  
1.3.2.2 Transposition and disease The	  prevalence	  of	  TEs	  throughout	  the	  genome	  and	  the	  multitude	  of	  ways	  they	  can	  affect	  gene	  expression	  raise	  the	  possibility	  that	  TE	  transposition	  plays	  a	  role	  in	  disease.	  The	  first	  evidence	  for	  this	  arose	  from	  the	  discovery	  that	  de	  novo	  insertion	  of	  a	  TE	  causes	  haemophilia	  A	  (Kazazian	  et	  al.,	  1988).	  A	  growing	  body	  of	  evidence	  suggests	  that	  human	  diseases	  caused	  by	  TE	  insertion	  range	  from	  cancers	  (Konkel	  and	  Batzer,	  2010,	  Belancio	  et	  al.,	  2010,	  Lerat	  and	  Semon,	  2007),	  thalassemia	  (Semenza	  et	  al.,	  1984,	  Kioussis	  et	  al.,	  1983)	  and	  Hirschsprung’s	  disease	  (Grice	  et	  al.,	  2005,	  Emison	  et	  al.,	  2005),	  to	  Apert	  syndrome	  (Oldridge	  et	  al.,	  1999)	  and	  granulomatous	  disease	  (Chen	  et	  al.,	  2005).	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LINE-­‐1	  retrotransposition	  is	  believed	  to	  play	  a	  role	  in	  certain	  cancers.	  Early	  studies	  revealed	  that	  hypomethylation	  of	  the	  LINE-­‐1	  promoter	  are	  correlated	  with	  increased	  LINE-­‐1	  expression	  and/or	  the	  production	  of	  the	  LINE-­‐1	  ORF1-­‐encoded	  protein	  in	  breast,	  ovarian	  and	  colorectal	  tumours	  (Belancio	  et	  al.,	  2010,	  Asch	  et	  al.,	  1996,	  Alves	  et	  al.,	  1996).	  Moreover,	  engineered	  LINE-­‐1s	  were	  readily	  retrotransposed	  in	  human	  ESCs	  (Garcia-­‐Perez	  et	  al.,	  2007),	  induced	  pluripotent	  stem	  cells	  (Wissing	  et	  al.,	  2012)	  and	  different	  teratocarcinoma	  cell	  lines	  (Garcia-­‐Perez	  et	  al.,	  2010),	  but	  generally	  had	  lower	  levels	  of	  retrotransposition	  activity	  in	  normal	  human	  cells	  such	  as	  fibroblasts	  (Shi	  et	  al.,	  2007,	  Kubo	  et	  al.,	  2006,	  Moran	  et	  al.,	  1996).	  Interestingly,	  it	  has	  been	  proposed	  that	  cancer	  stem	  cells	  may	  contain	  oncogenic	  LINE-­‐1	  driver	  mutations	  or	  are,	  at	  the	  very	  least,	  permissive	  of	  LINE-­‐1	  activity	  (Carreira	  et	  al.,	  2014).	  	  Second-­‐generation	  DNA	  sequencing	  revealed	  nine	  tumour-­‐specific	  LINE-­‐1	  insertions	  in	  20	  lung	  cancer	  samples,	  and	  six	  samples	  with	  LINE-­‐1	  insertions	  also	  displayed	  a	  hypomethylated	  DNA	  profile	  relative	  to	  the	  matched	  normal	  tissue	  (Iskow	  et	  al.,	  2010).	  Study	  on	  16	  colorectal	  tumor	  and	  matched	  normal	  DNAs	  found	  excessive	  mutations,	  which	  were	  caused	  by	  human-­‐specific	  LINE-­‐1s	  (Solyom	  et	  al.,	  2012).	  Twelve	  de	  novo	  LINE-­‐1	  insertions	  were	  identified	  in	  a	  cohort	  of	  hepatocellular	  carcinoma	  patients	  using	  retrotransposon	  capture	  sequencing,	  a	  hybridisation-­‐based	  approach	  to	  enrich	  DNA	  for	  recent	  LINE-­‐1,	  Alu	  and	  SVA	  insertions,	  followed	  by	  deep	  sequencing	  (Shukla	  et	  al.,	  2013,	  Baillie	  et	  al.,	  2011).	  Cancer-­‐specific	  LINE-­‐1-­‐driven	  hybrid	  transcripts	  were	  identified	  in	  breast	  and	  colon	  cancer	  cell	  lines	  (Cruickshanks	  and	  Tufarelli,	  2009).	  The	  expression	  of	  fusion	  transcripts	  between	  LINE-­‐1	  and	  the	  proto-­‐oncogene	  c-­‐Met	  was	  induced	  using	  demethylation	  agents	  in	  colon	  cancer	  and	  leukaemia	  cell	  lines	  (Weber	  et	  al.,	  2010a).	  	  Alu	  elements	  are	  responsible	  for	  over	  two-­‐thirds	  of	  the	  TE	  integration-­‐induced	  germline	  human	  diseases	  (over	  43	  reported	  cases	  compared	  to	  16	  by	  LINE-­‐1	  and	  four	  by	  SVA)	  (Belancio	  et	  al.,	  2008).	  Alu	  insertions	  in	  genes	  such	  as	  CFTR	  (Chen	  et	  al.,	  2008)	  and	  BRCA1	  (Deininger	  and	  Batzer,	  1999)	  contribute	  to	  disease	  in	  many	  individuals.	  Moreover,	  Alu	  elements	  increase	  the	  occurrence	  of	  non-­‐allelic	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homologous	  recombination,	  which	  causes	  about	  0.3%	  of	  human	  genetic	  diseases	  (Ostertag	  and	  Kazazian,	  2001).	  Expression	  of	  viral-­‐like	  particles	  from	  the	  HERV-­‐K	  family	  was	  implicated	  in	  the	  progression	  of	  melanoma	  (Serafino	  et	  al.,	  2009).	  HERV	  loci,	  particularly	  the	  envelope	  genes,	  were	  abundantly	  expressed	  in	  a	  variety	  of	  other	  cancers,	  including	  ovarian	  (Ahn	  and	  Kim,	  2009),	  colon	  (Liang	  et	  al.,	  2009)	  and	  testicular	  (Herbst	  et	  al.,	  1998),	  when	  compared	  to	  normal	  tissues.	  Meanwhile,	  high	  levels	  of	  envelope	  transcripts	  were	  detected	  in	  testis	  tumours	  for	  HERV-­‐K,	  liver	  and	  lung	  tumours	  for	  HERV-­‐H,	  and	  colon	  and	  liver	  tumours	  for	  HERV-­‐P	  (Wang-­‐Johanning	  et	  al.,	  2007).	  	  Recent	  studies	  suggested	  that	  retrotransposons	  may	  also	  associate	  with	  the	  regulation	  of	  brain	  function.	  In	  an	  animal	  model	  of	  post-­‐traumatic	  stress	  disorder,	  SELF	  (stress-­‐enhanced	  fear	  learning)	  rats,	  transcripts	  of	  LINE-­‐1	  retrotransposons	  were	  highly	  upregulated	  in	  the	  basolateral	  amygdala	  of	  SELF	  rats	  compared	  with	  controls,	  suggesting	  that	  a	  single	  stress	  exposure	  could	  result	  in	  long-­‐term	  activation	  of	  retrotransposons	  (Ponomarev	  et	  al.,	  2010,	  Rau	  and	  Fanselow,	  2009).	  It	  was	  also	  shown	  that	  acute	  restraint	  stress	  in	  rats	  inhibited	  expression	  of	  several	  classes	  of	  retrotransposons	  in	  the	  hippocampus	  through	  increasing	  repressive	  histone	  H3	  lysine	  9	  trimethylation	  (Hunter	  et	  al.,	  2012).	  Another	  study	  was	  conducted	  in	  the	  post-­‐mortem	  human	  brains	  of	  alcoholics	  and	  control	  cases	  using	  Illumina	  microarrays	  (Ponomarev	  et	  al.,	  2012).	  Nearly	  4000	  probes	  could	  be	  mapped	  to	  one	  of	  three	  classes	  of	  retrotransposons	  (LINEs,	  SINEs	  and	  LTRs),	  as	  well	  as	  to	  DNA	  transposons.	  Gene	  clustering	  revealed	  that	  at	  least	  two	  TE	  classes	  (SINEs	  and	  LTRs)	  were	  highly	  correlated	  across	  samples.	  In	  addition,	  the	  LTR	  modules	  were	  upregulated	  in	  alcoholics	  (Ponomarev	  et	  al.,	  2012).	  	  
1.3.2.3 Transposition in early development Although	  TEs	  are	  capable	  of	  transposing	  throughout	  the	  life	  of	  the	  host	  organism,	  studies	  suggest	  that	  TEs	  are	  highly	  mobile	  early	  in	  development.	  The	  evidence	  for	  this	  comes	  primarily	  from	  investigating	  murine	  ERV-­‐like	  (MuERV-­‐L)	  and	  the	  related	  mammalian	  apparent	  LTR	  retrotransposon	  (MaLR)	  LTR	  elements	  in	  mice.	  MuERV-­‐L	  elements	  are	  highly	  transcribed	  in	  one-­‐cell	  and	  two-­‐cell	  stage	  embryos,	  and	  they	  produce	  virus-­‐like	  particles.	  It	  is	  likely	  that	  they	  facilitate	  their	  
Chapter	  1	  General	  Introduction	  
	  35	  
amplification	  to	  high	  copy	  numbers	  in	  the	  mouse	  genome	  (Ribet	  et	  al.,	  2008,	  Peaston	  et	  al.,	  2004).	  These	  groundbreaking	  studies	  showed	  that	  MT	  (mouse	  transcript)	  and	  MuERV-­‐L	  LTRs,	  both	  class	  III	  ERVs,	  can	  drive	  the	  developmentally	  regulated	  expression	  of	  many	  genes	  in	  the	  mature	  oocyte	  and	  two-­‐cell	  stage	  embryo	  by	  acting	  as	  alternative	  promoters	  (Peaston	  et	  al.,	  2004).	  In	  mammals,	  the	  IAP	  and	  LINE-­‐1	  retrotransposons	  are	  hypomethylated	  in	  the	  female	  germline;	  they	  constitute	  a	  high	  proportion	  of	  mRNA	  in	  oocytes,	  and	  are	  subsequently	  deposited	  in	  the	  embryo	  (Peaston	  et	  al.,	  2004).	  In	  contrast,	  non-­‐autonomous	  SINEs	  are	  hypomethylated	  in	  sperm	  (Allen	  et	  al.,	  2003).	  Consistent	  with	  these	  findings,	  high	  levels	  of	  LINE-­‐1	  elements	  were	  associated	  with	  paternally	  expressed	  autosomal	  imprinted	  genes	  (Greally,	  2002),	  whereas	  SINE	  elements	  were	  excluded	  from	  the	  promoters	  of	  these	  same	  genes	  (Rubin	  et	  al.,	  1994).	  All	  these	  studies	  raise	  the	  possibility	  that	  different	  classes	  of	  TEs	  may	  contribute	  to	  differential	  expression	  of	  paternally	  and	  maternally	  imprinted	  genes	  in	  early	  development.	  Most	  importantly,	  studies	  on	  both	  patients	  in	  vivo	  and	  human	  embryonic	  stem	  cells	  in	  vitro	  suggest	  that	  LINE-­‐1	  retrotransposition	  events	  may	  occur	  at	  early	  stages	  in	  human	  embryogenesis	  (Garcia-­‐Perez	  et	  al.,	  2007,	  van	  den	  Hurk	  et	  al.,	  2007).	  	  Given	  that	  TEs	  affect	  the	  genome	  in	  a	  multitude	  of	  ways	  and	  are	  implicated	  in	  the	  regulation	  of	  both	  normal	  development	  and	  in	  disease,	  understanding	  how	  TE	  transposition	  and	  expression	  are	  regulated	  is	  a	  critical	  aspect	  of	  understanding	  genome	  function.	  	  
1.3.3 Epigenetic regulation of transposable elements An	  important	  question	  is	  how	  the	  cell	  keeps	  TE	  translocation	  and	  expression	  in	  check	  to	  prevent	  deleterious	  effects	  on	  genome	  function.	  One	  example	  is	  the	  control	  of	  LINE-­‐1s	  (Figure	  1.5).	  Several	  layers	  of	  control	  have	  been	  described,	  including	  DNA	  methylation	  and	  RNA	  interference.	  Added	  to	  those,	  it	  is	  now	  becoming	  clear	  that	  chromatin	  structure	  also	  plays	  a	  role	  in	  TE	  regulation,	  as	  outlined	  below.	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1.3.3.1 DNA methylation Cytosine	  methylation	  (5-­‐methylcytosine)	  is	  an	  important	  DNA	  modification.	  The	  majority	  of	  methylated	  cytosines	  in	  human	  genomic	  DNA	  occur	  in	  repetitive	  sequences	  such	  as	  TEs.	  It	  has	  been	  proposed	  that	  DNA	  methylation	  evolved	  primarily	  as	  a	  defence	  mechanism	  against	  TEs	  (Yoder	  et	  al.,	  1997).	  Moreover,	  the	  methylation	  can	  be	  inherited	  by	  new	  DNA	  strands	  upon	  DNA	  replication	  to	  keep	  the	  TEs	  silenced,	  either	  symmetrically	  (in	  both	  DNA	  strands)	  or	  asymmetrically,	  in	  plants	  and	  mammals	  (Woodcock	  et	  al.,	  1997).	  Methylation	  of	  IAP	  retrotransposons	  is	  established	  during	  gametogenesis	  (Kato	  et	  al.,	  2007,	  Walsh	  et	  al.,	  1998).	  Loss	  of	  IAP	  methylation	  by	  point	  mutation	  of	  the	  methyltransferase	  Dnmt1	  results	  in	  higher	  levels	  of	  IAP	  transcription	  in	  mouse	  ESCs	  (Damelin	  and	  Bestor,	  2007).	  The	  reactivation	  of	  IAP	  due	  to	  hypomethylation	  may	  cause	  certain	  cancers.	  In	  thymic	  lymphomas,	  endogenous	  IAP	  was	  inserted	  at	  the	  Notch1	  locus	  and	  activated	  this	  oncogene	  (Howard	  et	  al.,	  2008).	  In	  addition,	  TE	  DNA	  methylation	  is	  very	  important	  for	  normal	  development.	  Male	  mice	  lacking	  DNMT3L	  displayed	  hypomethylation	  at	  the	  promoters	  of	  LTR	  (IAP)	  and	  non-­‐LTR	  (LINE-­‐1)	  retrotransposons,	  which	  consequently	  reactivated	  TE	  expression	  in	  spermocytes	  and	  spermatogonia,	  leading	  to	  meiotic	  catastrophe	  in	  male	  germ	  cells	  and	  complete	  loss	  of	  post-­‐zygotene	  spermatocytes	  (Bourc'his	  and	  Bestor,	  2004).	  	  
1.3.3.2 Small RNA inhibition RNA-­‐induced	  silencing	  can	  also	  control	  TE	  mobility,	  via	  the	  small	  interfering	  RNA	  (siRNA)	  pathway	  and	  the	  PIWI-­‐interacting	  RNA	  (piRNA)	  pathway.	  Details	  vary	  by	  organism	  and	  source	  of	  RNA,	  but	  in	  general,	  miRNAs	  and	  siRNAs	  are	  cleaved	  from	  short	  hairpin	  and	  double-­‐stranded	  RNA	  (dsRNA)	  precursors	  by	  Dicer	  endonucleases,	  and	  bound	  by	  Argonaute	  proteins	  in	  a	  large	  multiprotein	  complex	  called	  RISC.	  RISC	  is	  targeted	  to	  homologous	  sequences	  in	  cellular	  RNAs,	  forcing	  their	  degradation	  or	  suppressing	  translation	  (Pratt	  and	  MacRae,	  2009).	  Control	  of	  TEs	  by	  RNA	  interference	  (RNAi)	  was	  identified	  first	  in	  plants	  and	  subsequently	  in	  other	  eukaryotes.	  In	  the	  nematode	  Caenorhabditis	  elegans,	  genes	  that	  are	  required	  for	  RNAi	  are	  essential	  for	  silencing	  the	  Tc1	  DNA	  transposon	  in	  the	  germline	  (Sijen	  and	  Plasterk,	  2003,	  Tabara	  et	  al.,	  1999).	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Figure 1.5 How the cell controls retrotransposons.  1.	  DNA	  methylation	  suppresses	  LINE-­‐1	  transcription.	  2.	  LINE-­‐1	  transcription	  is	  interrupted	  by	  premature	  polyadenylation.	  3.	  A	  LINE-­‐1	  antisense	  promoter	  generates	  antisense	  LINE-­‐1	  transcripts,	  leading	  to	  transcription	  of	  neighbouring	  5ʹ′	  sequences	  and	  antisense-­‐derived	  small	  interfering	  RNA	  (siRNA).	  4.	  LINE-­‐1	  transcription	  is	  regulated	  via	  PIWI-­‐interacting	  RNA	  (piRNA).	  5mC,	  5-­‐methylcytosine;	  Ago2,	  argonaute-­‐2.	  Figure	  reproduced	  from	  (St	  Laurent	  et	  al.,	  2010).	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TEs	  give	  rise	  to	  numerous	  siRNAs	  (Watanabe	  et	  al.,	  2006)	  in	  most	  species,	  including	  humans	  (Yang	  and	  Kazazian,	  2006),	  and	  TE	  siRNA	  levels	  are	  correlated	  with	  element	  activity	  (Lippman	  et	  al.,	  2003).	  Forward	  and	  reversed	  retrotransposons	  sitting	  within	  transcribed	  genes,	  along	  with	  both	  sense	  and	  antisense	  activity	  from	  the	  LINE-­‐1	  5ʹ′	  untranslated	  region	  (UTR)	  promoter,	  set	  up	  a	  pool	  of	  dsRNAs	  available	  for	  siRNA	  production.	  For	  example,	  an	  antisense	  promoter	  located	  within	  the	  human	  LINE-­‐1	  5ʹ′	  UTR	  allows	  the	  production	  of	  an	  antisense	  RNA	  that,	  in	  principle,	  could	  base	  pair	  with	  sense	  strand	  LINE-­‐1	  mRNA	  to	  establish	  a	  dsRNA	  substrate	  for	  Dicer.	  Although	  this	  study	  did	  not	  demonstrate	  that	  dsRNA	  was	  actually	  formed	  as	  a	  precursor	  to	  LINE-­‐1	  siRNA	  production,	  depletion	  of	  Dicer	  in	  cultured	  cells	  doubles	  LINE-­‐1	  retrotransposition	  while	  transcription	  is	  only	  modestly	  increased	  (Yang	  and	  Kazazian,	  2006).	  In	  contrast,	  co-­‐transfecting	  LINE-­‐1	  siRNAs	  diced	  in	  vitro	  with	  a	  LINE-­‐1	  that	  is	  active	  in	  cell	  culture	  reduced	  its	  retrotransposition	  (Soifer	  et	  al.,	  2005).	  Deep	  sequencing	  of	  small	  RNA	  libraries	  from	  mouse	  oocytes	  found	  a	  preponderance	  of	  LINE-­‐1	  and	  LTR	  retrotransposons	  and	  pseudogene	  fragments	  (Tam	  et	  al.,	  2008,	  Watanabe	  et	  al.,	  2008).	  	  In	  addition	  to	  siRNAs,	  Dicer-­‐produced	  miRNA	  is	  also	  important	  for	  transposon	  silencing	  in	  somatic	  cells.	  In	  a	  mouse	  model	  of	  age-­‐related	  macular	  degeneration,	  mutation	  of	  Dicer	  specifically	  in	  retinal	  pigment	  epithelium	  was	  accompanied	  by	  Alu-­‐containing	  RNA	  accumulation	  and	  cytotoxicity	  (Kaneko	  et	  al.,	  2011).	  Expression	  of	  Alu	  RNA,	  rather	  than	  retrotransposition	  per	  se,	  appeared	  to	  be	  disease	  causing	  (Kaneko	  et	  al.,	  2011).	  Interestingly,	  about	  12%	  of	  miRNAs	  in	  the	  miRBASE	  database	  have	  significant	  homology	  to	  all	  classes	  of	  transposable	  elements,	  with	  L2,	  MIR	  and	  DNA	  transposon	  sequences	  the	  most	  common.	  Furthermore,	  almost	  30	  human	  miRNAs	  share	  5ʹ′	  seed	  target	  complementarity	  to	  a	  conserved	  site	  within	  Alus	  (Smalheiser	  and	  Torvik,	  2006,	  Smalheiser	  and	  Torvik,	  2005).	  	  Evidence	  is	  stronger	  that	  piRNAs	  silence	  mammalian	  TEs,	  a	  process	  that	  was	  first	  characterised	  in	  Drosophila	  (Aravin	  et	  al.,	  2006,	  Aravin	  et	  al.,	  2007b).	  piRNAs	  are	  not	  derived	  from	  dsRNA	  precursors,	  but	  from	  genomic	  loci	  encoding	  long	  
Chapter	  1	  General	  Introduction	  
	  39	  
precursor	  RNAs	  that	  contain	  the	  remnants	  of	  different	  families	  of	  TEs.	  Once	  piRNAs	  are	  generated	  from	  the	  precursor	  RNAs	  to	  form	  mature	  26–31	  nt	  RNAs,	  a	  subfamily	  of	  Argonaute	  proteins,	  known	  as	  PIWI	  proteins,	  binds	  mature	  antisense	  piRNAs	  and	  directs	  them	  to	  complementary	  sequences	  in	  TE	  mRNA	  (Aravin	  et	  al.,	  2007a).	  They	  are	  then	  amplified	  by	  a	  “ping-­‐pong”	  mechanism	  (Aravin	  et	  al.,	  2007a,	  Malone	  et	  al.,	  2009).	  Disruption	  of	  piRNA	  pathways	  derepressed	  retrotransposons	  in	  the	  Drosophila	  male	  germline	  (Klattenhoff	  and	  Theurkauf,	  2008).	  Deletion	  of	  two	  RNAs,	  Nct1/2,	  within	  a	  piRNA	  cluster	  on	  mouse	  chromosome	  2	  increased	  LINE-­‐1	  RNA	  and	  ORF1p	  expression	  many	  fold	  in	  spermatocytes	  (Xu	  et	  al.,	  2008).	  Mouse	  mutants	  lacking	  PIWIL4	  (MIWI2)	  exhibited	  a	  loss	  of	  LINE-­‐1	  and	  IAP	  retrotransposon	  DNA	  methylation;	  this	  loss	  correlated	  with	  their	  transcriptional	  activity	  in	  male	  germ	  cells	  (Kuramochi-­‐Miyagawa	  et	  al.,	  2008).	  Similarly,	  mice	  lacking	  a	  Mili	  interacting	  protein,	  Tudor	  domain	  containing	  1,	  exhibited	  loss	  of	  LINE-­‐1	  DNA	  methylation	  and	  reactivation	  of	  LINE-­‐1	  expression	  (Reuter	  et	  al.,	  2009),	  as	  did	  animals	  lacking	  PIWIL1	  or	  DNMT3L	  activity	  (De	  Fazio	  et	  al.,	  2011,	  Kuramochi-­‐Miyagawa	  et	  al.,	  2004,	  Reuter	  et	  al.,	  2011).	  	  However	  piRNA	  sequences	  exhibit	  stark	  differences	  between	  species	  and	  this	  sequence	  complexity	  of	  piRNA	  populations	  makes	  deducing	  function	  challenging.	  	  Although	  piRNAs	  are	  remarkably	  enriched	  for	  transposon	  sequences	  in	  the	  Drosophila;	  a	  survey	  of	  piRNA	  mapping	  data	  currently	  available	  indicates	  that	  this	  may	  not	  be	  same	  for	  mammal	  (Mani	  and	  Juliano,	  2013).	  This	  suggests	  there	  are	  other	  functions	  that	  go	  beyond	  transposon	  control.	  	  
1.3.3.3 Chromatin modifications Chromatin	  organisation	  regulates	  gene	  expression	  at	  multiple	  levels	  (see	  section	  1.1).	  An	  important	  question	  is	  what	  is	  the	  role	  of	  chromatin	  structure,	  in	  particular	  H2A.Z,	  in	  regulating	  TEs?	  	  How	  are	  histone	  post-­‐translational	  modifications	  play	  a	  major	  role	  in	  regulating	  TE	  transcription?	  In	  one	  study,	  Alu	  elements	  were	  shown	  to	  be	  targeted	  for	  H3K9	  histone	  methylation	  (Kondo	  and	  Issa,	  2003).	  An	  analysis	  of	  repressive	  histone	  lysine	  methylation	  states	  across	  TEs	  in	  the	  mouse	  genome	  revealed	  selective	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patterns	  of	  H3K9,	  H3K27	  and	  H4K20	  methylation	  associated	  with	  different	  TEs	  (Mikkelsen	  et	  al.,	  2007).	  Mutations	  in	  genes	  required	  for	  repressive	  histone	  tail	  modifications	  lead	  to	  TE	  reactivation;	  for	  example,	  mutations	  in	  the	  histone	  H3K9	  methyltransferase	  gene	  Suv39	  resulted	  in	  enrichment	  of	  TE	  transcripts	  in	  mouse	  ESCs	  (Martens	  et	  al.,	  2005).	  	  Several	  recent	  findings	  led	  to	  a	  model	  for	  silencing	  TEs	  during	  mammalian	  development,	  involving	  repressive	  processes	  including	  histone	  methylation,	  DNA	  methylation	  and	  the	  PIWI	  pathway.	  The	  model	  starts	  with	  the	  methylation	  of	  H3K27	  and	  DNA	  in	  germline	  LINE-­‐1,	  which	  is	  dependent	  on	  the	  methylation	  of	  H3K9.	  Meanwhile,	  the	  PIWI	  pathway	  is	  required	  to	  maintain	  a	  high	  level	  of	  the	  repressive	  H3K9me3	  histone	  modification	  on	  LINE-­‐1	  (Pezic	  et	  al.,	  2014).	  Another	  study	  showed	  strong	  enrichment	  of	  H3K9me3	  on	  LINE-­‐1s	  in	  mouse	  ESCs,	  while	  its	  levels	  were	  decreased	  in	  differentiated	  cells	  (mouse	  embryonic	  fibroblasts),	  which	  coincided	  with	  increased	  DNA	  methylation	  (Bulut-­‐Karslioglu	  et	  al.,	  2014).	  	  Removal	  of	  histone	  acetylation	  is	  linked	  to	  gene	  silencing,	  and	  histone	  deacetylases	  (HDACs)	  are	  considered	  to	  be	  transcriptional	  co-­‐repressors	  (Yang	  and	  Seto,	  2008).	  Brunmeir	  and	  colleagues	  monitored	  the	  expression	  of	  active	  TEs	  in	  mouse	  fibroblasts	  with	  impaired	  histone	  deacetylase	  capacity	  (Brunmeir	  et	  al.,	  2010).	  They	  found	  that	  chemical	  inhibition	  of	  HDACs	  resulted	  in	  local	  hyperacetylation	  and	  reactivation	  of	  a	  defined	  subset	  of	  VL30	  LTR	  retrotransposons.	  Furthermore,	  they	  showed	  that	  not	  histone	  acetylation	  alone,	  but	  rather	  histone	  phosphorylation	  in	  concert	  with	  acetylation	  activated	  transcription	  of	  VL30	  elements	  (Brunmeir	  et	  al.,	  2010).	  	  Proteins	  that	  are	  implicated	  in	  chromatin	  packaging	  and	  condensation	  are	  also	  involved	  in	  TE	  silencing.	  For	  example,	  the	  SWI2/SNF2-­‐like	  protein	  DDM1,	  a	  chromatin	  remodelling	  protein,	  is	  specifically	  required	  for	  TE	  silencing	  and	  chromatin	  condensation	  in	  A.	  thaliana.	  In	  DDM1	  mutants,	  DNA	  and	  H3K9	  methylation	  are	  both	  lost,	  which	  activates	  TEs	  (Lippman	  et	  al.,	  2004).	  Interestingly,	  TEs	  remain	  activated	  and	  do	  not	  regain	  DNA	  and	  H3K9	  methylation	  when	  passed	  from	  a	  DDM1-­‐mutant	  background	  to	  a	  wide-­‐type	  background	  (Kato	  et	  al.,	  2004).	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The	  DDM1	  homologue	  LSH1	  (HELLS),	  a	  member	  of	  the	  SNF2/helicase	  family	  of	  chromatin	  remodelers,	  co-­‐precipitates	  with	  DNMT3A	  and	  DNMT3B	  (Zhu	  et	  al.,	  2006),	  and	  with	  LINEs,	  SINEs	  and	  IAP	  genomic	  loci	  in	  vitro	  (Huang	  et	  al.,	  2004).	  Lsh	  null	  mice	  die	  in	  the	  perinatal	  period	  (Geiman	  et	  al.,	  2001),	  and	  exhibit	  hypomethylation	  of	  LINEs,	  SINEs	  and	  IAPs	  (Dennis	  et	  al.,	  2001),	  and	  derepressive	  histone	  H3	  and	  H4	  acetylation	  marks	  associated	  with	  IAPs	  (Huang	  et	  al.,	  2004).	  	  While	  most	  studies	  of	  TE	  regulation	  focus	  on	  histone	  modification,	  the	  histone	  variants,	  particularly	  H2A.Z,	  have	  been	  largely	  ignored.	  However,	  there	  is	  some	  evidence	  suggesting	  they	  may	  play	  an	  important	  role	  in	  this	  process.	  In	  wild-­‐type	  A.	  
thaliana,	  the	  majority	  of	  transposons	  are	  heavily	  methylated,	  but	  lack	  H2A.Z.	  However,	  when	  DNA	  methyltransferase	  MET1	  was	  mutated,	  the	  transposons	  that	  lost	  DNA	  methylation	  became	  enriched	  for	  H2A.Z	  (Zilberman	  et	  al.,	  2008).	  In	  contrast,	  when	  H2A.Z	  was	  mutated,	  transposons	  marked	  by	  H2A.Z	  became	  DNA	  methylated.	  Therefore,	  the	  authors	  proposed	  that	  transposons	  are	  either	  hypermethylated	  or	  enriched	  for	  H2A.Z,	  and	  eliminating	  either	  mark	  enables	  the	  other	  to	  take	  its	  place	  (Zilberman	  et	  al.,	  2008).	  A	  study	  of	  human	  bladder	  cancers	  found	  that	  active	  LINE-­‐1s	  that	  switched	  from	  a	  tetranucleosome	  to	  a	  dinucleosome	  structure	  acquired	  H2A.Z	  nucleosomes	  (Wolff	  et	  al.,	  2010).	  Most	  excitingly,	  it	  was	  shown	  for	  the	  first	  time	  that	  H3.3	  plays	  a	  direct	  role	  in	  silencing	  ERV	  in	  mouse	  ESCs	  (Elsasser	  et	  al.,	  2015).	  Based	  on	  these	  findings,	  it	  would	  be	  very	  interesting	  to	  investigate	  whether	  H2A.Z	  has	  a	  role	  in	  TE	  regulation.	  	  
1.4	  Project	  aims	  The	  localisation	  and	  biological	  functions	  of	  H2A.Z,	  especially	  its	  function	  in	  transcriptional	  regulation	  and	  its	  role	  in	  hetrochromatin	  formation	  (discussed	  in	  section	  1.2),	  suggest	  that	  it	  may	  be	  involved	  in	  the	  control	  of	  TEs	  as	  well	  as	  of	  protein	  coding	  genes.	  Preliminary	  data	  from	  the	  Tremethick	  laboratory	  has	  demonstrated	  that	  the	  association	  of	  H2A.Z	  and	  H2A	  with	  LINE-­‐1	  is	  different	  from	  other	  TEs,	  such	  as	  LTR	  and	  SINE,	  in	  mouse	  L929	  cells.	  To	  further	  investigate	  H2A.Z	  functions	  in	  transcriptional	  regulation,	  especially	  in	  LINE-­‐1s,	  this	  thesis	  had	  three	  aims.	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1.4.1 What is the histone profile of LINE-1s? The	  first	  aim	  of	  this	  thesis	  was	  to	  determine	  the	  profile	  of	  different	  histones	  on	  LINE-­‐1s	  and	  neighbouring	  genes	  in	  the	  mouse	  fibroblast	  cell	  line	  L929,	  using	  ChIP	  and	  real-­‐time	  PCR.	  LINE-­‐1s	  have	  a	  different	  level	  of	  retrotransposition	  activity	  in	  different	  cell	  types,	  with	  high	  levels	  of	  retrotransposition	  in	  undifferentiated	  cells	  and	  low	  levels	  in	  more	  committed	  cells	  (Branciforte	  and	  Martin,	  1994).	  To	  further	  investigate	  histones	  on	  LINE-­‐1s	  with	  this	  property	  in	  mind,	  two	  other	  cell	  lines	  were	  also	  included:	  mouse	  embryonic	  fibroblasts	  (MEFs)	  and	  mouse	  trophoblast	  stem	  cells	  (TSCs).	  	  
1.4.2 What is the role of histone variant H2A.Z on LINE-1s? Many	  studies	  have	  demonstrated	  that	  H2A.Z	  is	  linked	  to	  both	  gene	  activation	  and	  repression.	  However,	  the	  direct	  function	  of	  H2A.Z	  in	  LINE-­‐1	  transcription	  has	  not	  yet	  been	  investigated.	  Based	  on	  preliminary	  data,	  here	  it	  was	  hypothesised	  that	  if	  H2A.Z	  plays	  a	  role	  in	  repressing	  LINE-­‐1s,	  H2A.Z	  knockdown	  would	  derepress	  LINE-­‐1	  transcription.	  A	  robust	  method	  for	  silencing	  H2A.Z	  expression	  in	  L929	  cells	  and	  TSCs	  was	  established	  by	  testing	  both	  constitutive	  and	  inducible	  RNAi	  systems,	  followed	  by	  examination	  of	  the	  changes	  in	  LINE-­‐1	  expression.	  	  
1.4.3 Does H2A.Z play a key role in establishing the 
chromatin signature? As	  discussed	  in	  section	  1.2.3,	  there	  is	  contradictory	  data	  in	  different	  organisms	  suggesting	  that	  H2A.Z	  plays	  either	  a	  positive	  or	  a	  negative	  role	  in	  transcription	  (Hardy	  et	  al.,	  2009).	  However,	  how	  H2A.Z	  performs	  these	  two	  opposite	  roles	  has	  remained	  unclear.	  Recent	  studies	  tried	  to	  obtain	  an	  answer	  by	  investigating	  the	  association	  between	  H2A.Z	  and	  RNA	  polymerase	  II	  on	  gene	  regulatory	  regions	  during	  the	  transition	  between	  a	  poised	  and	  an	  active	  state;	  however,	  mostly	  in	  
vitro	  models	  were	  used,	  with	  specific	  chemicals	  required	  to	  change	  the	  expression	  of	  genes.	  As	  a	  first	  step	  to	  understand	  H2A.Z	  association	  with	  RNA	  polymerase	  II	  during	  the	  regulation	  of	  genes	  in	  vivo,	  a	  thymocyte	  development	  system	  was	  used	  in	  this	  thesis,	  because	  this	  process	  has	  several	  stages	  and	  encompasses	  both	  the	  transcriptional	  activation	  and	  repression	  of	  numerous	  genes.	  It	  was	  hypothesised	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that	  the	  recruitment	  of	  H2A.Z	  to	  an	  inducible	  promoter	  would	  precede	  the	  recruitment	  of	  RNA	  polymerase	  II	  and	  may	  establish	  chromatin	  marks	  prior	  to	  transcription.	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2.1	  Materials	  
2.1.1 Cell lines The	  L929	  cell	  line,	  a	  murine	  aneuploid	  fibrosarcoma	  line,	  was	  from	  ATCC	  (Manassas,	  VA,	  USA).	  Mouse	  trophoblast	  stem	  cells	  (TSCs)	  were	  routinely	  cultured	  in	  the	  laboratory.	  Mouse	  embryonic	  fibroblasts	  (MEFs)	  were	  derived	  from	  C57BL/6	  mice	  and	  were	  kindly	  provided	  by	  Prof	  Klaus	  Matthei	  (Australian	  National	  University,	  Canberra,	  Australia).	  All	  cells	  were	  maintained	  in	  an	  atmosphere	  of	  5%	  CO2	  at	  37	  °C,	  unless	  otherwise	  stated.	  	  
2.1.2 Reagents The	  general	  reagents	  used	  in	  this	  thesis	  are	  shown	  in	  Table	  2.1.	  	  
Table 2.1 General reagents	  
Name	   Supplier	  1,4-­‐Dithiothreitol	  (DTT)	   Sigma-­‐Aldrich	  (St	  Louis,	  MO,	  USA)	  2-­‐Mercaptoethanol	   Sigma-­‐Aldrich	  Agar	   BD	  (NSW,	  Australia)	  Agarose	  LE	  (gel	  electrophoresis)	   Promega	  (Madison,	  WI,	  USA)	  Ammonium	  chloride	   Sigma-­‐Aldrich	  Ampicillin	   Sigma-­‐Aldrich	  Betaine	   Sigma-­‐Aldrich	  BigDye	  system	   Applied	  Biosystems	  (Foster,	  CA,	  USA)	  Bromophenol	  blue	   Sigma-­‐Aldrich	  BSA	  (bovine	  serum	  albumin)	   Sigma-­‐Aldrich	  Calcium	  chloride,	  AnalaR	   Merck	  BDH	  Chemicals	  (Kilsyth,	  Australia)	  Complete	  protease	  inhibitor	  cocktail	   Roche	  Diagnostics	  (Risch-­‐Rotkreuz,	  Switerland)	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DAPI	   Roche	  Diagnostics	  DMEM	   Sigma-­‐Aldrich	  DMSO	  (dimethyl	  sulfoxide)	   Sigma-­‐Aldrich	  dNTP	  mix	   Sigma-­‐Aldrich	  EDTA	   Life	  Technologies	  (Grand	  Island,	  NY,	  USA)	  EGTA	   Sigma-­‐Aldrich	  Ethidium	  bromide	   Amresco	  (Solon,	  OH,	  USA)	  FBS	  (foetal	  bovine	  serum)	   Life	  Technologies	  FBS	  (embryonic	  stem	  (ES)	  cell	  qualified)	   Life	  Technologies	  Fibroblast	  growth	  factor	  4	  (FGF4)	   Life	  Technologies	  Fluorescent	  Mounting	  Medium	   Sigma-­‐Aldrich	  Formaldehyde	   Chem-­‐supply	  (Port	  Adelaide,	  Australia)	  Geneticin	   Life	  Technologies	  Glycerol	   Life	  Technologies	  Heparin	   Sigma-­‐Aldrich	  HEPES	   Life	  Technologies	  Kanamycin	   Sigma-­‐Aldrich	  L-­‐glutamine	   Life	  Technologies	  Lipofectamine	  2000	   Life	  Technologies	  Lipofectamine	  LTX	  and	  PLUS	  Reagent	   Life	  Technologies	  Lithium	  chloride	  (LiCl2)	   Sigma-­‐Aldrich	  Mitomycin	  C	   Life	  Technologies	  NP-­‐40	  (IGEPAL	  CA-­‐630)	   Sigma-­‐Aldrich	  Nuclease-­‐free	  water	   Life	  Technologies	  NuPAGE®	  Novex®	  Bis-­‐Tris	  Gels	  (4–12%)	   Life	  Technologies	  NuPAGE®	  LDS	  sample	  buffer	  (4x)	   Life	  Technologies	  NuPAGE®	  MES	  SDS	  Running	  Buffer	  (20x)	   Life	  Technologies	  Opti-­‐MEM	  I	  Reduced	  Serum	  Medium	   Life	  Technologies	  Paraformaldehyde	   Chem-­‐supply	  PCR	  Purification	  Kit	   QIAGEN	  (Hilden,	  Germany)	  Penicillin	   Life	  Technologies	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Plasmid	  Mini	  Purification	  Kit	   QIAGEN	  PMSF	   Sigma-­‐Aldrich	  Polybrene	   Sigma-­‐Aldrich	  Ponasterone	  A	   Life	  Technologies	  Power	  SYBR	  Green	  kit	   Applied	  Biosystems	  Propidium	  iodide	   Sigma-­‐Aldrich	  Proteinase	  K	   Life	  Technologies	  PureYieldTM	  Plasmid	  Midiprep	  Kit	   Promega	  Puromycin	   Merck	  Millipore	  (Darmstadt,	  Germany)	  QIAprep	  Spin	  Miniprep	  Kit	   QIAGEN	  QIAquick	  Gel	  Extraction	  Kit	   QIAGEN	  Recombinant	  Tag	  DNA	  polymerase	  and	  buffer	   Promega	  RNase	  A	   Sigma-­‐Aldrich	  RNeasy	  Mini	  Kit	   QIAGEN	  RPMI	  1640	   Life	  Technologies	  SDS	   Sigma-­‐Aldrich	  Sodium	  azide	   Sigma-­‐Aldrich	  Sodium	  bicarbonate	  (NaHCO3)	   Sigma-­‐Aldrich	  Sodium	  deoxycholate	   Sigma-­‐Aldrich	  Sodium	  pyruvate	   Life	  Technologies	  Streptomycin	   Life	  Technologies	  SuperScript	  III	  First-­‐Strand	  Synthesis	  system	   Life	  Technologies	  T4	  DNA	  ligase	  and	  buffer	   New	  England	  Biolabs	  (MA,	  USA)	  Tris	  base	   Sigma-­‐Aldrich	  Trypsin-­‐EDTA	  (0.25%/0.5%)	   Life	  Technologies	  Tween-­‐20	   Sigma-­‐Aldrich	  X-­‐tremeGENE	  HP	   Roche	  Diagnostics	  Zeocin	   Life	  Technologies	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The	  plasmids	  obtained	  from	  external	  sources	  are	  shown	  in	  Table	  2.2,	  while	  plasmids	  created	  for	  use	  in	  this	  thesis	  are	  shown	  in	  Table	  2.3.	  	  
Table 2.2 Plasmids: commercial and gifts 
	  	  
Table 2.3 Plasmids created for use in this thesis	  
Name	   Description	  pIND-­‐adaptor	   H2A.Z-­‐GFP	  (green	  fluorescent	  protein)	  was	  removed	  from	  pIND-­‐H2A.Z-­‐GFP	  and	  extra	  restriction	  enzyme	  sites	  were	  added	  to	  create	  pIND-­‐adaptor	  pTRIPz-­‐shRNA	  H2A.Z	   Double-­‐stranded	  oligonucleotide	  encoding	  H2A.Z	  short	  hairpin	  RNA	  (shRNA)	  was	  inserted	  downstream	  of	  red	  fluorescent	  protein	  (RFP)	  in	  pTRIPz	  
Name	   Source	  pVgRXR	   Life	  Technologies	  pIND-­‐H2A.Z-­‐GFP	   Generous	  gift	  of	  Dr	  Danny	  Rangasamy	  (Australian	  National	  University,	  ACT,	  Australia)	  pIND-­‐shRNA	  H2A.Z	   Generous	  gift	  of	  Dr	  Danny	  Rangasamy	  pTRIPz	   Thermo	  Scientific	  (Waltham,	  MA,	  USA)	  pTRIPz-­‐shRNA	  scramble	   Thermo	  Scientific	  pMD2.G	   Generous	  gift	  of	  Prof	  Didier	  Trono	  (EPFL,	  Lausanne,	  Switzerland)	  psPAX2	   Generous	  gift	  of	  Prof	  Didier	  Trono	  pLVTHM	   Generous	  gift	  of	  Dr	  Luc	  Gaudreau	  (University	  of	  Sherbrooke,	  QC,	  Canada)	  pLVTHM-­‐shRNA	  Control	   Generous	  gift	  of	  Dr	  Luc	  Gaudreau	  pEGFP-­‐N1	   Clontech	  (Mountain	  View,	  CA,	  USA)	  pEGFP-­‐H2A.Z	   Generous	  gift	  of	  Dr	  Belinda	  Ryan	  (NHMRC,	  ACT,	  Australia)	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pIND-­‐RFP-­‐shRNA	  scramble	   RFP-­‐shRNA	  scramble	  was	  removed	  from	  pTRIPz-­‐shRNA	  scramble	  and	  inserted	  into	  pIND-­‐adaptor	  pIND-­‐RFP-­‐shRNA	  H2A.Z	   RFP-­‐shRNA	  H2A.Z	  was	  removed	  from	  pTRIPz-­‐shRNA	  H2A.Z	  and	  inserted	  into	  pIND-­‐adaptor	  pIND-­‐GFP	   GFP	  was	  removed	  from	  EGFP-­‐N1	  and	  inserted	  into	  pIND-­‐adaptor	  pLVTHM-­‐shRNA	  H2A.Z-­‐1	  and	  pLVTHM-­‐shRNA	  H2A.Z-­‐2	   H2A.Z	  shRNA	  (1	  or	  2)	  was	  inserted	  into	  pLVTHM	  	  	  The	  antibodies	  used	  in	  this	  thesis	  are	  shown	  in	  Table	  2.4.	  	  
Table 2.4 Antibodies	  
Antigen	   Species	   Isotype	   Conjugate	   Clone	  and	  
supplier	  
Product	  
number	  Human	  H2A	   Rabbit	   IgG	   –	   Polyclonal,	  Abcam	   ab18255	  H2A.Z	   Sheep	   IgG	   -­‐	   Rasied	  in	  our	  laboratory	   	  
Beta	  Actin	   Rabbit	   IgG	   -­‐	   Abcam	   ab8227	  
Purified	  wheat	  germ	  RNA	  polymerase	  II	  
Mouse	   IgG2a	   –	   8WG16,	  Abcam	   ab817	  
Human	  HP1α	   Mouse	   IgG1	   –	   15.19s2,	  Merck	  Millipore	  
05-­‐689	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Synthetic	  γ-­‐tubulin	  peptide	  (amino	  acids	  38–53)	  
Mouse	   IgG1	   –	   GTU-­‐88,	  Sigma-­‐Aldrich	   T5326	  
Mouse	  CD4	   Rat	   IgG2a,	  κ	   APC	   RM4-­‐5,	  BD	  Biosciences	   553932	  Mouse	  CD69	   Armenian	  hamster	   IgG1,	  λ3	   PE	   H1.2F3,	  BD	  Biosciences	   553237	  Mouse	  CD8a	   Rat	   IgG2a,	  κ	   FITC	   53-­‐6.7,	  BioLegend	   100706	  Rabbit	  IgG	   Sheep	   IgG	   HRP	   Polyclonal,	  Merck	  Millipore	  
AP322P	  
Mouse	  IgG	  (H+L)	   Donkey	   IgG	   HRP	   Polyclonal,	  Jackson	  Immuno-­‐Research	  
715-­‐035-­‐150	  
Goat/Sheep	  IgG	   Donkey	   IgG	   HRP	   Polyclonal,	  Merck	  Millipore	  
AB324P	  
	  	  The	  oligonucleotides	  (oligos)	  used	  are	  shown	  in	  Table	  2.5.	  All	  oligos	  were	  synthesised	  by	  Sigma-­‐Aldrich.	  	  
Table 2.5 Oligos and PCR primers	  
Oligo	   Sequence	  (5ʹ′–3ʹ′)	  A-­‐5ʹ′UTR	  F	   TAAGAGAGCTTGCCAGCAGAGA	  A-­‐5ʹ′UTR	  R	   GCAGACCTGGAGACAGATTCT	  B-­‐5ʹ′UTR	  F	   AGAGAGCTTGCCAGCAGAGAGT	  B-­‐5ʹ′UTR	  R	   GCAGACCTGGAGACAGATTCT	  C-­‐5ʹ′UTR	  F	   TGTCTCCCAGGTCTGCTGATAGA	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C-­‐5ʹ′UTR	  R	   GATTGTTCTTCTGGTGATTCTGTTACC	  CD69-­‐0.15	  F	   GCAGCTCACCACAACAACAC	  CD69-­‐0.15	  R	   TGATCTCGGAGGATTTCAGC	  CD69-­‐0.15(Ex)	  F	   CCTCCGAGATCAAGACACTGA	  CD69-­‐0.15(Ex)	  R	   TCTGCCCTCTCTCCAGATGT	  CD69-­‐0.5(In)	  F	   AAATTGCCTGGCTTGACCTA	  CD69-­‐0.5(In)	  R	   GCTGCTAACCACTGGAGGAT	  CD69-­‐0.6	  F	   AAAAGAAGTGAATGCCACACG	  CD69-­‐0.6	  R	   TGTACCAGGTGCTGTTGGTG	  CD69-­‐1	  F	   GGTCCTTTGACAATCTCTCCA	  CD69-­‐1	  R	   TTGAGCACCACATAAATGCAG	  CD69-­‐2	  F	   ATATGGGGCTTGAGAGGTGA	  CD69-­‐2	  R	   TCACAAGCAATGTGAGTTTCCT	  Cdx2	  F	   CAAGGACGTGAGCATGTATCC	  Cdx2	  R	   GTAACCACCGTAGTCCGGGTA	  ChIP	  1	  F	   TGACTGAAGCCAAGATGA	  ChIP	  1	  R	   CCACAGGTAACCCAACAA	  ChIP	  2	  F	   GCCAGAACATATTCCCCTTG	  ChIP	  2	  R	   CGGCTACCTGGACTACTTGG	  ChIP	  3	  F	   GCTAGGCAAGCACTCTATCAACTG	  ChIP	  3	  R	   TGTCTTGCAAATGGCACAATATC	  ChIP	  4	  F	   AGGCCAGTCACTAAAATCACATC	  ChIP	  4	  R	   CACTGCTGTAGGCTTGGAGT	  ChIP	  5	  F	   ACCCAAGTTCAATCTCCAGCAT	  ChIP	  5	  R	   CCCCAGAAACGATTGTTGTGT	  ChIP	  6	  F	   TGTTGACAGACATCTGGGTT	  ChIP	  6	  R	   TCAGTTTGGCGATTCCTT	  ChIP	  7	  F	   TGAGTCTGATTGTGGAGTCATTCA	  ChIP	  7	  R	   CTTCCCCTTGTGAGTCATCCAA	  ChIP	  8	  F	   TTTGGGCCTTCTTCTTCG	  ChIP	  8	  R	   AGTGGGAGTGCTGGGTTC	  ChIP	  9	  F	   TCCTGCTCCAGCCACCAT	  ChIP	  9	  R	   GCTTACAGTTCCAGGGCAACA	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ChIP	  10	  F	   GCATGGGTCATTCTGAACCT	  ChIP	  10	  R	   CCCAGCACTCAGTAGGAAGC	  ChIP	  11	  F	   CTCAACAGCCCTTTGCTTTCACCAG	  ChIP	  11	  R	   TGGTCACTCTTGAGGCACTGTTCTCC	  ChIP	  12	  F	   GAAGATGAAAAACAAGTTAAGGGATGA	  ChIP	  12	  R	   ATACTGAAGAAATGACCATCCAGAGA	  ChIP	  13	  F	   GAGGGTAATAACCCAAAAGGATTTG	  ChIP	  13	  R	   CGACCCCAGATGTCTCTTAAATG	  ChIP	  A	  F	   GAAACCCCGTCTCAAAACAA	  ChIP	  A	  R	   TAGGCATTTGGGCTATGGAG	  ChIP	  B	  F	   TCAATCCCCTTGAGGATGTC	  ChIP	  B	  R	   TGCTGTAGGCTTGGAGTCCT	  ChIP	  C	  F	   CACTGGCCTTTTTCCATCAT	  ChIP	  C	  R	   ACCCTCTTCCCCTTGTGAGT	  ChIP	  D	  F	   CCAGGACTCCGCAGAACTTA	  ChIP	  D	  R	   TTGTGTTTGGACCTCCTCCT	  Eomes	  F	   TGATCATCACCAAACAGGGC	  Eomes	  R	   ACTGTGTCTCTGAGAAGGTG	  Esrrβ	  F	   GCACCTGGGCTCTAGTTGC	  Esrrβ	  R	   TACAGTCCTCGTAGCTCTTGC	  Fgfr2	  F	   GCCTCTCGAACAGTATTCTCCT	  Fgfr2	  R	   ACAGGGTTCATAAGGCATGGG	  GAPDH-­‐P2	  F	   TGGCAACAATCTCCACTTTG	  GAPDH-­‐P2	  R	   ATAGCTGATGGCTGCAGGTT	  Gcm1	  F	   AACACCAACAACCACAACTCC	  Gcm1	  R	   CAGCTTTTCCTCTGCTGCTT	  H2A	  F	   CCATCTGCAACTAGCTGTGAG	  H2A	  R	   TCCGTTTTCTTCGGAAGTAAGAC	  L1	  orf1a	  F	   ACTCAAAGCGAGGCAACACTAGA	  L1	  orf1a	  R	   GTTCCAGATTTCTTTCCTAGGGTTTC	  L1	  orf1b	  F	   AGGCTACTATACCCAGCCAAACTCT	  L1	  orf1b	  R	   TACTTTGGTTTCTCCCTCTATGATAATTG	  L1	  orf2a	  F	   CCTCCATTGTTGGTGGGATT	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L1	  orf2a	  R	   GGAACCGCCAGACTGATTTC	  L1	  orf2b	  F	   CTGGCGAGGATGTGGAGAA	  L1	  orf2b	  R	   CCTGCAATCCCACCAACAAT	  L1Md	  A2	  5ʹ′UTR	  F	   ATTGAAGAGGGACAGAAAAACAAAG	  L1Md	  A2	  5ʹ′UTR	  R	   ACTGTGGTCAGGGCACAAATG	  L1Md	  A2	  ORF2	  F	   AATCGACAAATGGGACCTAATGA	  L1Md	  A2	  ORF2	  R	   GTAAAGATCCTTTCCCAATCTGTTG	  LINE	  ORF1	  F	   GCAGGAAAACACAGCTAAACAGGTGATGG	  LINE	  ORF1	  R	   CCAGCGTTGCCTCGCTTTGGGTTTT	  LINE	  ORF2	  F	   GCGCTGAGTGCCTCCAAGAAGAAACG	  LINE	  ORF2	  R	   CCTGCCGTCTACTCCTCTTGGGTGA	  Pl-­‐I	  F	   GGTGTCAAGCCTACTCCTTTG	  Pl-­‐I	  R	   GTATTATGGAGCAGTTCAGCCAA	  Pl-­‐II	  F	   CCAACGTGTGATTGTGGTGT	  Pl-­‐II	  R	   TCTTCCGATGTTGTCTGGTG	  Rplp0	  F	   AGATTCGGGATATGCTGTTGGC	  Rplp0	  R	   TCGGGTCCTAGACCAGTGTTC	  synA	  F	   CCCTTGTTCCTCTGCCTACTC	  synA	  R	   TCATGGGTGTCTCTGTCCAA	  Tpbpα	  F	   CGGAAGGCTCCAACATAGAA	  Tpbpα	  R	   TCAAATTCAGGGTCATCAACAA	  Uni	  H2A.Z	  F	   GAAAGGCCAAGACAAAGGC	  Uni	  H2A.Z	  R	   ATGGCTGCGCTGTACACAG	  F,	  forward	  primer,	  complementary	  to	  the	  template/anti-­‐sense	  strand	  of	  the	  target	  sequence;	  R,	  reverse	  primer,	  complementary	  to	  the	  coding/sense	  strand	  of	  the	  target	  sequence.	  	  
2.1.3 Buffers and solutions Cell	  culture	  media	  used	  in	  this	  thesis	  are	  shown	  in	  Table	  2.6,	  while	  buffers	  and	  other	  solutions	  are	  shown	  in	  Table	  2.7.	  	  
Table 2.6 Cell culture media	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Name	   Ingredients	  DMEM	  complete	  medium	   2	  mM	  100	  µg/mL	  100	  U/mL	  10%	  (v/v)	  1	  mM	  
L-­‐glutamine	  streptomycin	  penicillin	  heat-­‐inactivated	  FBS	  sodium	  pyruvate	  In	  DMEM	  TS	  medium	   2	  mM	  50	  µg/mL	  50	  U/mL	  20%	  (v/v)	  1	  mM	  100	  µM	  
L-­‐glutamine	  streptomycin	  penicillin	  heat-­‐inactivated	  ES-­‐FBS	  sodium	  pyruvate	  2-­‐mercaptoethanol	  In	  RPMI	  1640	  70CM	  +	  F4H	  medium	   30%	  (v/v)	  70%	  (v/v)	  25	  ng/mL	  1	  µg/mL	  
TS	  medium	  MEF-­‐conditioned	  medium	  FGF4	  heparin	  	  	  
Table 2.7 Buffers and solutions recipes	  
Name	   Ingredients	  Blocking	  buffer	  (Western	  blot)	   5%	  (w/v)	  0.05%	  (v/v)	   skim	  milk	  powder	  Tween-­‐20	  In	  phosphate-­‐buffered	  saline	  (PBS)	  ChIP	  dilution	  buffer	   0.01%	  (v/v)	  1.1%	  (v/v)	  1.2	  mM	  16.7	  mM	  167	  mM	  
SDS	  Triton	  X-­‐100	  EDTA	  Tris-­‐HCl	  NaCl	  In	  nuclease-­‐free	  water,	  to	  pH	  8.1	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Elution	  buffer	   1%	  (v/v)	  0.1	  M	   SDS	  NaHCO3	  FACS	  buffer	   5%	  (v/v)	  0.1%	  (v/v)	   FBS	  sodium	  azide	  In	  PBS	  2x	  HeBS	  buffer	   0.05	  M	  0.28	  M	  1.5	  mM	  
HEPES	  NaCl	  Na2HPO4	  To	  pH	  7	  4x	  Laemmli	  buffer	   8%	  (v/v)	  0.24	  M	  0.004%	  (v/v)	  40%	  (v/v)	  
SDS	  Tris-­‐HCl,	  pH	  6.8	  bromophenol	  blue	  glycerol	  LB	   1%	  (w/v)	  0.5%	  (w/v)	  0.1	  M	  
tryptone	  yeast	  extract	  NaCl	  To	  pH	  7	  LB	  agar	  plate	   15%	   agar	  In	  LB,	  then	  autoclaved	  LiCl2	  wash	  buffer	   0.25	  M	  1%	  1%	  1	  mM	  10	  mM	  
LiCl2	  NP-­‐40	  sodium	  deoxycholate	  EDTA	  Tris-­‐HCl,	  pH	  8.1	  Low	  salt	  wash	  buffer	   0.1%	  1%	  2	  mM	  20	  mM	  150	  mM	  
SDS	  Triton	  X-­‐100	  EDTA	  Tris-­‐HCl,	  pH	  8.1	  NaCl	  PBST	   0.05%	  (v/v)	   Tween-­‐20	  In	  PBS	  PI	  staining	  solution	   100	  µg/mL	   propidium	  iodide	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0.1%	  (v/v)	  0.1%	  (w/v)	  20	  µg/mL	  0.1%	  (w/v)	  
NP-­‐40	  BSA	  RNase	  A	  sodium	  azide	  In	  PBS	  RIPA	  buffer	   140	  mM	  10	  mM	  1	  mM	  1%	  (v/v)	  0.1%	  (w/v)	  0.1%	  (w/v)	  1	  mM	  
NaCl	  Tris-­‐HCl,	  pH	  8.0	  EDTA	  Triton	  X-­‐100	  SDS	  sodium	  deoxycholate	  PMSF	  SDS	  lysis	  buffer	   0.1%	  (v/v)	  10	  mM	  50	  mM	  
SDS	  EDTA	  Tris	  base	  To	  pH	  8.1	  1x	  TAE	   40	  mM	  20	  mM	  1	  mM	  
Tris	  base	  glacial	  acetic	  acid	  EDTA	  To	  pH	  8.0	  TE	   10	  mM	  1	  mM	   Tris-­‐HCl	  EDTA	  To	  pH	  8.0	  Transfer	  buffer	  (Western	  blot)	   25	  mM	  190	  mM	  15%	  (v/v)	  
Tris	  base	  glycine	  ethanol	  	  	  
2.2	  Recombinant	  DNA	  methods	  
2.4.1 Designing inhibitory DNA oligos against H2A.Z To	  design	  miRNA-­‐adapted	  shRNAs	  (shRNAmirs)	  against	  H2A.Z	  and	  to	  clone	  them	  into	  two	  different	  lentiviral	  vectors	  (pTRIPz	  and	  pLVTHM),	  two	  different	  sets	  of	  19	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nt	  target	  sequences	  were	  chosen	  from	  published	  studies	  (Creyghton	  et	  al.,	  2008,	  Rangasamy	  et	  al.,	  2004).	  From	  those,	  the	  top	  and	  bottom	  strands	  were	  designed	  according	  to	  the	  following	  protocols:	  http://dharmacon.gelifesciences.com/uploadedfiles/resources/ptripz-­‐inducible-­‐lentiviral-­‐manual.pdf	  (pTRIPz)	  and	  http://tronolab.epfl.ch/webdav/site/tronolab/shared/protocols/cloning_strategies.html	  	  (pLVTHM).	  	  
2.4.2 Generating double-stranded oligos After	  briefly	  spinning	  down	  each	  oligo	  pellet,	  all	  oligos	  were	  dissolved	  in	  TE	  buffer	  to	  concentration	  of	  100	  µM.	  The	  two	  complementary	  oligos	  were	  mixed	  together	  in	  equal	  amounts,	  to	  a	  final	  concentration	  of	  50	  µM	  for	  each	  oligo.	  After	  heating	  the	  mixed	  oligos	  at	  94	  °C	  for	  4	  min,	  they	  were	  placed	  at	  room	  temperature	  to	  cool,	  to	  allow	  annealing	  of	  the	  single-­‐stranded	  oligos.	  The	  resulting	  product	  was	  centrifuged	  briefly	  (~5	  sec)	  in	  a	  microcentrifuge	  and	  then	  stored	  at	  −20	  °C.	  	  
2.4.3 Restriction endonuclease digestion of DNA Restriction	  endonucleases	  and	  their	  specific	  buffers	  were	  supplied	  by	  New	  England	  Biolabs.	  Digestion	  of	  DNA	  with	  restriction	  endonucleases	  was	  performed	  according	  to	  the	  manufacturer’s	  protocols.	  A	  standard	  20	  µL	  reaction	  contained	  1	  
µL	  of	  each	  enzyme,	  500	  ng–1	  µg	  of	  DNA,	  1	  µL	  of	  100X	  BSA	  and	  2	  µL	  of	  10x	  restriction	  enzyme	  buffer.	  Reactions	  were	  incubated	  at	  37	  °C	  for	  2	  h	  before	  the	  digested	  DNA	  was	  run	  on	  an	  agarose	  gel	  or	  purified	  using	  a	  PCR	  Purification	  kit.	  	  
2.4.4 Agarose gel electrophoresis of DNA Following	  restriction	  enzyme	  digestion,	  DNA	  fragments	  were	  separated	  and	  purified	  by	  agarose	  gel	  electrophoresis.	  Samples	  were	  pre-­‐stained	  with	  EZ-­‐Vision	  loading	  dye	  (Amresco),	  loaded	  into	  wells	  of	  a	  0.8–1.5%	  agarose	  gel,	  submerged	  in	  1x	  TAE	  buffer	  in	  a	  Mini-­‐Sub	  Cell	  GT	  System	  (Bio-­‐Rad,	  Carlsbad,	  CA,	  USA),	  and	  electrophoresed	  with	  a	  constant	  voltage	  of	  100	  V.	  The	  separated	  DNA	  fragments	  were	  visualised	  under	  UV	  light,	  and	  images	  were	  captured	  using	  a	  GeneGenius	  Bio	  Imaging	  System	  (Syngene,	  Cambridge,	  UK)	  and	  GeneSnap	  software	  (Syngene).	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2.4.5 Purification of DNA fragments A	  QIAquick	  Gel	  Extraction	  kit	  was	  used	  to	  purify	  DNA	  fragments	  for	  cloning,	  following	  the	  manufacturer’s	  instructions.	  	  
2.4.6 Ligation of insert DNA and vector DNA For	  sticky-­‐end	  ligations,	  reactions	  were	  set	  up	  in	  microcentrifuge	  tubes	  on	  ice.	  The	  20	  µL	  ligation	  reaction	  contained	  2	  µL	  of	  10x	  T4	  DNA	  ligase	  buffer,	  1	  µL	  of	  T4	  DNA	  ligase,	  and	  a	  three-­‐	  to	  six-­‐fold	  molar	  excess	  of	  insert	  DNA	  over	  purified	  vector	  DNA,	  and	  was	  incubated	  at	  room	  temperature	  for	  1	  h.	  Double-­‐stranded	  oligos	  were	  diluted	  to	  10	  nM	  before	  cloning	  into	  vectors.	  For	  optimal	  results,	  a	  15:1	  molar	  ratio	  of	  double-­‐stranded	  oligo	  insert	  to	  vector	  was	  used	  in	  ligations.	  A	  ligation	  using	  nuclease-­‐free	  water	  instead	  of	  oligo	  was	  performed	  as	  negative	  control	  for	  ligation	  reactions.	  Ligations	  were	  immediately	  used	  for	  transformation.	  	  
2.4.7 Preparation and transformation of chemically 
competent TOP10 bacteria Cells	  from	  a	  glycerol	  stock	  of	  the	  Escherichia	  coli	  TOP10	  strain	  were	  streaked	  onto	  an	  LB	  agar	  plate	  for	  single	  colonies	  and	  incubated	  overnight	  at	  37	  °C.	  An	  individual	  colony	  was	  picked	  and	  grown	  in	  25	  mL	  of	  LB,	  in	  a	  shaker	  at	  37	  °C	  overnight.	  1	  mL	  of	  overnight	  culture	  was	  inoculated	  into	  100	  mL	  of	  fresh	  LB	  and	  grown	  shaking	  at	  37	  °C	  until	  the	  OD600	  (optical	  density	  at	  600	  nm)	  reached	  0.4–0.6	  (2–3	  h).	  After	  cooling	  down	  on	  ice	  for	  10	  min,	  the	  cells	  were	  centrifuged	  in	  50	  mL	  tubes	  at	  4000	  rpm	  for	  10	  min	  at	  room	  temperature,	  and	  the	  supernatant	  was	  discarded.	  The	  cells	  were	  carefully	  resuspended	  in	  25	  mL	  of	  ice-­‐cold	  50	  mM	  CaCl2	  and	  incubated	  on	  ice	  for	  20	  min.	  The	  cells	  were	  then	  centrifuged	  at	  4000	  rpm	  for	  10	  min	  at	  room	  temperature	  and	  resuspended	  in	  5	  mL	  of	  ice-­‐cold	  50	  mM	  CaCl2.	  Sterile	  glycerol	  (100%)	  was	  added	  to	  the	  cells	  to	  a	  final	  concentration	  of	  15%,	  and	  the	  cells	  were	  aliquoted	  and	  stored	  at	  −70	  °C.	  	  Ligation	  reactions	  were	  transformed	  into	  chemically	  competent	  TOP10	  E.	  coli.	  Briefly,	  2	  µL	  of	  ligation	  was	  added	  to	  50	  µL	  of	  competent	  TOP10	  cells	  and	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incubated	  on	  ice	  for	  20	  min.	  The	  mixture	  was	  heat-­‐shocked	  for	  45	  sec	  and	  immediately	  transferred	  to	  ice.	  After	  adding	  1	  mL	  of	  room	  temperature	  LB	  and	  shaking	  horizontally	  (225	  rpm)	  at	  37	  °C	  for	  1	  h,	  the	  transformed	  cells	  were	  spread	  on	  a	  pre-­‐warmed	  LB	  agar	  plate	  containing	  100	  µg/mL	  ampicillin,	  and	  incubated	  overnight	  at	  37	  °C.	  	  
2.4.8 Isolation of plasmid DNA from bacterial colonies 
(minipreparation) Several	  individual	  colonies	  were	  picked	  from	  LB	  agar	  plates	  and	  each	  was	  transferred	  to	  5	  mL	  of	  LB	  supplemented	  with	  100	  µg/mL	  ampicillin	  or	  10	  µg/mL	  kanamycin.	  The	  liquid	  cultures	  were	  incubated	  overnight	  at	  37	  °C	  with	  agitation,	  then	  plasmid	  DNA	  was	  isolated	  from	  the	  cultures	  using	  the	  QIAGEN	  Plasmid	  Mini	  Purification	  Kit.	  Recombinant	  clones	  were	  determined	  by	  restriction	  enzyme	  digestion.	  	  
2.4.9 Quantification of nucleic acids Quantification	  of	  DNA	  and	  RNA	  was	  performed	  by	  measuring	  the	  OD	  at	  260	  nm	  using	  a	  NanoDrop	  ND-­‐1000	  Spectrophotometer	  (NanoDrop	  Technologies,	  Thermo	  Scientific).	  	  
2.4.10 DNA sequencing All	  plasmid	  constructs	  generated	  in	  this	  study	  were	  sequenced	  at	  the	  ACRF	  Biomolecular	  Resource	  Facility	  (The	  John	  Curtin	  School	  of	  Medical	  Research,	  Australian	  National	  University).	  The	  DNA	  sequencing	  reaction	  contained	  4	  µL	  BigDye	  Terminator,	  3.2	  pmol	  primer,	  4	  µL	  5x	  sequencing	  buffer,	  2	  µL	  10x	  PCR	  enhancer	  (Life	  Technologies),	  500–800	  ng	  DNA	  template	  and	  nuclease-­‐free	  water	  to	  a	  final	  volume	  of	  20	  µL.	  Cycling	  conditions	  used	  were:	  94	  °C	  for	  5	  min	  (1	  cycle);	  30	  cycles	  of	  96	  °C	  for	  10	  sec	  (denaturation),	  50	  °C	  for	  5	  sec	  (annealing)	  and	  60	  °C	  for	  4	  min	  (elongation);	  and	  hold	  at	  4	  °C.	  	  PCR	  products	  were	  precipitated	  to	  remove	  unincorporated	  dye-­‐labelled	  terminators.	  To	  precipitate	  a	  20	  µL	  sequencing	  reaction,	  5	  µL	  of	  125	  mM	  EDTA	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was	  added,	  followed	  by	  60	  µL	  of	  100%	  ethanol.	  Samples	  were	  mixed	  and	  incubated	  at	  room	  temperature	  for	  15	  min.	  After	  centrifugation	  at	  maximum	  speed	  (12,000–13,000	  rpm)	  at	  room	  temperature	  for	  20	  min,	  the	  supernatant	  was	  carefully	  removed	  and	  the	  pellet	  was	  washed	  with	  250	  µL	  of	  70%	  ethanol	  (freshly	  made).	  Samples	  were	  centrifuged	  at	  maximum	  speed	  for	  5	  min	  and	  the	  pellet	  was	  dried	  in	  a	  SpeedVac	  (Savant;	  Thermo	  Scientific)	  for	  15	  min.	  Samples	  were	  stored	  at	  –20	  °C.	  DNA	  sequencing	  was	  performed	  by	  the	  ACRF	  Biomolecular	  Resource	  Facility	  using	  an	  AB	  3730	  capillary	  sequencer.	  	  
2.4.11 Large-scale preparation of plasmid DNA Large-­‐scale	  plasmid	  DNA	  (approximately	  60–100	  µg	  DNA)	  was	  prepared	  using	  the	  PureYield	  Plasmid	  Midiprep	  Kit,	  according	  to	  the	  manufacturer’s	  protocol.	  Briefly,	  100	  mL	  of	  transformed	  E.	  coli	  cell	  culture	  was	  grown	  overnight	  (16–21	  h)	  at	  37	  °C	  with	  rotation	  at	  225	  rpm.	  The	  cells	  were	  harvested	  by	  centrifugation	  at	  4000	  rpm	  for	  15	  min	  and	  lysed.	  Cell	  debris	  was	  cleared	  using	  a	  PureYield	  clearing	  column,	  and	  DNA	  was	  bound	  to	  a	  PureYield	  binding	  column.	  Endotoxin	  contaminants	  were	  removed	  by	  the	  Endotoxin	  Removal	  Wash,	  and	  plasmid	  DNA	  was	  eluted	  in	  nuclease-­‐free	  water.	  	  
2.3	  Cell	  culture	  
2.3.1 Mammalian cell culture Mouse	  L929	  cells	  were	  cultured	  in	  a	  10%	  CO2-­‐containing	  atmosphere	  in	  DMEM	  containing	  10%	  FBS,	  penicillin	  and	  streptomycin	  (DMEM	  complete	  medium).	  	  TSCs	  were	  maintained	  undifferentiated	  in	  70CM	  +	  F4H	  medium	  (see	  Table	  2.6),	  and	  were	  allowed	  to	  differentiate	  in	  TS	  medium.	  	  MEFs	  of	  low	  passage	  number	  were	  cultured	  in	  DMEM	  +	  10%	  FBS	  to	  ~90%	  confluency.	  Fresh	  DMEM	  +	  10%	  FBS	  containing	  10	  µg/mL	  mitomycin	  C	  (MMC)	  was	  added	  to	  the	  cells,	  and	  incubated	  for	  2	  h.	  The	  medium	  was	  removed,	  and	  cells	  were	  washed	  twice	  with	  PBS	  before	  adding	  fresh	  DMEM	  complete	  medium.	  The	  cells	  were	  then	  cultured	  for	  three	  days	  without	  changing	  the	  medium.	  This	  conditioned	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medium	  (MMC-­‐MEF)	  was	  collected,	  filtered	  using	  a	  0.22	  µm	  filter	  (Merck	  Millipore,	  Darmstadt,	  Germany)and	  stored	  at	  −20	  °C.	  In	  total,	  three	  batches	  of	  MMC-­‐MEF	  were	  collected	  from	  the	  cells	  over	  nine	  days.	  	  
2.3.2 DNA transfection with Lipofectamine L929	  cells	  were	  transiently	  transfected	  using	  Lipofectamine	  2000.	  L929	  cells	  were	  seeded	  in	  wells	  of	  a	  6-­‐well	  tissue	  culture	  plate	  (Corning,	  Oneonta,	  NY,	  USA),	  and	  were	  transfected	  when	  they	  reached	  80%	  confluency.	  2	  µg	  DNA	  and	  5	  µL	  Lipofectamine	  2000	  reagent	  were	  diluted	  separately	  in	  Opti-­‐MEM,	  and	  incubated	  for	  5	  min	  at	  room	  temperature.	  The	  DNA	  mixture	  was	  added	  gently	  by	  pipetting	  into	  the	  Lipofectamine	  2000	  mixture.	  After	  a	  20	  min	  incubation	  at	  room	  temperature,	  the	  whole	  reaction	  was	  added	  dropwise	  to	  cells.	  The	  DNA–Lipofectamine-­‐containing	  medium	  was	  replaced	  by	  DMEM	  complete	  medium	  after	  6	  h	  at	  37	  °C.	  Cells	  were	  analysed	  24–72	  h	  post-­‐transfection.	  	  TSC	  transient	  transfection	  conditions	  were	  optimised	  using	  three	  different	  reagents:	  Lipofectamine	  2000,	  Lipofectamine	  LTX	  with	  PLUS	  Reagent	  and	  X-­‐tremeGENE	  HP.	  Transfections	  were	  performed	  in	  60	  mm	  tissue	  culture	  dishes.	  Transfection	  solution	  was	  prepared	  according	  to	  each	  manufacturer’s	  instructions	  (see	  Table	  2.8).	  	  
Table 2.8 Transfection conditions for different transfection reagents	  




Total	  volume	  of	  
Opti-­‐MEM	  Lipofectamine	  2000	   4	  µg	   10	  µL	   500	  µL	  Lipofectamine	  LTX	  +	  PLUS	  Reagent	   4	  µg	   10	  µL	  LTX,	  4	  µL	  PLUS	   500	  µL	  X-­‐tremeGENE	  HP	   4	  µg	   16	  µL	   500	  µL	  	  	  Plasmid	  DNA	  and	  each	  transfection	  reagent	  were	  separately	  diluted	  in	  Opti-­‐MEM	  and	  incubated	  for	  5	  min	  at	  room	  temperature.	  The	  two	  solutions	  were	  mixed	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gently	  by	  pipetting	  and	  incubated	  for	  20–40	  min	  at	  room	  temperature	  before	  being	  added	  to	  the	  culture	  dish.	  TSCs	  (to	  be	  at	  50%	  confluency	  when	  seeded)	  were	  resuspended	  in	  1	  mL	  70CM	  +	  1.5x	  F4H	  and	  added	  dropwise	  to	  the	  transfection	  solution.	  After	  4–5	  h	  at	  37	  °C,	  the	  supernatant	  was	  transferred	  to	  a	  15	  mL	  tube.	  1	  mM	  EDTA/PBS	  was	  added	  to	  the	  dish	  to	  strip	  the	  cells	  adhered	  to	  the	  dish,	  and	  cells	  were	  collected	  and	  added	  to	  the	  same	  15	  mL	  tube,	  then	  centrifuged	  at	  800	  rpm	  for	  7	  min.	  The	  supernatant	  was	  discarded	  and	  the	  cells	  were	  resuspended	  in	  5	  mL	  of	  70CM	  +	  1.5x	  F4H	  medium,	  then	  seeded	  in	  a	  10	  cm	  tissue	  culture	  dish.	  Cells	  were	  analysed	  48–72	  h	  post-­‐transfection.	  	  
2.3.3 Lentiviral production and transduction of mammalian 
cell lines 
2.3.3.1 Production of lentivirus To	  transduce	  L929	  cells,	  lentivirus	  was	  produced	  in	  HEK293	  producer	  cells.	  HEK293	  cells	  were	  seeded	  in	  a	  10	  cm	  tissue	  culture	  dish	  before	  transfection	  so	  that	  they	  would	  reach	  at	  70%	  confluency	  in	  DMEM	  complete	  medium	  on	  the	  day	  of	  transfection.	  One	  hour	  prior	  to	  transfection,	  the	  medium	  was	  replaced	  with	  9	  mL	  fresh	  DMEM	  complete	  medium.	  6	  µg	  of	  transfer	  vector	  (pLVTHM)	  carrying	  the	  shRNA,	  4	  µg	  of	  packaging	  vector	  (psPAX2)	  and	  2	  µg	  of	  envelope	  plasmid	  (pMD2.G)	  were	  added	  to	  1.5	  mL	  Opti-­‐MEM,	  while	  30	  µL	  Lipofectamine	  2000	  was	  diluted	  in	  1.5	  mL	  Opti-­‐MEM.	  After	  incubating	  for	  5	  min,	  the	  Lipofectamine	  mix	  was	  added	  to	  the	  DNA	  mix	  and	  incubated	  for	  20	  min	  at	  room	  temperature.	  The	  DNA–Lipofectamine	  mixture	  was	  added	  to	  the	  cells,	  and	  mixed	  by	  agitating	  back	  and	  forth	  in	  each	  direction.	  After	  incubation	  at	  37	  °C/5%	  CO2	  for	  6	  h,	  the	  cells	  were	  washed	  once	  with	  warm	  DMEM,	  and	  10	  mL	  of	  DMEM	  complete	  medium	  was	  replaced.	  Lentiviral-­‐containing	  supernatant	  was	  harvested	  48	  h	  post-­‐transfection,	  and	  centrifuged	  for	  10	  min	  at	  2000	  g	  to	  remove	  debris.	  	  To	  transduce	  TSCs,	  lentivirus	  was	  produced	  in	  HEK293	  producer	  cells.	  HEK293	  cells	  were	  seeded	  in	  75	  cm2	  tissue	  culture	  flasks	  at	  70%	  confluency	  in	  DMEM	  complete	  medium.	  One	  hour	  prior	  to	  transfection,	  the	  medium	  was	  replaced	  with	  9	  mL	  fresh	  DMEM	  complete	  medium.	  The	  plasmid	  mixture	  was	  prepared	  in	  200	  µL	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of	  2	  M	  CaCl2	  by	  adding	  10	  µg	  transfer	  vector	  (pLVTHM),	  6.5	  µg	  packaging	  plasmid	  (psPAX2)	  and	  3.5	  µg	  envelope	  plasmid	  (pMD2.G),	  a	  total	  of	  20	  µg	  plasmid	  DNA.	  The	  volume	  was	  brought	  up	  to	  1.5	  mL	  with	  sterile	  water.	  The	  DNA	  mixture	  was	  added	  dropwise	  into	  1.5	  mL	  of	  2x	  HeBS	  buffer,	  and	  after	  30	  min	  the	  precipitate	  was	  added	  dropwise	  to	  the	  HEK293	  cells.	  After	  8	  h,	  the	  cells	  were	  rinsed	  with	  PBS	  pH	  7.4	  and	  fresh	  DMEM	  complete	  medium	  was	  added.	  Supernatant	  was	  collected	  48	  h	  and	  72	  h	  post-­‐transfection;	  these	  supernatants	  were	  combined	  and	  filtered	  using	  a	  0.45	  µm	  filter.	  	  The	  lentiviral	  supernatant	  was	  then	  concentrated	  using	  Lenti-­‐X	  Concentrator	  (Clontech).	  The	  supernatant	  was	  transferred	  to	  a	  sterile	  container	  and	  combined	  with	  Lenti-­‐X	  Concentrator	  at	  a	  ratio	  of	  1:3	  (v/v;	  Lenti-­‐X	  Concentrator	  to	  supernatant).	  The	  mixture	  was	  incubated	  at	  4	  °C	  for	  30	  min	  to	  overnight,	  then	  centrifuged	  at	  1500	  g	  for	  45	  min	  at	  4	  °C.	  The	  supernatant	  was	  carefully	  removed	  from	  the	  pellet,	  and	  the	  pellet	  containing	  the	  viral	  particles	  was	  resuspended	  in	  100	  µL	  70CM	  by	  gently	  pipetting	  up	  and	  down.	  The	  concentrated	  virus	  was	  used	  directly	  to	  infect	  TSCs.	  	  
2.3.3.2 Lentiviral transduction To	  infect	  L929	  cells	  at	  90%	  confluency	  in	  a	  10	  cm	  dish,	  a	  final	  concentration	  of	  4	  
µg/mL	  polybrene	  with	  4	  mL	  viral	  supernatant	  and	  3	  mL	  DMEM	  complete	  medium	  was	  added	  to	  cells.	  After	  incubating	  at	  37	  °C/5%	  CO2	  for	  24	  h,	  the	  cells	  were	  rinsed	  with	  PBS	  five	  times	  and	  replaced	  with	  fresh	  complete	  medium.	  Cells	  were	  allowed	  to	  grow	  another	  24	  h	  before	  harvest.	  Cells	  were	  resuspended	  in	  1%	  FBS/PBS	  and	  sorted	  for	  GFP-­‐expressing	  stably	  transduced	  cells.	  	  Twenty-­‐four	  hours	  before	  infection,	  20,000	  TSCs	  were	  seeded	  in	  each	  well	  of	  a	  12-­‐well	  tissue	  culture	  plate	  (Corning).	  On	  the	  day	  of	  transduction,	  a	  final	  concentration	  of	  5	  µg/mL	  polybrene	  with	  100	  µL	  concentrated	  virus	  and	  700	  µL	  70CM	  +	  F4H	  was	  added	  to	  TSCs.	  After	  incubating	  at	  37	  °C/5%	  CO2	  for	  24	  h,	  the	  cells	  were	  rinsed	  with	  PBS	  five	  times	  and	  replaced	  with	  fresh	  70CM	  +	  F4H	  medium.	  Cells	  were	  allowed	  to	  grow	  another	  five	  days	  before	  harvest,	  and	  were	  then	  sorted	  for	  GFP-­‐expressing	  stably	  transduced	  cells.	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2.3.4 Frozen mammalian cell stocks Cells	  were	  frozen	  in	  the	  appropriate	  freezing	  medium	  (Table	  2.9).	  The	  cells	  were	  stored	  in	  a	  freezing	  container	  at	  −80	  °C	  for	  48	  h	  before	  being	  transferring	  to	  liquid	  nitrogen	  storage	  (−196	  °C).	  
Table 2.9 Freezing medium for different cell types 
Cells	   Freezing	  medium	  L929	   10%	  DMSO	  in	  DMEM/10%	  FBS	  TSCs	   10%	  DMSO,	  25%	  FBS	  in	  TS	  medium	  MEFs	   10%	  DMSO,	  25%	  FBS	  in	  DMEM	  complete	  medium	  	  	  
2.4	  RNA	  expression	  analysis	  
2.4.1 Total RNA extraction Total	  RNA	  was	  isolated	  from	  cells	  using	  TRIzol	  Reagent	  (Life	  Technologies).	  Cells	  were	  lysed	  directly	  on	  the	  plate	  by	  adding	  1	  mL	  of	  TRIzol	  Reagent	  to	  a	  60	  mm	  dish.	  The	  samples	  were	  transferred	  to	  microcentrifuge	  tubes	  and	  incubated	  for	  5	  min	  at	  room	  temperature.	  200	  µL	  of	  chloroform	  was	  added	  and	  mixed	  vigorously	  for	  15	  sec,	  and	  samples	  were	  incubated	  at	  room	  temperature	  for	  2–3	  min.	  The	  mixture	  was	  centrifuged	  at	  12,000	  g	  for	  15	  min	  at	  4	  °C.	  The	  aqueous	  phase	  was	  transferred	  to	  a	  fresh	  microcentrifuge	  tube	  and	  an	  equal	  volume	  of	  isopropanol	  was	  added.	  The	  samples	  were	  mixed	  by	  vortexing,	  and	  incubated	  at	  room	  temperature	  for	  10	  min	  to	  precipitate	  RNA.	  Samples	  were	  centrifuged	  at	  12,000	  g	  for	  10	  min	  at	  4	  °C	  and	  RNA	  pellets	  were	  washed	  with	  1	  mL	  of	  75%	  (v/v)	  ice-­‐cold	  ethanol,	  then	  centrifuged	  at	  7500	  g	  for	  5	  min	  at	  4	  °C.	  The	  RNA	  pellets	  were	  air-­‐dried	  briefly	  and	  dissolved	  in	  50	  µL	  RNase-­‐free	  water	  by	  pipetting	  up	  and	  down.	  The	  RNA	  concentration	  was	  calculated	  using	  a	  NanoDrop.	  RNA	  samples	  were	  then	  subjected	  to	  DNase	  treatment.	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2.4.2 DNase treatment of RNA Traces	  of	  DNA	  in	  RNA	  samples	  were	  removed	  using	  the	  TURBOTM	  DNA-­‐free	  kit	  (Ambion;	  Thermo	  Scientific).	  RNA	  samples	  were	  treated	  with	  0.1	  volume	  10x	  TURBO	  DNase	  buffer	  and	  1	  µL	  TURBO	  DNase,	  and	  incubated	  at	  37	  °C	  for	  20–30	  min.	  DNase	  was	  inactivated	  by	  adding	  0.1	  volume	  DNase	  inactivation	  reagent	  and	  incubating	  for	  2	  min	  at	  room	  temperature,	  and	  the	  samples	  were	  centrifugation	  at	  10,000	  g	  for	  90	  sec.	  The	  supernatant	  (containing	  RNA)	  was	  transferred	  to	  a	  fresh	  tube.	  	  
2.4.3 cDNA synthesis cDNA	  was	  synthesised	  from	  1	  µg	  of	  DNase-­‐treated	  total	  RNA	  by	  reverse	  transcription	  using	  the	  Superscript	  III	  First-­‐Strand	  Synthesis	  kit,	  following	  the	  manufacturer’s	  protocol.	  Each	  reaction	  contained	  RNA,	  1 µL	  of	  oligo(dT)	  primer	  or	  random	  hexamers,	  1	  µL	  of	  10	  µM	  dNTPs,	  and	  RNase-­‐free	  water	  to	  a	  final	  volume	  of	  13	  µL.	  The	  reaction	  was	  incubated	  at	  65	  °C	  for	  5	  min,	  followed	  by	  incubation	  on	  ice	  for	  2	  min,	  and	  was	  then	  briefly	  centrifuged.	  4	  µL	  of	  5x	  First-­‐Strand	  buffer,	  1 µL	  of	  0.1	  M	  DTT	  and	  1 µL	  of	  0.25	  U	  reverse	  transcriptase	  were	  added,	  and	  the	  samples	  were	  further	  incubated	  at	  50	  °C	  for	  50	  min.	  The	  reaction	  was	  inactivated	  by	  incubating	  at	  85	  °C	  for	  5	  min,	  and	  samples	  were	  stored	  at	  −20	  °C.	  	  
2.4.4 Quantitative real-time PCR Approximately	  10	  ng	  of	  cDNA	  (or	  genomic	  DNA	  or	  ChIP	  DNA)	  was	  used	  in	  a	  total	  volume	  of	  10	  µL,	  which	  contained	  5 µL	  of	  2x	  SYBR	  Green	  PCR	  Master	  Mix	  (Applied	  Biosystems),	  each	  of	  the	  forward	  and	  reverse	  primers	  at	  a	  final	  concentration	  of	  0.15	  µM,	  and	  distilled	  water.	  Amplifications	  were	  performed	  in	  384-­‐well	  optical	  reaction	  plates	  (Applied	  Biosystems)	  with	  a	  7900HT	  Fast	  Real-­‐Time	  PCR	  System,	  at	  the	  ACRF	  Biomolecular	  Resource	  Facility.	  PCR	  reactions	  were	  performed	  in	  duplicate	  with	  the	  following	  thermocycler	  conditions:	  50	  °C	  for	  2	  min	  (1	  cycle);	  95	  °C	  for	  10	  min	  (1	  cycle);	  40	  cycles	  of	  95	  °C	  for	  15	  sec	  and	  60	  °C	  for	  1	  min.	  SDS	  2.4	  software	  (Applied	  Biosystems)	  was	  used	  to	  analyse	  the	  raw	  data.	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To	  quantify	  relative	  amounts	  of	  mRNA	  expression,	  the	  fixed	  fluorescent	  threshold	  was	  set	  to	  0.2	  and	  the	  baseline	  level	  was	  set	  in	  the	  range	  of	  3–15	  cycles.	  The	  comparative	  CT	  method	  was	  used	  to	  calculate	  the	  relative	  fold	  difference	  in	  gene	  expression	  using	  the	  formula	  2−ΔΔCT,	  which	  assumes	  equal	  primer	  efficiency.	  Cycle	  threshold	  (CT)	  values	  were	  determined	  for	  Gapdh	  or	  Rplp0	  (reference	  housekeeping	  genes),	  and	  were	  subtracted	  from	  the	  CT	  values	  of	  the	  target	  gene	  of	  interest	  (target)	  to	  generate	  ΔΔCT,	  or	  CT(target)	  −	  CT(reference).	  The	  resulting	  relative	  values	  are	  referred	  to	  as	  “relative	  mRNA	  levels”.	  To	  calculate	  the	  fold	  change	  in	  gene	  expression	  relative	  to	  reference	  cells,	  the	  following	  formula	  was	  used:	  2−ΔΔCT(target)/2−ΔΔCT(reference)	  	  
2.5	  Protein	  expression	  analysis	  
2.5.1 Protein preparation and Western blot analysis Mammalian	  cells	  (1–10	  x	  106)	  in	  the	  log	  phase	  of	  growth	  were	  washed	  with	  10	  mL	  of	  ice-­‐cold	  PBS,	  and	  scraped	  off	  the	  plate	  with	  100	  µL	  of	  4x	  Laemmli	  buffer	  containing	  10%	  2-­‐mercaptoethanol	  to	  lyse	  the	  cells.	  The	  cell	  lysate	  was	  boiled	  at	  95	  °C	  for	  5	  min	  and	  stored	  on	  ice	  before	  use.	  	  Cell	  lysates	  were	  loaded	  on	  a	  NuPAGE	  Novex	  4–12%	  Bis-­‐Tris	  gel.	  The	  protein	  molecular	  weight	  markers	  used	  were	  Novex® Sharp	  Pre-­‐Stain	  Protein	  Ladder	  (Life	  Technologies)	  and	  PageRuler	  Prestained	  Protein	  Ladder	  (Thermo	  Scientific). Electrophoresis	  was	  performed	  using	  the	  XCell	  SureLock	  Mini-­‐Cell	  apparatus	  (Life	  Technologies)	  with	  1x	  MES	  Running	  Buffer	  at	  200	  V,	  until	  the	  dye	  front	  reached	  the	  end	  of	  the	  gel.	  Proteins	  were	  then	  transferred	  to	  Whatman	  Protran	  nitrocellulose	  blotting	  membrane	  (GE	  Healthcare,	  UK)	  in	  transfer	  buffer,	  using	  a	  Pharmacia	  LKB	  Novablot	  (GE	  Healthcare),	  at	  45	  mA	  for	  1	  h.	  	  The	  nitrocellulose	  blotting	  membrane	  onto	  which	  proteins	  had	  been	  transferred	  was	  probed	  with	  specific	  antibodies	  as	  follows.	  The	  membrane	  was	  placed	  flat	  in	  a	  dish	  and	  washed	  with	  at	  least	  20	  mL	  distilled	  water,	  and	  then	  incubated	  with	  MemCodeTM	  Stain	  (Pierce;	  Thermo	  Scientific),	  shaking	  for	  30	  sec	  until	  protein	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bands	  appeared	  on	  the	  membrane.	  After	  being	  rinsed	  four	  times	  and	  washed	  for	  5	  min	  in	  distilled	  water,	  the	  membrane	  was	  cut	  into	  pieces	  based	  on	  the	  molecular	  weight	  of	  target	  proteins,	  and	  incubated	  at	  room	  temperature	  for	  1	  h	  in	  20	  mL	  blocking	  buffer	  to	  block	  the	  membrane.	  The	  membrane	  was	  then	  transferred	  to	  a	  small	  bag	  made	  from	  Parafilm	  (Bemis	  Company,	  Oshkosh,	  WI,	  USA),	  and	  incubated	  overnight	  at	  4	  °C	  with	  3	  mL	  of	  blocking	  buffer	  and	  primary	  antibody	  (see	  Table	  2.4).	  The	  bag	  was	  continually	  rotated	  on	  a	  mechanical	  roller	  to	  ensure	  that	  the	  membrane	  did	  not	  dry	  out	  and	  was	  evenly	  coated	  with	  the	  antibody.	  	  All	  washes	  described	  below	  were	  performed	  by	  gently	  agitating	  the	  membrane	  for	  15	  min	  at	  room	  temperature.	  The	  membrane	  was	  washed	  three	  times	  with	  ~20	  mL	  PBST,	  and	  then	  incubated	  with	  20	  mL	  of	  PBST	  containing	  5%	  (w/v)	  skim	  milk	  powder	  and	  horse	  radish	  peroxidase	  (HRP)-­‐conjugated	  secondary	  antibody	  (1:15,000	  dilution)	  for	  1	  h	  at	  room	  temperature.	  The	  membrane	  was	  washed	  three	  times,	  the	  excess	  PBST	  removed	  by	  blotting	  briefly	  on	  absorbent	  paper,	  and	  the	  presence	  of	  bound	  antibody	  revealed	  by	  incubating	  with	  Immobilon	  Chemiluminescent	  HRP	  Substrate	  (Merck	  Millipore),	  and	  visualised	  with	  an	  ImageQuant	  LAS	  4000	  biomolecular	  imager	  (GE	  Healthcare).	  	  
2.5.2 Chromatin immunoprecipitation (ChIP) To	  prepare	  chromatin,	  approximately	  2	  x	  106	  cells	  were	  cross-­‐linked	  using	  1%	  formaldehyde	  for	  10	  min	  at	  room	  temperature	  with	  gentle	  shaking,	  followed	  by	  the	  addition	  of	  glycine	  to	  a	  final	  concentration	  of	  0.125	  M,	  and	  incubation	  for	  10	  min	  at	  room	  temperature.	  Cells	  were	  washed	  twice	  with	  ice-­‐cold	  PBS	  containing	  Complete	  protease	  inhibitor	  cocktail,	  before	  they	  were	  scraped	  and	  pelleted	  for	  4	  min	  at	  2000	  rpm	  at	  4	  °C.	  106	  cells	  were	  lysed	  on	  ice	  for	  10	  min	  in	  200	  µL	  SDS	  lysis	  buffer	  containing	  Complete	  protease	  inhibitor	  cocktail.	  Cell	  lysate	  was	  sheared	  using	  a	  sonicator	  (Bioruptor;	  Diagenode,	  Liege,	  Belgium)	  set	  at	  100	  V,	  high	  level,	  connected	  to	  a	  recirculating	  chiller	  (Thermo	  Scientific)	  to	  maintain	  the	  temperature	  at	  4	  °C	  (30–40	  sets	  of	  30	  sec	  pulses),	  to	  yield	  DNA	  fragments	  ranging	  from	  200	  to	  500	  bp.	  To	  check	  for	  shearing	  efficiency,	  about	  20	  µL	  of	  sonicated	  lysate	  was	  saved	  from	  each	  experiment	  for	  reverse	  cross-­‐linking	  by	  adding	  5	  µL	  of	  10%	  SDS	  and	  2.5	  µL	  of	  proteinase	  K,	  and	  incubated	  at	  65	  °C	  for	  5	  h,	  followed	  by	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recovery	  by	  phenol–chloroform	  extraction,	  and	  were	  analysed	  by	  agarose	  gel	  electrophoresis.	  The	  sonicated	  chromatin	  samples	  were	  stored	  at	  −80	  °C	  for	  further	  analysis.	  	  For	  chromatin	  immunoprecipitation,	  20	  µL	  Protein	  G	  and	  20	  µL	  Protein	  A	  Dynabeads	  (Dynal	  Biotech;	  Thermo	  Scientific)	  were	  mixed,	  and	  washed	  twice	  with	  600	  µL	  PBS/0.02%	  Tween-­‐20,	  centrifuging	  at	  1000	  rpm	  for	  1	  min	  between	  washes.	  Anti-­‐H2A.Z	  antibody,	  5	  µg	  in	  200	  µL	  of	  PBS/0.02%	  Tween-­‐20,	  was	  added	  to	  the	  washed	  beads	  and	  incubated	  for	  1	  h	  at	  room	  temperature	  on	  a	  rotating	  wheel,	  to	  allow	  complete	  antibody	  binding.	  Beads	  were	  then	  washed	  twice	  with	  900	  µL	  PBS/0.02%	  Tween-­‐20	  to	  remove	  unbound	  antibody,	  centrifuging	  at	  1000	  rpm	  for	  1	  min	  between	  washes.	  The	  DNA	  concentration	  of	  chromatin	  samples	  was	  measured	  using	  a	  NanoDrop.	  For	  each	  reaction,	  10–100	  µg	  of	  chromatin	  was	  made	  up	  to	  a	  1	  mL	  volume	  with	  RIPA	  buffer	  and	  mixed	  with	  antibody-­‐bound	  beads,	  then	  incubated	  at	  4	  °C	  overnight	  on	  a	  rotating	  wheel.	  	  Beads	  with	  antibody–chromatin	  complexes	  were	  washed	  once	  with	  RIPA	  buffer,	  three	  times	  with	  RIPA	  buffer/0.5	  M	  NaCl,	  once	  with	  LiCl2	  buffer	  and	  twice	  with	  TE	  buffer.	  All	  washing	  steps	  were	  each	  10	  min	  on	  a	  rotating	  wheel	  at	  4	  °C,	  except	  the	  wash	  with	  LiCl2	  buffer	  was	  5	  min.	  Samples	  were	  centrifuged	  at	  1000	  rpm	  for	  1	  min	  between	  washes.	  Washed	  beads	  were	  resuspended	  in	  91	  µL	  of	  ice-­‐cold	  TE	  buffer	  and	  treated	  with	  1	  µL	  RNase	  A	  for	  30	  min	  at	  37	  °C.	  All	  the	  beads	  were	  then	  transferred	  to	  0.2	  mL	  PCR	  tubes,	  followed	  by	  adding	  5	  µL	  of	  10%	  SDS	  and	  2.5	  µL	  of	  proteinase	  K,	  and	  incubated	  at	  65	  °C	  for	  5	  h.	  De-­‐crosslinked	  DNA	  was	  recovered	  using	  Agencourt	  AMPure	  XP	  beads	  (Beckman-­‐Coulter,	  CA,	  USA),	  according	  to	  the	  manufacturer’s	  protocol.	  	  
2.5.3 Immunofluorescence Cells	  were	  plated	  on	  coverslips	  placed	  in	  the	  wells	  of	  a	  12-­‐well	  plate.	  Before	  staining,	  cells	  were	  fixed	  in	  4%	  paraformaldehyde/PBS	  for	  10	  min	  at	  room	  temperature,	  and	  washed	  three	  times	  (5	  min	  each	  wash)	  with	  PBS.	  Permeabilisation	  of	  the	  cells	  was	  performed	  with	  0.5%	  (v/v)	  Triton	  X-­‐100	  in	  PBS	  
Chapter	  2	  Materials	  and	  Methods	  
	  69	  
for	  10	  min.	  Cells	  were	  then	  incubated	  for	  30	  min	  in	  blocking	  solution	  (2%	  BSA,	  0.1%	  Triton	  X-­‐100	  in	  PBS).	  Samples	  were	  incubated	  overnight	  in	  a	  humidified	  chamber	  at	  4	  °C	  with	  primary	  antibody	  (1:1000).	  The	  primary	  antibody	  was	  removed	  and	  the	  cells	  were	  washed	  three	  times	  with	  PBS	  (5	  min	  each	  wash).	  Detection	  was	  performed	  with	  the	  appropriate	  Alexa	  Fluor-­‐conjugated	  antibodies,	  by	  incubating	  at	  a	  1:500	  dilution	  in	  blocking	  solution	  for	  1	  h	  at	  room	  temperature	  in	  the	  dark.	  After	  secondary	  antibody	  incubation,	  cells	  were	  washed	  three	  times	  with	  PBS	  (5	  min	  each	  wash).	  Nuclei	  were	  stained	  with	  1µg/mL	  DAPI	  for	  1	  min	  and	  followed	  by	  washing	  with	  PBS.	  Cells	  incubated	  without	  primary	  antibodies	  served	  as	  controls.	  	  
2.5.5 Flow cytometry analysis 
2.5.5.1 Fluorescence-activated cell scanning (FACS) Cells	  subjected	  to	  FACS	  analysis	  expressed	  the	  fluorescent	  proteins	  enhanced	  GFP	  (EGFP)	  and	  RFP,	  and	  were	  also	  stained	  with	  1µg/mL	  DAPI.	  All	  samples	  were	  washed	  and	  resuspended	  in	  400	  µL	  PBS	  with	  1	  mM	  EDTA	  before	  being	  scanned	  on	  an	  LSR	  II	  flow	  cytometer.	  The	  acquisition	  flow	  rate	  was	  kept	  at	  around	  300	  events/sec	  by	  choosing	  an	  appropriate	  scanning	  speed,	  to	  keep	  the	  resolution	  as	  accurate	  as	  possible.	  Dead	  cells	  and	  cell	  debris	  were	  excluded	  by	  gating	  the	  cells	  using	  either	  a	  forward	  scatter	  threshold	  of	  200	  (inclusion	  of	  cells	  above	  the	  threshold),	  or	  inclusion	  of	  DAPI-­‐positive	  cells.	  Cells	  not	  expressing	  GFP,	  RFP	  or	  DAPI	  were	  used	  as	  negative	  controls	  in	  each	  FACS	  sitting,	  in	  order	  to	  adjust	  the	  instrument	  settings	  for	  positive	  fluorescent	  samples.	  The	  instrument	  settings	  were	  kept	  consistent	  for	  all	  batches	  of	  samples	  from	  one	  experiment.	  Data	  analysis	  was	  performed	  using	  FlowJo	  Version	  8.8.7	  software.	  	  
2.5.5.2 Fluorescence-activated cell sorting (FACSorting) L929	  and	  TSCs	  infected	  with	  lentivirus	  (see	  section	  2.3.3)	  were	  washed	  and	  resuspended	  in	  medium	  for	  flow	  sorting	  on	  a	  FACSAria	  (BD	  Biosciences).	  Live	  transduced	  cells	  were	  identified	  on	  the	  basis	  of	  their	  forward	  scatter,	  side	  scatter	  and	  GFP	  fluorescence,	  and	  sorted	  into	  tubes	  containing	  FBS.	  The	  sorted	  cells	  were	  counted	  and	  cultured	  in	  the	  appropriate	  complete	  medium	  for	  each	  cell	  type.	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2.5.6 Antibody purification Gel	  electrophoresis	  of	  the	  about	  100µg	  target	  protein	  H2A.Z	  (made	  in	  the	  lab)	  was	  performed	  as	  described	  in	  section	  2.5.1.	  Proteins	  were	  transferred	  from	  the	  gel	  to	  PVDF	  membrane	  (Life	  Technologies).	  After	  the	  transfer,	  the	  membrane	  was	  incubated	  in	  0.2%	  Ponceau	  S/1%	  acetic	  acid	  (Sigma-­‐Aldrich)	  until	  bands	  were	  clearly	  seen.	  After	  washing	  the	  membrane	  several	  times	  with	  distilled	  water	  to	  remove	  background	  staining,	  the	  strip	  containing	  H2A.Z	  protein	  was	  cut	  out	  of	  the	  membrane	  and	  blocked	  for	  1	  h	  at	  room	  temperature	  in	  3%	  BSA/0.02%	  sodium	  azide	  in	  PBS.	  To	  pull	  out	  anti-­‐H2A.Z	  antibodies,	  the	  pre-­‐blocked	  strip	  was	  transferred	  to	  a	  2	  mL	  tube	  containing	  300–600	  µL	  of	  antibody	  serum	  raised	  in	  the	  sheep	  diluted	  equally	  with	  the	  blocking	  solution,	  and	  incubated	  overnight	  at	  4	  °C	  on	  a	  rotating	  wheel.	  The	  strip	  was	  washed	  twice	  in	  10	  mL	  of	  PBS	  for	  20	  min	  each	  time.	  The	  bound	  antibodies	  were	  eluted	  in	  0.2	  M	  glycine	  (pH	  2.8)/1	  mM	  EGTA,	  by	  incubating	  the	  strip	  for	  20	  min	  at	  room	  temperature	  on	  a	  rotating	  wheel.	  Eluted	  antibody	  was	  transfer	  to	  a	  microcentrifuge	  tube	  and	  neutralised	  immediately	  by	  adding	  0.1	  volume	  of	  1	  M	  Tris,	  pH	  8.	  After	  neutralisation,	  the	  antibody	  solution	  was	  mixed	  with	  0.1	  volume	  of	  10x	  PBS	  and	  sodium	  azide	  to	  a	  final	  concentration	  of	  0.02%,	  and	  stored	  at	  −20	  °C.	  	  
2.6	  Mouse	  thymus	  tissue	  preparation	  
2.6.1 Mice All	  mice	  were	  housed	  in	  specific	  pathogen-­‐free	  conditions.	  The	  Australian	  National	  University	  Animal	  Ethics	  and	  Experimentation	  Committee	  approved	  all	  mouse	  experiments	  performed	  in	  this	  thesis.	  Four-­‐	  to	  six-­‐week-­‐old	  female	  C57BL/6J	  mice	  were	  used;	  mice	  were	  obtained	  from	  Australian	  Phenomics	  Facility,	  and	  were	  originally	  from	  the	  Jackson	  Laboratory	  (Bar	  Harbor,	  ME,	  USA).	  Mice	  were	  euthanized	  by	  cervical	  dislocation.	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2.6.2 Thymocyte preparation and antibody staining Thymuses	  from	  15	  C57BL/6J	  mice	  were	  collected	  in	  RPMI	  1640	  medium.	  A	  single	  cell	  suspension	  was	  prepared	  by	  mashing	  the	  thymuses	  using	  the	  rubber	  end	  of	  a	  3	  mL	  syringe	  through	  a	  70	  µm	  nylon	  cell	  strainer	  (BD	  Biosciences)	  with	  PBS/0.1%	  FBS.	  The	  cell	  solution	  was	  collected	  with	  a	  syringe	  and	  transferred	  to	  a	  15	  mL	  tube.	  Cells	  were	  centrifuged	  at	  1200	  rpm	  at	  4	  °C	  for	  8	  min	  and	  resuspended	  in	  3	  mL	  of	  PBS/0.1%	  FBS.	  Approximately	  15	  µL	  of	  cell	  suspension	  was	  added	  to	  wells	  of	  a	  96-­‐well	  tissue	  culture	  plate	  (Corning),	  and	  the	  plate	  was	  centrifuged	  at	  1200	  rpm	  for	  3	  min	  at	  4	  °C.	  Each	  diluted	  antibody	  (CD4-­‐APC,	  CD8-­‐FITC,	  CD69-­‐PE)	  (1:200)	  was	  added	  to	  the	  cells	  for	  20	  min	  at	  4	  °C	  as	  a	  staining	  control.	  The	  rest	  of	  the	  cell	  suspension	  was	  mixed	  with	  three	  different	  antibodies	  (CD4-­‐APC,	  CD8-­‐FITC,	  CD69-­‐PE)	  in	  the	  same	  15	  mL	  tube	  by	  vortexing,	  followed	  by	  being	  covered	  with	  aluminium	  wrap	  and	  incubated	  for	  45	  min	  at	  4	  °C	  on	  a	  rotator.	  After	  incubation,	  the	  samples	  were	  passed	  through	  a	  cell	  strainer	  and	  collected	  in	  5	  mL	  tubes.	  For	  the	  96-­‐well	  plate,	  the	  cells	  were	  centrifuged	  at	  12,000	  rpm	  for	  5	  min	  and	  resuspended	  in	  PBS/0.1%	  FBS.	  The	  cells	  from	  15	  mL	  tube	  were	  sorted	  on	  a	  FACSAria	  and	  the	  subpopulations	  were	  collected	  into	  15	  mL	  tubes	  in	  5	  mL	  of	  RPMI	  1640.	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3.1	  Introduction	  LINE-­‐1s	  are	  class	  I	  transposable	  elements	  and	  move	  in	  a	  “copy	  and	  paste”	  manner,	  involving	  reverse	  transcription	  of	  their	  RNA	  and	  insertion	  of	  the	  cDNA	  copy	  at	  a	  new	  site	  in	  the	  genome	  (Ostertag	  and	  Kazazian,	  2001).	  Human	  LINE-­‐1s	  are	  ~6	  kb	  in	  length	  and	  consist	  of	  an	  internal	  bidirectional	  promoter,	  ,	  two	  open	  reading	  frames	  (ORF1	  and	  ORF2),	  and	  a	  short	  3ʹ′	  UTR	  that	  ends	  in	  a	  poly	  (A)	  tail	  (Ostertag	  and	  Kazazian,	  2001).	  Murine	  LINE-­‐1s	  share	  similar	  structural	  and	  functional	  features,	  except	  that	  the	  5’	  UTR	  is	  organized	  into	  monomeric	  units	  that	  function	  as	  an	  upstream	  promoter.	  	  (Martin	  and	  Bushman,	  2001).	  There	  are	  at	  least	  three	  subfamilies	  of	  LINE-­‐1s,	  L1Md,	  V,	  F,	  and	  A,	  which	  have	  been	  identified	  in	  the	  mouse	  (Hayward	  et	  al.,	  1997).	  It	  has	  been	  reported	  that	  the	  A	  subfamily,	  together	  with	  the	  newly	  evolved	  GF	  (Goodier	  et	  al.,	  2001)	  and	  TF	  (Casavant	  et	  al.,	  2000)	  subfamilies,	  makes	  up	  a	  total	  of	  3,000	  actively	  transposing	  full-­‐length	  elements	  within	  the	  mouse	  genome.	  Each	  subfamily	  of	  LINE-­‐1	  contains	  different	  multiple	  copies	  of	  repeated	  sequences	  called	  monomers	  in	  their	  5’region	  (Martin,	  1991)Monomers	  function	  as	  promoters,	  with	  increases	  in	  promoters	  activity	  as	  the	  number	  of	  monomers	  increase	  (DeBerardinis	  and	  Kazazian,	  1999).	  Although	  the	  majority	  of	  the	  LINE-­‐1	  copies	  in	  the	  genome	  are	  truncated	  at	  their	  5ʹ′	  ends	  and	  are	  transcriptionally	  incompetent,	  a	  number	  of	  young,	  intact	  LINE-­‐1s	  are	  active	  and	  observed	  in	  cancer	  cells	  (Belancio	  et	  al.,	  2008).	  To	  guard	  against	  the	  potential	  danger	  of	  retrotransposition	  causing	  genomic	  damage,	  several	  sophisticated	  mechanisms	  have	  been	  found	  to	  limit	  and	  regulate	  LINE-­‐1	  activity	  in	  the	  germline	  and	  in	  somatic	  cells,	  including	  chromatin	  modification	  (Goodier	  and	  Kazazian,	  2008,	  Goff,	  2004).	  	  A	  range	  of	  chromatin	  modifications	  suppresses	  LINE-­‐1	  transcription,	  including	  DNA	  methylation	  (Yoder	  et	  al.,	  1997,	  Bestor	  and	  Tycko,	  1996),	  modification	  of	  histone	  tails	  and	  heterochromatin	  formation	  (Lippman	  et	  al.,	  2004).	  Mapping	  studies	  performed	  across	  large	  chromosomal	  regions	  revealed	  a	  strong	  correlation	  between	  DNA	  repeats,	  noncoding	  RNA,	  H3K9me3	  and	  DNA	  methylation,	  which	  are	  signs	  of	  transcriptionally	  repressive	  and	  inactive	  chromatin	  (Lippman	  et	  al.,	  2004).	  It	  has	  been	  proposed	  that	  transcription	  across	  DNA	  repeats	  induces	  the	  formation	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of	  dsRNA,	  which	  in	  turn	  recruits	  repressive	  chromatin	  modifications	  and	  DNA	  methylation	  to	  the	  underlying	  chromatin	  template	  by	  the	  RNAi	  machinery.(Tamaru	  and	  Selker,	  2001,	  Hall	  et	  al.,	  2002,	  Volpe	  et	  al.,	  2002,	  Chan	  et	  al.,	  2004,	  Lippman	  and	  Martienssen,	  2004,	  Verdel	  et	  al.,	  2004).	  	  As	  one	  means	  by	  which	  chromatin	  can	  be	  modified,	  histone	  variants	  have	  essential	  roles	  in	  regulating	  gene	  transcription.	  H2A.Z,	  extensively	  studied	  by	  the	  Tremethick	  laboratory	  and	  implicated	  in	  maintaining	  chromosome	  integrity,	  is	  a	  histone	  variant	  that	  is	  extensively	  linked	  to	  transcriptional	  regulation	  and	  heterochromatic	  formation	  (Rangasamy	  et	  al.,	  2004,	  Rangasamy	  et	  al.,	  2003,	  Greaves	  et	  al.,	  2007).	  However,	  the	  question	  of	  whether	  histone	  variants	  regulate	  TE	  transcription,	  particularly	  of	  LINE-­‐1,	  has	  been	  largely	  ignored.	  	  Notably,	  there	  are	  several	  clues	  suggesting	  that	  H2A.Z	  may	  be	  involved	  in	  regulating	  LINE-­‐1s.	  One	  is	  a	  study	  in	  plants,	  demonstrating	  that	  H2A.Z	  and	  DNA	  methylation	  localisation	  was	  mutually	  exclusive	  in	  transposons	  (Zilberman	  et	  al.,	  2008).	  In	  addition,	  a	  study	  in	  human	  bladder	  cancer	  showed	  that	  transcriptional	  activation	  of	  the	  LINE-­‐1	  promoter	  by	  hypomethylation	  required	  H2A.Z	  (Wolff	  et	  al.,	  2010).	  On	  the	  other	  hand,	  H2A.Z	  is	  required	  for	  heterochromatic	  formation	  at	  major	  and	  minor	  satellites	  in	  mouse	  cell	  lines.	  Further,	  recent	  data	  from	  the	  Tremethick	  laboratory	  strengthens	  the	  idea	  that	  H2A.Z	  is	  involved	  in	  LINE-­‐1	  regulation.	  Specifically,	  approximately	  100	  randomly	  picked	  clones	  from	  H2A.Z	  and	  H2A	  ChIP	  libraries	  from	  mouse	  fibroblast	  L929	  cells	  were	  examined	  (done	  by	  Dr.	  Danny	  Rangasamy).	  The	  clones	  were	  sequenced	  and	  their	  genomic	  locations	  determined	  using	  BLAST	  and	  Ensembl	  Mouse	  Genome	  Browser.	  While	  the	  majority	  of	  cloned	  H2A.Z	  (Appendix	  Table	  S1)	  and	  H2A	  (Appendix	  Table	  S2)	  ChIP	  DNA	  fragments	  were	  repetitious	  DNA	  sequences,	  a	  striking	  observation	  was	  that	  the	  ChIP	  DNA	  ratio	  of	  H2A.Z	  to	  H2A	  LINE-­‐1s	  (30%	  vs.	  8%	  of	  H2A.Z	  and	  H2A	  clones	  sequenced,	  respectively)	  was	  different	  from	  other	  repetitive	  elements	  such	  as	  LTR	  retrotransposons	  (3%	  vs.	  18%	  of	  H2A.Z	  and	  H2A	  clones	  sequenced,	  respectively)	  and	  SINEs.	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In	  light	  of	  these	  data,	  this	  chapter	  sought	  to	  test	  the	  hypothesis	  that	  H2A.Z	  is	  preferentially	  associated	  with	  LINE-­‐1s.	  This	  was	  investigated	  by	  performing	  ChIP	  experiments	  using	  H2A.Z	  and	  H2A	  in	  three	  different	  cell	  types	  (L929,	  MEFs	  and	  TSCs),	  and	  analysed	  by	  real-­‐time	  PCR	  using	  consensus	  primers	  that	  detect	  LINE-­‐1s.	  L1Md	  (L1	  in	  Mus	  domesticus)	  is	  the	  major	  mouse	  retrotransposon,	  with	  randomly	  truncated	  sequences	  toward	  the	  5’	  end	  resulting	  in	  high	  frequency	  repeats	  off	  extreme	  3’	  sequences	  (Voliva	  et	  al.,	  1983)	  .	  Three	  A-­‐type	  subfamily	  members	  have	  been	  described,	  L1Md_A2	  with	  4	  and	  2/3,	  L1Md_A13	  with	  2	  and	  2/3,	  and	  L1Md_9	  with	  1	  and	  2/3	  copies	  of	  monomers	  (Naas	  et	  al.,	  1998,	  Loeb	  et	  al.,	  1986).	  To	  investigate	  a	  specific	  subfamily	  of	  LINE-­‐1s,	  H2A.Z	  and	  H2A	  occupancy	  on	  the	  L1Md_A2	  subfamily	  was	  also	  examined.	  	  
3.2	  Results	  
3.2.1 The histone profile of LINE-1s and neighbouring 
genes in L929 cells To	  determine	  the	  possible	  functions	  of	  H2A.Z	  in	  repetitive	  elements,	  especially	  LINE-­‐1,	  which	  is	  an	  active	  TE	  family	  in	  mammalian	  cells,	  first	  the	  presence	  of	  H2A.Z	  on	  LINE-­‐1s	  in	  mouse	  L929	  cells	  was	  assessed	  using	  ChIP	  assays.	  Chromatin	  from	  mouse	  L929	  cell	  lysates	  was	  chemically	  cross-­‐linked,	  sonicated	  and	  immunoprecipitated	  with	  H2A.Z	  and	  H2A	  antibodies.	  The	  immunoprecipitated	  DNA	  was	  analysed	  by	  real-­‐time	  PCR	  using	  LINE-­‐1	  primer	  sets.	  To	  allow	  accurate	  determination	  of	  H2A.Z	  enrichment	  on	  LINE-­‐1	  specific	  subfamilies,	  different	  primers	  were	  designed	  that	  could	  recognise	  either	  consensus	  LINE-­‐1	  sequence,	  which	  includes	  different	  LINE-­‐1	  families	  (Figure	  3.1A),	  or	  L1Md_A2	  sequence	  (Figure	  3.1B),	  one	  of	  the	  active	  subfamilies	  in	  mice.	  For	  normalisation,	  primers	  to	  the	  Gapdh	  gene	  were	  used.	  	  First,	  the	  profile	  of	  H2A.Z	  and	  H2A	  enrichment	  across	  the	  genome	  was	  examined,	  by	  normalising	  the	  ChIP	  signal	  to	  that	  of	  total	  genomic	  DNA	  (input)	  and	  calculating	  the	  ratio	  between	  the	  ChIP	  signal	  for	  a	  given	  region	  and	  Gapdh	  (Figure	  3.1A).	  As	  shown	  in	  Figure	  3.1A,	  H2A.Z	  was	  enriched	  at	  LINE-­‐1s	  relative	  to	  Gapdh,	  while	  H2A	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was	  not.	  This	  selective	  enrichment	  for	  H2A.Z	  was	  also	  observed	  at	  a	  specific	  LINE-­‐1,	  L1Md_A2	  (Figure	  3.1B).	  	  Given	  the	  theory	  that	  heterochromatin	  composed	  of	  TEs	  may	  be	  able	  to	  spread	  (Boyle	  et	  al.,	  1990,	  Chow	  et	  al.,	  2010,	  Lippman	  et	  al.,	  2004,	  Schramke	  and	  Allshire,	  2003),	  it	  was	  speculated	  whether	  H2A.Z	  was	  also	  enriched	  at	  the	  genes	  neighbouring	  LINE-­‐1s.	  To	  examine	  the	  association	  between	  H2A.Z	  and	  these	  neighbouring	  genes,	  information	  from	  Appendix	  Table	  S1	  was	  used	  to	  design	  specific	  primers	  across	  LINE-­‐1s	  at	  a	  unique	  genomic	  location.	  This	  region	  is	  at	  chromosome	  9	  A,	  and	  contains	  the	  Mbd3l1	  gene	  embedded	  between	  a	  full-­‐length	  LINE-­‐1	  (L1Md_F2)	  and	  several	  non-­‐functional	  LINE-­‐1s,	  and	  the	  flanking	  Muc16	  gene	  (Figure	  3.2A).	  Both	  of	  these	  genes	  are	  inactive	  in	  L929	  cells.	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Figure 3.1 Quantitation of LINE-1 fragments using real-time PCR from 
chromatin immunoprecipitation experiments with anti-H2A.Z and anti-H2A 
in L929 cells.  Schematic	  representations	  of	  (A)	  general	  LINE-­‐1	  elements,	  and	  (B)	  L1Md_A2,	  a	  LINE-­‐1	  family	  member,	  showing	  the	  locations	  of	  the	  PCR	  primer	  sets	  used.	  Values	  indicate	  enrichment	  relative	  to	  input,	  followed	  by	  normalisation	  to	  the	  control	  gene	  Gapdh.	  The	  dashed	  line	  represents	  a	  threshold	  signal	  of	  1.	  Representative	  experiments	  showing	  the	  mean	  and	  standard	  deviation	  for	  three	  biological	  replicates	  are	  shown.	  	   	  












Figure 3.2 Quantitation of fragments from a region in mouse chromosome 
9 encompassing several different LINE-1 families and two genes (Mbd3l1 
and Muc16), using real-time PCR from ChIP experiments.  (A)	  Schematic	  representation	  of	  the	  genomic	  organisation	  of	  an	  ~45	  kb	  region	  of	  mouse	  chr.	  9	  (build38,	  Dec.	  2011)	  showing	  the	  location	  of	  the	  PCR	  primer	  sets	  used.	  (B,	  C)	  ChIP	  was	  performed	  using	  H2A.Z,	  H2A	  or	  HP1α	  antibodies.	  Values	  indicate	  (B)	  enrichment	  relative	  to	  input,	  or	  (C)	  further	  normalisation	  to	  the	  control	  gene	  Gapdh.	  The	  dashed	  line	  in	  (C)	  represents	  a	  threshold	  signal	  of	  2.	  Representative	  experiments	  showing	  the	  mean	  for	  three	  biological	  replicates	  are	  shown.	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ChIP	  was	  performed	  using	  H2A.Z,	  H2A	  and	  HP1α	  antibodies,	  followed	  by	  real-­‐time	  PCR	  to	  analyse	  the	  ChIP	  DNA	  using	  repeat-­‐specific	  primer	  sets	  that	  span	  across	  the	  whole	  region	  (Figure	  3.2A).	  Occupancy	  of	  H2A.Z,	  H2A	  and	  HP1α	  was	  examined	  by	  normalising	  for	  total	  genomic	  DNA,	  which	  showed	  different	  enrichment	  on	  LINE-­‐1s	  (Figure	  3.2B).	  To	  compare	  the	  enrichment	  of	  H2A.Z	  and	  H2A	  at	  LINE-­‐1s,	  PCR	  product	  signals	  were	  again	  normalised	  to	  Gapdh	  and	  a	  threshold	  of	  2	  was	  applied	  (Figure	  3.2C).	  It	  was	  observed	  that	  in	  contrast	  to	  H2A,	  H2A.Z	  was,	  overall,	  enriched	  across	  this	  entire	  region.	  H2A.Z	  occupancy	  was	  relatively	  higher	  within	  the	  Mbd3l1	  gene,	  the	  intergenic	  regions	  separating	  Mbd3l1	  from	  L1MB3	  and	  L1_Mus3,	  and	  the	  intergenic	  region	  between	  L1_Mus3	  and	  L1Md_F2.	  Given	  that	  primer	  sets	  6	  and	  8	  will	  recognise	  other	  similar	  LINE-­‐1s,	  additional	  primer	  sets	  were	  designed	  that	  recognise	  unique	  DNA	  sequences	  in	  L1_Mus3	  and	  L1Md_F2	  (primer	  sets	  12	  and	  13,	  respectively;	  Figure	  3.2A).	  Employing	  these	  primer	  sets,	  the	  ChIP–PCR	  results	  showed	  that	  H2A.Z	  occupancy	  of	  L1_Mus3	  and	  L1Md_F2	  was	  greater	  than	  occupancy	  of	  H2A	  (Figure	  3.2C).	  	  It	  was	  previously	  proposed	  that	  H2A.Z	  and	  the	  chromatin	  silencing	  protein	  HP1α	  work	  together	  to	  establish	  a	  specialised	  conformation	  at	  constitutive	  heterochromatic	  domains	  (Rangasamy	  et	  al.,	  2003,	  Greaves	  et	  al.,	  2007,	  Fan	  et	  al.,	  2004).	  Given	  this	  structural	  and	  functional	  relationship	  between	  H2A.Z	  and	  HP1α,	  it	  was	  investigated	  whether	  HP1α	  colocalises	  with	  H2A.Z	  at	  this	  locus.	  ChIP	  assays	  employing	  HP1α	  antibody	  showed	  that	  indeed,	  like	  H2A.Z,	  HP1α	  was	  also	  present	  on	  Mbd3l1	  and	  L1Md_F2	  (Figure	  3.2B).	  Taken	  together,	  these	  results	  show	  that	  the	  region	  spanning	  the	  Mbd3l1	  gene	  and	  L1Md_F2	  is	  enriched	  with	  H2A.Z	  and	  HP1α,	  suggesting	  that	  these	  proteins	  may	  have	  a	  transcriptional	  function	  in	  the	  region.	  	  
3.2.2 Differential occupancy of H2A and H2A.Z on LINE-1s 
in MEFs and TSCs Several	  studies	  reported	  that	  LINE-­‐1s	  are	  transcriptionally	  repressed	  in	  terminally	  differentiated	  cells,	  and	  highly	  active	  in	  embryonic,	  undifferentiated	  cells	  (Packer	  et	  al.,	  1993,	  Poznanski	  and	  Calarco,	  1991).	  In	  addition,	  repeat-­‐associated	  histone	  lysine	  methylation	  (H3K9,	  H3K27,	  H4K20	  mono-­‐,	  di-­‐	  and	  trimethylation)	  profiles	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displayed	  significant	  variability	  in	  different	  cell	  types	  (Martens	  et	  al.,	  2005).	  To	  determine	  whether	  the	  differences	  in	  LINE-­‐1	  expression	  are	  paralleled	  by	  different	  enrichment	  of	  H2A.Z,	  several	  types	  of	  mouse	  cells	  available	  in	  the	  laboratory	  were	  surveyed,	  and	  it	  was	  decided	  to	  use	  mouse	  embryonic	  fibroblasts	  (MEFs)	  and	  a	  trophoblast	  stem	  cell	  (TSC)	  line	  (Figure	  3.3A).	  The	  cell	  lines	  represent	  three	  different	  cell	  states:	  committed	  cells	  (L929,	  MEFs)	  and	  stem	  cells	  (TSCs).	  	  To	  directly	  examine	  LINE-­‐1	  expression,	  real-­‐time	  PCR	  was	  performed	  using	  total	  RNA	  from	  L929	  cells,	  MEFs	  and	  TSCs.	  For	  comparison,	  the	  L929	  cell	  transcript	  level	  for	  each	  LINE-­‐1	  region	  (Figure	  3.3B)	  was	  set	  at	  1,	  and	  relative	  expression	  in	  the	  other	  cell	  populations	  was	  determined.	  Consistent	  with	  other	  studies	  (Packer	  et	  al.,	  1993,	  Poznanski	  and	  Calarco,	  1991),	  expression	  levels	  of	  all	  LINE-­‐1s	  were	  significantly	  higher	  in	  undifferentiated	  cells	  (TSCs)	  compared	  to	  committed	  cells	  (L929	  and	  MEFs).	  This	  raised	  the	  possibility	  that	  H2A.Z	  occupancy	  may	  be	  associated	  with	  different	  levels	  of	  LINE-­‐1	  expression	  in	  different	  cell	  types.	  	  To	  investigate	  this,	  ChIP	  experiments	  were	  performed	  using	  H2A.Z	  and	  H2A	  antibodies	  in	  L929	  cells,	  MEFs	  and	  TSCs.	  Different	  levels	  of	  H2A.Z	  enrichment	  were	  observed	  in	  all	  LINE-­‐1s	  and	  in	  L1Md_A2.	  In	  the	  5ʹ′	  UTR	  and	  ORF1	  region	  of	  all	  LINE-­‐1s,	  which	  had	  low	  transcript	  levels,	  there	  was	  high	  enrichment	  of	  H2A.Z	  in	  MEFs	  and	  L929	  cells,	  while	  there	  was	  low	  occupancy	  of	  H2A.Z	  in	  TSCs,	  which	  had	  high	  transcript	  levels	  of	  LINE-­‐1s	  (Figure	  3.3C).	  Other	  LINE-­‐1	  regions	  also	  displayed	  different	  H2A.Z	  occupancy	  in	  the	  three	  cell	  lines.	  In	  the	  ORF2	  region	  of	  all	  LINE-­‐1s,	  H2A.Z	  enrichment	  in	  L929	  cells	  was	  slightly	  higher	  than	  in	  both	  TSCs	  and	  MEFs	  (Figure	  3.3C).	  In	  addition,	  the	  profiles	  of	  H2A.Z	  occupancy	  in	  these	  cells	  were	  similar	  to	  those	  observed	  in	  the	  L1Md_A2	  family,	  except	  that	  H2A.Z	  was	  highly	  enriched	  in	  L929	  cells	  compared	  to	  MEFs	  and	  TSCs	  in	  5ʹ′	  UTR	  of	  L1Md_A2	  (Figure	  3.3D).	  Together,	  the	  results	  illustrate	  the	  variability	  of	  H2A.Z	  enrichment	  at	  LINE-­‐1s	  in	  the	  distinct	  chromatin	  environments	  of	  different	  cell	  types.	  Moreover,	  this	  was	  an	  inverse	  correlation	  between	  the	  amount	  of	  H2A.Z	  and	  the	  level	  of	  LINE-­‐1	  expression.	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Figure 3.3 Different distribution of H2A.Z on LINE-1s is associated with 
LINE-1 transcript level in TSCs, MEFs and L929 cells.  (A)	  Bright-­‐field	  images	  of	  cultured	  mouse	  L929	  cells,	  MEFs	  and	  TSCs,	  Magnification:	  x20.	  (B)	  Real-­‐time	  PCR	  analysis	  of	  LINE-­‐1	  transcript	  levels	  in	  TSCs,	  MEFs	  and	  L929	  cells.	  RNA	  levels	  were	  normalised	  to	  Rplp0	  levels.	  Error	  bars	  indicate	  the	  standard	  deviation	  of	  three	  replicates.	  (C)	  ChIP–PCR	  analysis	  of	  H2A.Z	  enrichment	  on	  all	  LINE-­‐1s	  (left)	  or	  the	  L1Md	  A2	  family	  (right).	  Normalisation	  was	  performed	  using	  the	  formula:	  (H2A.ZLINE-­‐1s/H2A.ZGapdh)	  /	  (H2ALINE-­‐1s/H2AGapdh)	  The	  dashed	  line	  represents	  a	  threshold	  signal	  of	  1;	  values	  above	  this	  line	  indicate	  enrichment	  for	  H2A.Z,	  and	  those	  below	  indicate	  enrichment	  for	  H2A.	  ChIP	  experiments	  were	  repeated	  three	  times.	  Error	  bars	  indicate	  standard	  deviation.	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3.2.3 Dynamic changes to H2A.Z and H2A patterns on 
LINE-1s between undifferentiated and differentiated 
trophoblasts LINE-­‐1	  expression	  and	  enrichment	  of	  H2A.Z	  vary	  between	  cells	  at	  different	  ends	  of	  the	  differentiation	  spectrum.	  However,	  it	  is	  unknown	  how	  these	  change	  throughout	  the	  process	  of	  differentiation	  for	  a	  given	  cell	  type.	  An	  attractive	  hypothesis	  is	  that	  upon	  TSCs	  differentiation,	  LINE-­‐1s	  become	  repressed	  and	  this	  is	  associated	  with	  a	  gain	  of	  H2A.Z.	  	  To	  investigate	  this,	  TSCs	  were	  used	  as	  a	  model.	  TSCs	  are	  derived	  from	  the	  outer	  layer	  of	  a	  blastocyst,	  trophectoderm,	  which	  exclusively	  contributes	  to	  formation	  of	  the	  placenta.	  They	  represent	  the	  stem	  cells	  of	  the	  trophoblast	  lineage,	  and	  retain	  the	  capacity	  to	  differentiate	  into	  all	  trophoblast	  derivatives	  of	  the	  later	  placenta	  in	  vitro	  (Uy	  et	  al.,	  2002,	  Tanaka	  et	  al.,	  1998).	  	  TSCs	  can	  be	  induced	  to	  differentiate	  into	  trophoblast	  giant	  cells	  (TGCs)	  when	  deprived	  of	  fibroblast	  growth	  factor	  4	  (FGF4),	  a	  mitogen	  prominently	  involved	  in	  mammalian	  embryogenesis	  (Basilico	  et	  al.,	  1997,	  Feldman	  et	  al.,	  1995).	  This	  phenomenon	  can	  be	  recapitulated	  in	  vitro	  (Simmons	  and	  Cross,	  2005).	  In	  the	  presence	  of	  FGF4	  and	  medium	  conditioned	  by	  primary	  embryonic	  fibroblasts,	  TSCs	  proliferate	  in	  vitro	  to	  form	  tightly	  packed	  colonies.	  When	  FGF4	  and	  conditioned	  medium	  are	  replaced	  with	  normal	  culture	  medium,	  TSCs	  spontaneously	  differentiate	  into	  TGCs	  (Hu	  and	  Cross,	  2010),	  an	  event	  characterised	  by	  increased	  cell	  size,	  genome	  endoreduplication	  and	  the	  expression	  of	  specific	  genes.	  	  To	  test	  the	  hypothesis	  that	  H2A.Z	  enrichment	  on	  LINE-­‐1s	  is	  dynamic	  upon	  cell	  differentiation,	  the	  culture	  system	  for	  TSC	  differentiation	  was	  validated.	  When	  TSCs	  were	  grown	  without	  FGF4	  for	  six	  days,	  they	  formed	  TGCs	  (Figure	  3.4A).	  The	  differences	  between	  of	  TSCs	  and	  TGCs	  were	  confirmed	  by	  morphology	  changes	  (Figure	  3.4B),	  and	  by	  real-­‐time	  PCR	  analysis	  for	  the	  markers	  Esrrbeta,	  Fgfr2	  (TSCs),	  and	  PL-­‐I	  (TGCs;	  Figure	  3.4C).	  Interestingly,	  total	  cellular	  H2A.Z	  was	  reduced	  during	  TSC	  differentiation	  (Figure	  3.5).	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H2A.Z	  and	  H2A	  ChIP	  was	  performed	  on	  both	  TSCs	  and	  TGCs,	  and	  found	  that,	  despite	  the	  reduction	  in	  H2A.Z	  levels,	  TGCs	  had	  greater	  occupancy	  of	  H2A.Z	  at	  LINE-­‐1s	  than	  TSCs,	  whereas	  H2A	  occupancy	  remained	  constant	  (Figure	  3.6A,	  B).	  This	  change	  in	  histone	  H2A.Z	  pattern	  may	  be	  reflected	  in	  transcript	  levels	  of	  LINE-­‐1s.	  Transcripts	  for	  different	  regions	  of	  all	  LINE-­‐1s	  were	  analysed	  in	  both	  TSCs	  and	  TGCs,	  and	  showed	  high	  levels	  of	  all	  LINE-­‐1	  mRNAs	  in	  TSCs	  and	  low	  expression	  in	  TGCs	  (Figure	  3.6C).	  Therefore,	  the	  data	  suggests	  that	  enrichment	  of	  H2A.Z	  on	  LINE-­‐1s	  during	  TSC	  differentiation	  is	  associated	  with	  a	  dramatic	  reduction	  in	  LINE-­‐1	  expression.	  	  
3.3	  Discussion	  The	  biological	  functions	  of	  H2A.Z	  have	  been	  extensively	  studied,	  especially	  its	  role	  in	  transcriptional	  regulation.	  In	  yeast	  (Guillemette	  et	  al.,	  2005,	  Raisner	  et	  al.,	  2005)	  and	  mammals	  (Barski	  et	  al.,	  2007),	  H2A.Z	  is	  preferentially	  located	  on	  gene	  regulatory	  regions	  such	  as	  promoters,	  insulators	  and	  enhancers.	  However,	  its	  association	  with	  TEs	  has	  not	  been	  extensively	  analysed	  genome-­‐wide.	  Preliminarily	  data	  from	  the	  Tremethick	  laboratory	  implied	  that	  H2A.Z	  could	  associate	  with	  LINE-­‐1s.	  To	  address	  this	  possibility,	  ChIP	  using	  H2A.Z	  and	  H2A	  antibodies	  was	  performed	  in	  mouse	  L929	  cells.	  The	  results	  showed	  that	  H2A.Z	  was	  enriched	  compared	  to	  H2A	  at	  LINE-­‐1s	  in	  general,	  and	  at	  the	  L1Md_A2	  subfamily.	  	  	  The	  spreading	  of	  repressive	  chromatin	  marks	  in	  the	  genome	  may	  regulate	  the	  expression	  of	  nearby	  genes,	  as	  demonstrated	  by	  the	  phenomenon	  of	  position	  effect	  variegation	  (Slotkin	  and	  Martienssen,	  2007,	  Schotta	  et	  al.,	  2003).	  HP1α	  is	  an	  essential	  heterochromatin-­‐associated	  protein	  that	  is	  typically	  involved	  in	  heterochromatin	  formation	  and	  gene	  silencing	  in	  many	  organisms	  (Bernstein	  et	  al.,	  2007).	  Previously,	  it	  was	  shown	  in	  vitro	  that	  HP1α	  specifically	  cooperated	  with	  H2A.Z,	  but	  not	  H2A,	  to	  promote	  nucleosome–nucleosome	  interactions	  and	  the	  formation	  of	  highly	  compacted	  chromatin	  structures	  (Fan	  et	  al.,	  2004).	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Figure 3.4 Characteristics of undifferentiated and differentiated mouse 
trophoblasts.  (A)	  Strategy	  for	  TSC	  differentiation.	  (B)	  Images	  of	  cultured	  mouse	  TSCs	  and	  TGCs.	  Magnification:	  20X.	  (C)	  RNA	  expression	  levels	  of	  markers	  of	  TSCs	  and	  differentiated	  TGCs,	  determined	  using	  real-­‐time	  PCR.	  RNA	  levels	  were	  normalised	  to	  Rplp0	  levels.	  Data	  represents	  the	  mean	  and	  standard	  deviation	  of	  three	  replicates/experiments.	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Figure 3.5 Protein expression levels of H2A.Z change during TSC 
differentiation.  TSCs	  were	  differentiated	  for	  four	  days	  or	  six	  days.	  Together	  with	  TSCs	  (day	  0),	  total	  cell	  lysate	  was	  prepared	  for	  each	  sample,	  followed	  by	  Western	  blot	  analysis	  using	  H2A.Z	  and	  β-­‐actin	  antibodies.	  Total	  Protein	  shows	  the	  membrane	  stained	  with	  Memcode	  TM	  Reversible	  Protein	  Stain	  Kit	  (Thermo	  Fisher,	  USA).	  	  	   	  





Figure 3.6 Distribution of H2A.Z on LINE-1s is associated with LINE-1 
transcript levels in TSCs and TGCs.  (A,	  B)	  ChIP–PCR	  analysis	  of	  H2A.Z	  enrichment	  on	  all	  LINE-­‐1s	  (A)	  or	  the	  L1Md	  A2	  family	  (B).	  Signal	  was	  normalised	  to	  H2A	  enrichment	  and	  the	  dashed	  line	  represents	  a	  threshold	  signal	  of	  1;	  values	  above	  this	  line	  indicate	  enrichment	  for	  H2A.Z,	  and	  those	  below	  indicate	  enrichment	  for	  H2A.	  ChIP	  experiments	  were	  repeated	  three	  times.	  Error	  bars	  indicate	  standard	  deviation.	  (C)	  Real-­‐time	  PCR	  analysis	  of	  LINE-­‐1	  transcript	  levels	  in	  TSCs	  and	  TGCs.	  RNA	  levels	  were	  normalised	  to	  Rplp0	  levels.	  Error	  bars	  indicate	  the	  standard	  deviation	  of	  three	  replicates/experiments.	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To	  investigate	  the	  role	  of	  H2A.Z	  in	  the	  expression	  of	  genes	  neighbouring	  LINE-­‐1s,	  the	  H2A.Z	  and	  HP1α	  occupancy	  across	  a	  genomic	  region	  encompassing	  a	  full-­‐length	  LINE-­‐1,	  several	  truncated	  LINE-­‐1s	  and	  silenced	  genes	  (Mbd3l1	  and	  Muc16)	  was	  analysed	  in	  mouse	  L929	  cells.	  The	  results	  showed	  that	  H2A.Z	  and	  HP1α,	  but	  not	  H2A,	  have	  the	  same	  enrichment	  pattern	  throughout	  this	  repressed	  region	  of	  the	  genome.	  Moreover,	  there	  were	  increased	  levels	  of	  H2A.Z	  and	  HP1α	  on	  the	  LINE-­‐1s	  and	  their	  neighbouring	  repressed	  genes.	  This	  is	  consistent	  with	  a	  study	  showing	  that	  LINE-­‐1	  antisense	  transcript,	  which	  overlaps	  the	  sense	  transcript,	  results	  in	  dsRNA	  production	  and	  is	  subject	  to	  RNAi,	  which	  may	  bring	  genes	  that	  neighbour	  the	  LINE-­‐1	  under	  its	  epigenetic	  control	  (Yang	  and	  Kazazian,	  2006).	  Taken	  together,	  the	  results	  suggest	  that	  H2A.Z	  together	  with	  HP1α	  reinforces	  the	  assembly	  of	  LINE-­‐1s	  into	  a	  repressed	  chromatin	  state.	  	  	  To	  examine	  whether	  the	  enrichment	  of	  H2A.Z	  at	  LINE-­‐1s	  is	  a	  general	  phenomenon	  of	  mammalian	  cells	  and	  correlated	  with	  LINE-­‐1	  repression,	  three	  different	  mouse	  cell	  types	  were	  compared	  (L929,	  MEFs,	  TSCs).	  Interestingly,	  there	  was	  significant	  variability	  of	  H2A.Z	  occupancy	  at	  LINE-­‐1s	  in	  these	  cell	  types,	  which	  was	  directly	  correlated	  with	  differences	  in	  LINE-­‐1	  RNA	  expression.	  Higher	  levels	  of	  LINE-­‐1	  transcripts	  were	  observed	  in	  TSCs	  compared	  to	  MEFs	  and	  L929	  cells.	  This	  increased	  expression	  coincided	  with	  a	  reduced	  ratio	  of	  H2A.Z	  to	  H2A	  in	  each	  region	  of	  all	  LINE-­‐1s.	  Overall,	  the	  high	  level	  of	  H2A.Z	  on	  LINE-­‐1s	  in	  committed	  cells	  (MEFs	  and	  L929	  cells)	  indicates	  that	  H2A.Z	  may	  target	  these	  elements	  for	  chromatin	  repression	  during	  lineage	  specification.	  	  Consequently,	  TSCs	  were	  differentiated	  to	  TGCs	  in	  vitro,	  leading	  to	  decreased	  LINE-­‐1	  transcript	  levels	  during	  TSC	  differentiation.	  Positively	  correlated	  with	  this	  repression	  was	  a	  gain	  in	  H2A.Z	  at	  LINE-­‐1s.	  This	  data	  suggests	  that	  H2A.Z	  may	  repress	  LINE-­‐1	  transcription.	  A	  growing	  body	  of	  experimental	  evidence	  suggests	  that	  LINE-­‐1	  retrotransposition	  may	  occur	  frequently	  during	  early	  development	  (Beck	  et	  al.,	  2011).	  In	  addition,	  LINE-­‐1	  plays	  an	  important	  role	  in	  X-­‐chromosome	  inactivation	  in	  female	  embryonic	  cells	  (Chow	  et	  al.,	  2010).	  This	  epigenetic	  plasticity	  may	  be	  particularly	  important	  for	  modulating	  the	  differentiation	  potential	  of	  progenitor	  or	  stem	  cells	  (Baxter	  et	  al.,	  2004).	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In	  conclusion,	  a	  genome-­‐wide	  study	  identified	  novel	  genomic	  locations	  of	  H2A.Z,	  which	  was	  relatively	  enriched	  in	  LINE-­‐1s	  and	  also	  its	  neighbouring	  genes	  at	  one	  specific	  genomic	  location.	  Combined	  with	  previous	  observations	  that	  H2A.Z	  also	  associates	  with	  satellite	  repeats	  (Greaves	  et	  al.,	  2007,	  Rangasamy	  et	  al.,	  2004,	  Rangasamy	  et	  al.,	  2003),	  it	  argues	  that	  H2A.Z	  has	  an	  important	  role	  in	  repressing	  LINE-­‐1	  expression.	  This	  proposal	  will	  be	  directly	  tested	  in	  the	  next	  chapter.	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CHAPTER 4 
ESTABLISHMENT OF H2A.Z KNOCKDOWN 
SYSTEM IN MOUSE L929 AND 
TROPHOBLAST STEM CELLS 
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4.1	  Introduction	  In	  Chapter	  3,	  H2A.Z	  was	  shown	  to	  be	  enriched	  at	  LINE-­‐1s	  in	  L929	  cells	  (Figures	  3.1	  and	  3.2).	  Moreover,	  there	  was	  an	  increase	  in	  the	  enrichment	  of	  H2A.Z	  at	  LINE-­‐1s	  when	  TSCs	  differentiated	  into	  TGCs,	  which	  was	  correlated	  with	  repression	  of	  LINE-­‐1	  expression	  (Figure	  3.6).	  Together,	  these	  data	  suggest	  that	  H2A.Z	  plays	  a	  role	  in	  repressing	  LINE-­‐1	  expression.	  To	  test	  this	  hypothesis,	  a	  robust	  method	  needed	  to	  be	  established	  for	  modulating	  H2A.Z	  expression	  in	  order	  to	  investigate	  the	  effects	  on	  LINE-­‐1	  expression.	  	  Modulation	  of	  gene	  expression	  can	  be	  achieved	  using	  a	  variety	  of	  approaches,	  such	  as	  RNA	  interference	  (RNAi)	  (Elbashir	  et	  al.,	  2001),	  zinc-­‐finger	  nucleases	  and	  transcription	  activator-­‐like	  effector	  nucleases	  (TALENs)	  (Gaj	  et	  al.,	  2013).	  Recently,	  a	  new	  system	  known	  as	  CRISPR/Cas9	  has	  become	  available,	  which	  is	  incredibly	  powerful	  in	  mammalian	  cell	  studies	  (Cho	  et	  al.,	  2014,	  Cong	  et	  al.,	  2013,	  Jinek	  et	  al.,	  2013,	  Mali	  et	  al.,	  2013).	  The	  variety	  of	  available	  techniques	  leads	  to	  the	  question	  of	  which	  one	  should	  be	  used.	  	  To	  select	  the	  most	  appropriate	  system	  to	  reduce	  the	  expression	  of	  H2A.Z,	  it	  was	  decided	  that	  the	  technique	  should	  generate	  hypomorphic	  knockdown	  rather	  than	  a	  complete	  knockout,	  because	  H2A.Z	  is	  an	  essential	  gene	  whose	  knockout	  would	  be	  lethal	  to	  cells.	  Two	  possible	  approaches	  were	  considered:	  RNAi	  and	  CRISPR/Cas9.	  However,	  while	  the	  rules	  for	  RNAi	  sequence	  design	  have	  been	  developed	  over	  many	  years,	  the	  field	  of	  single	  guide	  RNA	  design	  for	  CRISPR/Cas9	  is	  still	  developing	  and	  improving.	  Endogenous	  chromatin	  structure	  has	  been	  shown	  to	  strongly	  prevent	  Cas9	  binding	  to	  its	  target	  DNA	  site	  (Kuscu	  et	  al.,	  2014,	  Wu	  et	  al.,	  2014).	  Therefore,	  employing	  RNAi	  seemed	  to	  be	  the	  best	  approach.	  	  RNAi-­‐mediated	  gene	  silencing	  is	  a	  powerful	  tool	  and	  has	  been	  widely	  adopted	  for	  silencing	  the	  expression	  of	  specific	  genes	  in	  mammalian	  cells	  (Hannon	  and	  Rossi,	  2004,	  Dorsett	  and	  Tuschl,	  2004).	  It	  involves	  the	  introduction	  of	  an	  artificial	  RNA,	  which	  is	  complementary	  to	  an	  endogenous	  target	  mRNA,	  into	  the	  RNA-­‐induced	  silencing	  complex	  (RISC),	  which	  in	  turn	  promotes	  the	  degradation	  of	  target	  mRNA,	  thereby	  reducing	  target	  protein	  levels	  (Carthew	  and	  Sontheimer,	  2009).	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Having	  determined	  that	  RNAi	  was	  the	  most	  efficient	  and	  viable	  method	  for	  manipulating	  H2A.Z	  expression,	  it	  was	  then	  decided	  to	  use	  shRNAs	  driven	  by	  RNA	  polymerase	  II	  or	  III	  promoters	  (Paddison	  et	  al.,	  2004),	  instead	  of	  chemically	  synthesised	  siRNAs.	  shRNAs	  are	  encoded	  by	  DNA	  vectors,	  so	  they	  can	  be	  delivered	  to	  cells	  in	  any	  of	  the	  innumerable	  ways	  that	  allow	  ectopic	  mRNA	  expression.	  These	  include	  standard	  transient	  transfection,	  stable	  transfection	  and	  delivery	  using	  viruses,	  ranging	  from	  retroviruses	  to	  lentiviruses.	  Expression	  can	  also	  be	  driven	  by	  either	  constitutive	  or	  inducible	  promoters	  (Paddison	  et	  al.,	  2004).	  Constitutive	  expression	  of	  shRNA	  and	  suppression	  of	  gene	  expression	  for	  long	  periods	  impose	  limitations	  when	  analysing	  the	  function	  of	  genes	  essential	  for	  cell	  survival	  (such	  as	  H2A.Z),	  cell	  cycle	  regulation	  and	  cell	  development.	  Generating	  an	  inducible	  knockdown	  system	  can	  circumvent	  these	  limitations,	  as	  inhibition	  of	  gene	  expression	  occurs	  only	  when	  the	  inducing	  agent	  is	  present.	  This	  can	  allow	  control	  of	  the	  level	  of	  gene	  knockdown	  by	  varying	  the	  concentration	  of	  inducing	  agent	  (Gupta	  et	  al.,	  2004).	  	  shRNAs	  can	  be	  expressed	  in	  target	  cells	  using	  either	  plasmid	  or	  viral	  vectors.	  The	  most	  popular	  inducible	  shRNA	  systems	  are	  tetracycline	  controlled	  and	  ecdysone	  controlled	  (Gossen	  et	  al.,	  1995,	  No	  et	  al.,	  1996).	  The	  tetracycline-­‐inducible	  system	  is	  well	  characterised	  and	  has	  been	  used	  extensively	  to	  regulate	  a	  variety	  of	  genes.	  It	  comprises	  two	  expression	  units:	  the	  response	  plasmid,	  in	  which	  the	  gene	  of	  interest	  is	  placed	  under	  the	  tetracycline-­‐inducible	  promoter/tetracycline	  response	  element	  (TRE);	  and	  the	  regulatory	  plasmid,	  containing	  the	  tetracycline	  transactivator	  (rTA)	  or	  reverse	  tetracycline	  transactivator	  (rtTA),	  which	  are	  able	  to	  bind	  the	  inducer	  drug	  (tetracycline,	  or	  its	  analogue	  doxycycline)	  and	  induce	  gene	  knockdown	  in	  vitro	  (van	  de	  Wetering	  et	  al.,	  2003,	  Ohkawa	  and	  Taira,	  2000,	  Matsukura	  et	  al.,	  2003)	  (Figure	  4.1).	  However,	  the	  tetracycline-­‐induced	  system	  has	  certain	  limitations,	  such	  as	  relatively	  high	  background	  expression	  in	  the	  uninduced	  state	  in	  certain	  cell	  lines,	  and	  low	  induction	  of	  shRNA	  expression	  in	  the	  induced	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Figure 4.1 Tetracycline-inducible repression of gene expression. 	  In	  the	  absence	  of	  doxycycline,	  tetracycline	  repressor	  protein	  (tetR)	  binds	  to	  the	  tetO	  element	  placed	  within	  the	  H1	  RNA	  polymerase	  III	  (H1)	  promoter,	  blocking	  access	  of	  the	  RNA	  polymerase	  III	  transcription	  complex	  to	  the	  promoter.	  In	  the	  presence	  of	  the	  drug,	  tetR	  is	  sequestered	  from	  the	  H1	  promoter,	  allowing	  for	  transcription	  of	  shRNAs,	  which	  are	  then	  processed	  by	  Dicer	  to	  yield	  siRNAs.	  Figure	  modified	  from	  (Wiznerowicz	  et	  al.,	  2006).	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state	  (No	  et	  al.,	  1996,	  Van	  Craenenbroeck	  et	  al.,	  2001).	  These	  drawbacks	  have	  limited	  the	  accurate	  and	  quick	  assessment	  of	  gene	  knockdown	  phenotypes.	  	  The	  ecdysone-­‐inducible	  system,	  on	  the	  other	  hand,	  is	  tightly	  regulated	  (Matsukura	  et	  al.,	  2003,	  Stolarov	  et	  al.,	  2001),	  with	  no	  expression	  in	  the	  uninduced	  state	  and	  a	  rapid	  inductive	  response	  (Matsukura	  et	  al.,	  2003).	  It	  comprises	  the	  inducer,	  ponasterone	  A	  (PonA),	  which	  is	  an	  ecdysone	  analogue;	  the	  ecdysone	  receptor	  expression	  vector	  (pERV3	  or	  pVgRXR);	  and	  the	  shRNA	  expression	  vector	  (pIND).	  In	  the	  absence	  of	  ecdysone	  ligand,	  the	  ecdysone	  receptor	  exists	  in	  an	  inactive	  state	  and	  transcription	  of	  shRNA	  is	  repressed.	  In	  the	  presence	  of	  ligand	  (PonA),	  the	  ecdysone	  receptor	  forms	  a	  heterodimer	  with	  the	  retinoid	  X	  receptor,	  which	  then	  binds	  to	  the	  E/GRE	  response	  element	  in	  the	  shRNA	  promoter	  and	  activates	  shRNA	  synthesis	  (Rangasamy	  et	  al.,	  2008)	  (Figure	  4.2).	  Advantages	  of	  an	  ecdysone-­‐based	  system	  include	  the	  lipophilic	  nature	  of	  the	  ecdysone	  inducer	  (No	  et	  al.,	  1996,	  Stolarov	  et	  al.,	  2001),	  which	  facilitates	  efficient	  penetration	  into	  all	  mammalian	  cells,	  and	  the	  lack	  of	  interaction	  of	  ecdysone	  with	  endogenous	  pathways	  in	  mammalian	  cells	  (Van	  Craenenbroeck	  et	  al.,	  2001,	  Gupta	  et	  al.,	  2004).	  These	  advantages	  led	  to	  the	  decision	  to	  use	  the	  ecdysone-­‐inducible	  system	  to	  establish	  H2A.Z	  knockdown.	  	  In	  addition	  to	  bacterial	  vectors,	  viral	  vectors	  are	  also	  used	  for	  shRNA	  expression,	  especially	  in	  resting	  and	  differentiated	  cells	  such	  as	  stem	  cells,	  macrophages	  and	  neurones.	  Lentiviral	  vectors	  are	  particularly	  suited	  to	  long-­‐term	  shRNA	  expression	  and	  gene	  silencing,	  as	  the	  viral	  DNA	  is	  incorporated	  into	  the	  host	  genome.	  Some	  lentiviral	  vectors	  even	  contain	  a	  fluorescent	  marker	  (GFP	  or	  RFP)	  to	  track	  the	  cells	  with	  shRNA	  expression	  in	  real	  time.	  Other	  vectors	  confer	  antibiotic	  resistance,	  such	  as	  to	  puromycin,	  which	  is	  useful	  for	  selecting	  shRNA-­‐expressing	  cells.	  Although	  viral	  vectors	  efficiently	  deliver	  shRNA,	  leading	  to	  stable	  shRNA	  expression,	  they	  may	  also	  be	  toxic	  in	  vivo	  given	  that	  they	  result	  in	  long-­‐term	  shRNA	  expression,	  especially	  for	  genes	  whose	  inactivation	  results	  in	  embryonic	  lethality.	  Thus,	  the	  conditional	  versions	  of	  lentiviral	  RNAi	  vectors	  are	  invaluable	  tools	  to	  express	  shRNA	  only	  when	  needed,	  and	  they	  allow	  study	  of	  the	  kinetics	  of	  gene	  silencing	  and	  determination	  of	  the	  shRNA	  concentration	  needed	  for	  silencing	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Figure 4.2 The ecdysone-inducible RNAi system.  Functional	  ecdysone	  receptor	  components,	  ecdysone	  receptor	  (EcR)	  and	  retinoid	  X	  receptor	  (RXR),	  are	  expressed	  from	  pERV3	  in	  mammalian	  cells. In	  the	  absence	  of	  ecdysone	  ligand	  (−	  PonA),	  the	  receptor	  proteins	  do	  not	  interact	  and	  shRNA	  transcription	  is	  repressed.	  In	  the	  presence	  of	  ligand	  (+	  PonA),	  the	  receptors	  form	  a	  heterodimer	  that	  binds	  to	  the	  E/GRE	  response	  element,	  leading	  to	  shRNA	  transcription	  in	  the	  form	  of	  a	  preprocessed	  structure,	  which	  is	  subsequently	  cleaved	  by	  Drosha	  and	  Dicer	  complexes.	  A	  sample	  structure	  of	  miR-­‐30	  shRNA	  with	  predicted	  Drosha	  and	  Dicer	  cleavage	  sites	  is	  shown.	  The	  sense	  and	  antisense	  shRNA	  strands	  are	  depicted	  in	  green	  and	  red,	  respectively.	  Figure	  adapted	  from	  (Rangasamy	  et	  al.,	  2008).	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(Janas	  et	  al.,	  2006,	  Ventura	  et	  al.,	  2004,	  Tiscornia	  et	  al.,	  2004).	  All	  these	  drug-­‐inducible	  systems	  for	  the	  control	  of	  transgene	  expression	  and	  knockdown	  in	  mammalian	  cells	  are	  invaluable	  tools	  for	  genetic	  research,	  and	  may	  play	  important	  roles	  in	  translational	  research	  or	  gene	  therapy.	  	  In	  addition	  to	  the	  expression	  system,	  choosing	  an	  appropriate	  DNA	  delivery	  method	  is	  also	  important.	  There	  are	  many	  different	  methods,	  including	  electroporation	  (Furuya	  et	  al.,	  2003,	  Zwaka	  and	  Thomson,	  2003),	  nucleofection	  (Amaxa;	  Lonza,	  Cologne,	  Germany)	  (Lakshmipathy	  et	  al.,	  2004,	  Lorenz	  et	  al.,	  2004),	  and	  lipofection,	  a	  liposome-­‐based	  method	  (Eiges	  et	  al.,	  2001,	  Chung	  et	  al.,	  2002).	  The	  limitations	  of	  these	  direct	  gene	  transfer	  methods	  include	  low	  transfection	  efficiencies,	  especially	  in	  differentiated	  cells	  (Eiges	  et	  al.,	  2001,	  Chung	  et	  al.,	  2002),	  severe	  cytotoxic	  effects	  leading	  to	  major	  cell	  death	  (Furuya	  et	  al.,	  2003,	  Zwaka	  and	  Thomson,	  2003),	  and	  transient	  transgene	  expression	  (Lakshmipathy	  et	  al.,	  2004,	  Lorenz	  et	  al.,	  2004).	  A	  number	  of	  viral	  vectors	  have	  been	  developed	  to	  circumvent	  these	  drawbacks.	  With	  effective	  transduction,	  stable	  gene	  expression	  and	  relatively	  low	  cytotoxicity,	  the	  use	  of	  lentiviral	  vectors	  is	  one	  of	  most	  efficient	  and	  powerful	  methods	  for	  gene	  delivery	  in	  a	  variety	  of	  cell	  types	  in	  vitro	  and	  in	  vivo.	  	  In	  this	  chapter,	  the	  primary	  aim	  was	  to	  develop	  an	  ecdysone-­‐inducible	  shRNA	  system	  in	  mouse	  L929	  cells	  and	  TSCs.	  However,	  given	  the	  possibility	  that	  this	  system	  would	  not	  be	  effective	  in	  TSCs	  due	  to	  the	  difficulty	  of	  transfection,	  pTRIPz	  (a	  lentivirus	  inducible	  RNAi	  expression	  system)	  and	  pLVTHM	  (a	  lentivirus	  constitutive	  RNAi	  expression	  system)	  were	  evaluated	  in	  parallel.	  While	  attempting	  to	  use	  a	  commercially	  available	  ecdysone-­‐inducible	  system	  to	  establish	  stable	  H2A.Z	  knockdown	  in	  L929	  cells,	  vectors	  were	  also	  optimised	  to	  allow	  rapid	  selection	  of	  stable	  clones	  using	  fluorescence-­‐activated	  cell	  sorting.	  In	  addition,	  the	  conventional	  TSC	  transfection	  method	  was	  modified	  to	  increase	  transient	  transfection	  efficiency,	  to	  quickly	  assess	  shRNA	  expression.	  Furthermore,	  the	  stable	  H2A.Z	  RNAi	  expression	  system	  was	  successfully	  established	  in	  both	  L929	  cells	  and	  TSCs	  by	  using	  a	  constitutive	  lentiviral	  shRNA	  vector	  (pLVTHM)	  (Figure	  4.3).	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Figure 4.3 Strategies used to establish H2A.Z shRNA systems in L929 
cells and TSCs. 	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4.2	  Results	  
4.2.1 Modification of the mouse TSC transfection method To	  establish	  an	  ecdysone-­‐inducible	  shRNA	  system	  in	  TSCs,	  an	  efficient	  transfection	  protocol	  for	  TSCs	  was	  required,	  as	  TSCs	  are	  very	  difficult	  to	  transfect.	  Two	  transfection	  methods	  were	  tested,	  a	  conventional	  protocol	  based	  on	  the	  transfection	  reagents	  (Lipofectamine	  LTX,	  X-­‐tremeGENE,	  Lipofectamine	  2000)	  manufacturers’	  instructions	  (Figure	  4.4A),	  and	  a	  modified	  protocol	  based	  on	  a	  published	  study	  (Himeno	  et	  al.,	  2008)	  (Figure	  4.5A).	  The	  key	  difference	  between	  the	  protocols	  was	  to	  keep	  TSCs	  in	  suspension	  by	  using	  non-­‐tissue	  culture	  dishes	  during	  transfection.	  The	  cells	  can	  be	  transferred	  to	  tissue	  culture	  dishes	  5	  h	  post-­‐transfection	  (Figure	  4.5	  A).	  	  Specially	  designed	  cationic	  lipids,	  such	  as	  the	  Lipofectamine	  transfection	  reagents,	  facilitate	  DNA	  and	  siRNA	  delivery	  into	  cells	  (Chesnoy	  and	  Huang,	  2000,	  Hirko	  et	  al.,	  2003).	  Two	  different	  cationic	  lipid-­‐mediated	  delivery	  reagents	  were	  used:	  Lipofectamine	  2000	  and	  Lipofectamine	  LTX	  +	  PLUS	  Reagent.	  The	  non-­‐liposomal	  reagent	  X-­‐tremeGENE	  HP	  was	  also	  used,	  due	  to	  its	  reported	  extremely	  low	  cytotoxicity	  and	  high	  transfection	  efficiency	  (Roche	  Diagnostics).	  Cells	  were	  collected	  48	  h	  after	  transient	  transfection	  of	  pEGFP-­‐N1	  plasmid,	  and	  analysed	  by	  flow	  cytometry	  to	  measure	  the	  transfection	  efficiency.	  Flow	  cytometry	  analysis	  showed	  that	  less	  than	  10%	  of	  cells	  were	  transfected	  using	  the	  manufacturers’	  protocol	  for	  all	  three	  transfection	  reagents	  (Figure	  4.4C).	  	  Excitingly,	  the	  modified	  protocol	  showed	  higher	  TSC	  transfection	  efficiency	  (Figure	  4.5C).	  In	  addition,	  increased	  fluorescence	  was	  observed	  when	  the	  cells	  were	  changed	  into	  fresh	  medium	  5	  h	  after	  addition	  of	  the	  transfection	  reagent–DNA	  mixture.	  A	  significant	  difference	  in	  transfection	  efficiency	  between	  Lipofectamine	  LTX	  +	  PLUS	  Reagent	  (49.2%	  and	  53.5%;	  conventional	  protocol	  and	  modified	  protocol,	  respectively)	  and	  X-­‐tremeGENE	  HP	  (12%	  and	  24.4%)	  was	  also	  observed	  (Figure	  4.5C).	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Figure 4.4 Transfection efficiency of TSCs using a conventional protocol 
with different transfection reagents.  (A)	  Strategy	  used	  for	  TSC	  transfection.	  The	  plasmid	  pEGFP-­‐N1	  was	  transiently	  transfected	  into	  TSCs	  using	  three	  different	  transfection	  reagents	  by	  following	  the	  manufacturers’	  protocols.	  (B)	  Transfection	  of	  TSCs	  with	  pUC19	  (empty	  plasmid),	  and	  FACS	  analysis	  for	  setting	  the	  GFP-­‐positive	  (GFP+)	  gate.	  (C)	  FACS	  analysis	  of	  TSCs	  expressing	  GFP,	  with	  GFP	  expression	  represented	  on	  the	  y-­‐axis	  of	  the	  graphs.	  Transfection	  efficiency	  was	  measured	  by	  the	  percentage	  of	  GFP+	  cells.	  FSC,	  forward	  scatter;	  SSC,	  side	  scatter.	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Figure 4.5 Transfection efficiency of TSCs using a modified protocol with 
different transfection reagents.  (A)	  Modified	  strategy	  for	  the	  transfection	  of	  TSCs.	  (B)	  Transfection	  of	  TSCs	  with	  pUC19,	  and	  FACS	  analysis	  for	  setting	  the	  GFP+	  gate.	  (C)	  FACS	  analysis	  for	  TSCs	  expressing	  GFP,	  with	  GFP	  expression	  represented	  on	  the	  y-­‐axis	  of	  the	  graphs.	  Transfection	  efficiency	  was	  measured	  by	  the	  percentage	  of	  GFP+	  cells.	  FSC,	  forward	  scatter;	  SSC,	  side	  scatter.	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In	  conclusion,	  the	  optimal	  TSC	  transient	  transfection	  conditions	  were:	  Lipofectamine	  LTX	  +	  PLUS	  Reagent;	  TSCs	  in	  suspension	  during	  transfection;	  and	  change	  to	  fresh	  medium	  5	  h	  after	  transfection.	  This	  did	  not	  lead	  to	  abnormal	  morphology.	  	  
4.2.2 Design and characterisation of an ecdysone-inducible 
H2A.Z shRNA system 
4.2.2.1 Creating constructs for an ecdysone-inducible shRNA 
system An	  inducible	  system	  for	  vector-­‐based	  shRNA	  knockdown	  of	  H2A.Z	  was	  created.	  An	  ecdysone-­‐inducible	  shRNA	  system	  was	  chosen,	  as	  this	  system	  had	  been	  successfully	  set	  up	  in	  the	  Tremethick	  laboratory	  (Rangasamy	  et	  al.,	  2008).	  	  A	  miR-­‐30-­‐based	  cassette	  was	  designed,	  which	  consisted	  of	  H2A.Z-­‐specific	  stem–loop	  sequences	  that	  were	  designed	  and	  tested	  previously	  in	  the	  Tremethick	  laboratory	  (Rangasamy	  et	  al.,	  2004),	  flanked	  on	  either	  side	  by	  miR-­‐30	  sequences	  (Zeng	  et	  al.,	  2002)	  (Figure	  4.6A).	  Moreover,	  an	  ecdysone-­‐inducible	  system	  that	  carried	  a	  fluorescent	  reporter	  gene	  for	  shRNA	  expression	  was	  created,	  for	  easier	  assessment	  of	  transfection	  and	  induction	  efficiency.	  To	  do	  this,	  the	  pIND	  vector	  was	  modified	  as	  follows.	  H2A.Z	  shRNA	  sequences	  were	  cloned	  into	  the	  pTRIPz	  vector,	  with	  the	  resultant	  H2A.Z-­‐targeting	  vector	  denoted	  pTRIPz-­‐shRNA	  H2A.Z.	  The	  fluorescence	  marker	  TurboRFP	  was	  inserted	  upstream	  of	  the	  shRNAmir	  (shRNA	  H2A.Z),	  between	  the	  Xho	  I	  and	  EcoRI	  restriction	  enzyme	  sites	  (Figure	  4.6B).	  The	  inducible	  expression	  of	  TurboRFP	  enables	  observation	  of	  expression	  from	  the	  E/GRE	  promoter	  in	  the	  pIND	  plasmid,	  allowing	  quick	  assessment	  of	  factors	  such	  as	  basal	  expression,	  transfection	  efficiency,	  induction	  efficacy	  and	  overall	  technical	  success.	  	  The	  pIND	  vector	  was	  created	  by	  deleting	  the	  H2A.Z-­‐GFP	  region	  from	  pIND-­‐H2A.Z-­‐GFP	  and	  inserting	  an	  adaptor	  containing	  Age	  I	  and	  Mlu	  I	  restriction	  enzyme	  sites	  in	  its	  place.	  This	  allowed	  the	  TurboRFP-­‐shRNA	  H2A.Z	  region	  to	  be	  readily	  transferred	  from	  pTRIPz-­‐shRNA	  H2A.Z	  to	  the	  pIND	  vector,	  to	  create	  pIND-­‐RFP-­‐shRNA	  H2A.Z	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(Figure	  4.6B).	  The	  same	  strategy	  was	  used	  to	  create	  pIND-­‐RFP-­‐	  shRNA	  Scramble,	  using	  a	  scrambled	  shRNA	  sequence	  that	  was	  previously	  created	  in	  the	  Tremethick	  laboratory	  (Rangasamy	  et	  al.,	  2004).	  	  Four	  constructs	  were	  used	  in	  the	  modified	  ecdysone-­‐inducible	  shRNA	  system:	  the	  ecdysone	  receptor	  plasmid	  pVgRXR;	  pIND-­‐H2A.Z-­‐GFP	  (the	  base	  vector	  that	  was	  modified),	  for	  ectopic	  H2A.Z	  expression;	  pIND-­‐RFP-­‐shRNA	  H2A.Z;	  and	  pIND-­‐RFP-­‐shRNA	  Scramble.	  	  To	  validate	  if	  the	  modified	  vectors	  were	  functional,	  mouse	  L929	  cells	  were	  transiently	  transfected	  with	  pVgRXR	  and	  ecdysone-­‐inducible	  constructs	  (pIND-­‐RFP-­‐shRNA	  H2A.Z	  or	  pIND-­‐RFP-­‐shRNA	  Scramble),	  and	  induced	  with	  PonA	  for	  24	  h.	  Microscopy	  was	  used	  to	  confirm	  that	  TurboRFP	  was	  successfully	  expressed	  from	  the	  new	  constructs.	  Although	  the	  transfection	  efficiency	  was	  expected	  to	  be	  approximately	  80%,	  RFP-­‐shRNA	  induction	  was	  observed	  in	  only	  10–20%	  of	  cells	  (Figure	  4.7).	  This	  phenomenon	  has	  been	  observed	  in	  other	  studies	  using	  L929sA	  cells	  for	  establishing	  ecdysone-­‐inducible	  stable	  cell	  lines	  (Van	  Craenenbroeck	  et	  al.,	  2001).	  	  
4.2.2.2 Validating H2A.Z knockdown using the ecdysone-inducible 
shRNA system To	  determine	  the	  silencing	  capacity	  of	  the	  modified	  constructs	  on	  H2A.Z	  expression,	  experiments	  were	  performed	  as	  shown	  in	  Figure	  4.8A.	  Vectors	  expressing	  either	  EGFP-­‐tagged	  H2A.Z	  (H2A.Z-­‐GFP)	  or	  EGFP	  alone	  (pEGFP-­‐N1)	  and	  ecdysone-­‐inducible	  shRNA	  were	  transiently	  transfected	  into	  L929	  cells.	  If	  the	  knockdown	  system	  works,	  levels	  of	  the	  ectopically	  expressed	  H2A.Z-­‐GFP	  would	  be	  affected	  and	  be	  detected	  by	  flow	  cytometry,	  but	  expression	  of	  GFP	  alone	  should	  not	  be	  affected.	  The	  gating	  criteria	  were	  created	  using	  GFP-­‐positive	  (GFP+)	  and	  TurboRFP-­‐positive	  (RFP+;	  indicating	  cells	  expressing	  shRNA)	  cells,	  and	  GFP+	  and	  TurboRFP-­‐negative	  (RFP−;	  indicating	  cells	  not	  expressing	  shRNA)	  cells	  (Figure	  4.8B).	  	  
Chapter	  4	  Establishment	  of	  a	  H2A.Z	  Knockdown	  System	  in	  Mouse	  L929	  and	  
Trophoblast	  Stem	  Cells	  
104	  
Flow	  cytometry	  analysis	  revealed	  that	  the	  percentage	  of	  cells	  expressing	  the	  H2A.Z-­‐GFP	  fusion	  protein	  was	  reduced	  following	  transfection	  with	  shRNA	  H2A.Z	  compared	  to	  shRNA	  Scramble	  (Figure	  4.8C).	  EGFP	  expression	  was	  not	  affected	  by	  H2A.Z	  shRNA,	  nor	  was	  there	  a	  change	  in	  H2A.Z-­‐GFP	  expression	  in	  RFP− 	  cells	  (Figure	  4.8D,	  E).	  These	  data	  confirmed	  that	  H2A.Z	  expression	  was	  suppressed	  by	  the	  ecdysone-­‐inducible	  shRNA	  system.	  	  To	  confirm	  that	  endogenous	  H2A.Z	  levels	  were	  reduced,	  L929	  cells	  were	  analysed	  48	  h	  and	  72	  h	  after	  transient	  transfection	  with	  pVgRXR	  and	  pIND-­‐RFP-­‐shRNA	  Scramble	  or	  pVgRXR	  and	  pIND-­‐RFP-­‐shRNA	  H2A.Z,	  and	  induction	  with	  PonA,	  by	  immunofluorescence	  microscopy.	  Single	  RFP+	  cells	  were	  selected	  for	  analysis	  of	  H2A.Z	  expression,	  because	  the	  induction	  of	  shRNA	  expression	  was	  quite	  low	  in	  transiently	  transfected	  cells	  (Figure	  4.7).	  Notably,	  the	  expression	  of	  H2A.Z	  was	  reduced	  in	  shRNA	  H2A.Z-­‐transfected	  cells	  (Figure	  4.9B,	  D)	  compared	  to	  shRNA	  Scramble-­‐transfected	  cells	  (Figure	  4.9A,	  C),	  at	  both	  48	  h	  and	  72	  h	  of	  induction.	  	  Using	  the	  modified	  TSC	  transfection	  protocol	  (Figure	  4.5),	  TSCs	  were	  transiently	  transfected	  with	  the	  ecdysone-­‐inducible	  shRNA	  vectors	  and	  induced	  with	  PonA	  for	  48	  h.	  Figure	  4.10	  shows	  that	  this	  system	  can	  be	  induced	  in	  TSCs,	  but	  the	  induction	  efficiency	  was	  about	  5%,	  even	  though	  the	  transfection	  efficiency	  was	  45%.	  The	  same	  problem	  was	  also	  seen	  in	  L929	  cells.	  	  Following	  these	  transient	  transfection	  experiments	  in	  both	  cell	  types,	  the	  next	  step	  was	  to	  establish	  stable	  cell	  lines.	  To	  select	  a	  stable	  clone	  possessing	  the	  most	  desirable	  characteristics,	  the	  process	  frequently	  involves	  intensive	  cloning,	  cell	  culture	  and	  testing	  of	  each	  candidate	  clone,	  and	  is	  very	  time	  consuming.	  The	  process	  is	  further	  complicated	  here	  due	  to	  the	  need	  to	  stably	  integrate	  two	  vectors,	  and	  the	  low	  induction	  efficiency	  of	  the	  ecdysone-­‐inducible	  system	  in	  L929	  cells	  and	  TSCs	  (Figures	  4.7	  and	  4.10).	  This	  makes	  large-­‐scale	  screening	  for	  useful	  clones	  more	  difficult	  and	  uncertain	  using	  a	  conventional	  strategy.	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Figure 4.6 Strategy to modify the pIND-H2A.Z vector.  (A)	  H2A.Z	  shRNA	  sequences	  were	  synthesised,	  and	  (B)	  cloned	  into	  the	  pTRIPz	  vector,	  to	  produce	  pTRIPz-­‐shRNA	  H2A.Z.	  At	  the	  same	  time,	  the	  pIND-­‐H2A.Z-­‐GFP	  vector,	  which	  has	  an	  ecdysone-­‐inducible	  promoter,	  had	  the	  H2A.Z-­‐GFP	  region	  removed	  and	  an	  adapter	  inserted.	  Then,	  the	  TurboRFP	  (tRFP)	  and	  shRNA	  H2A.Z	  region	  of	  pTRIPz-­‐shRNA	  H2A.Z	  was	  cut	  out	  and	  ligated	  into	  pIND-­‐adaptor,	  to	  create	  pIND-­‐RFP-­‐shRNA	  H2A.Z.	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Figure 4.7 Analysis of mouse L929 cells for induced levels of TurboRFP 
expression.  L929	  cells	  were	  transiently	  transfected	  with	  pVgRXR	  and	  pIND-­‐RFP-­‐shRNA	  H2A.Z	  or	  pIND-­‐RFP-­‐shRNA	  Scramble.	  Cells	  were	  analysed	  48	  h	  post-­‐transfection.	  Magnification:	  10X.	  Phase,	  phase	  contrast.	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Figure 4.8 Validation of the ecdysone-inducible H2A.Z shRNA system in 
mouse L929 cells.  (A)	  Strategy	  used	  to	  assess	  the	  knockdown	  of	  ectopic	  H2A.Z	  expression	  using	  the	  inducible	  H2A.Z	  shRNA	  system.	  (B)	  FACS	  analysis	  gating	  criteria	  used	  for	  these	  experiments.	  (C,	  E)	  FACS	  analysis	  of	  L929	  cells	  48	  h	  post-­‐transfection	  with	  pIND-­‐H2A.Z-­‐GFP	  and	  either	  pIND-­‐RFP-­‐shRNA	  Scramble	  (grey	  filled	  curve)	  or	  pIND-­‐RFP-­‐shRNA	  H2A.Z	  (red	  curve),	  and	  induction	  with	  PonA.	  (C)	  shows	  GFP+	  RFP+	  gating,	  while	  (E)	  shows	  GFP+	  RFP− 	  gating.	  (D)	  FACS	  analysis	  of	  L929	  cells	  48	  h	  post-­‐transfection	  with	  pEGFP-­‐N1	  and	  either	  pIND-­‐RFP-­‐shRNA	  Scramble	  (grey	  filled	  curve)	  or	  pIND-­‐RFP-­‐shRNA	  H2A.Z	  (red	  curve),	  and	  induction	  with	  PonA.	  GFP+	  RFP+	  gating	  was	  used.	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Figure 4.9 Immunofluorescence analysis for the detection of endogenous 
H2A.Z expression following knockdown in L929 cells.  Knockdown of	  endogenous	  H2A.Z	  by	  inducible	  shRNA	  in	  L929	  cells	  transfected	  with	  pVgRXR	  and	  pIND-­‐RFP-­‐shRNA	  Scramble,	  or	  pVgRXR	  and	  pIND-­‐RFP-­‐shRNA	  H2A.Z.	  Cells	  were	  stained	  with	  an	  antibody	  against	  H2A.Z	  (green),	  and	  nuclei	  were	  stained	  with	  DAPI	  (grey).	  (A,	  B)	  Cells	  were	  induced	  with	  PonA	  (5	  µM)	  for	  48	  h.	  (C,	  
D)	  cells	  were	  induced	  with	  PonA	  (5	  µM)	  for	  72	  h.	  Magnification:	  60X.	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Figure 4.10 Analysis of TSCs for the induction of RFP-shRNA expression 
using the ecdysone-inducible shRNA system.  TSCs	  were	  transiently	  transfected	  with	  pVgRXR	  and	  pIND-­‐RFP-­‐shRNA	  Scramble,	  or	  pVgRXR	  and	  pIND-­‐RFP-­‐shRNA	  H2A.Z,	  and	  induced	  with	  PonA	  (5	  µM)	  for	  48	  h.	  Magnification:	  10X.	  Phase,	  phase	  contrast.	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To	  improve	  the	  probability	  of	  successfully	  obtaining	  clones	  that	  express	  TurboRFP	  (and	  so	  shRNA)	  upon	  PonA	  treatment,	  a	  selection	  strategy	  was	  used	  to	  enrich	  for	  cells	  stably	  transfected	  with	  the	  ecdysone	  receptor	  vector	  pVgRXR	  (resistant	  to	  Zeocin),	  in	  which	  a	  transiently	  transfected	  inducible	  reporter	  plasmid	  can	  be	  successfully	  induced	  upon	  the	  addition	  of	  PonA	  (Figure	  4.11).	  A	  polyclonal	  population	  of	  pVgRXR	  stably	  transfected	  cells	  was	  transiently	  transfected	  with	  pIND-­‐GFP,	  in	  which	  the	  EGFP	  reporter	  gene	  was	  under	  the	  control	  of	  the	  ecdysone	  promoter.	  The	  resulting	  cells	  were	  sorted	  for	  EGFP-­‐expressing	  cells	  using	  FACS	  sorting.	  Following	  expansion	  of	  the	  sorted	  cells,	  and	  two	  further	  rounds	  of	  sorting,	  the	  percentage	  of	  responding	  (GFP+)	  cells	  was	  not	  significantly	  increased	  (10%	  vs	  12%).	  This	  made	  the	  possibility	  of	  selecting	  stable	  cell	  lines	  with	  a	  stably	  integrated	  second	  vector	  (pIND-­‐RFP-­‐shRNA	  Scramble	  or	  pIND-­‐RFP-­‐shRNA	  H2A.Z)	  unlikely	  to	  succeed.	  Therefore,	  it	  was	  decided	  to	  change	  to	  a	  lentiviral	  system,	  pTRIPz.	  	  
4.2.3 Establishment and validation of an inducible lentiviral 
system in mouse L929 cells Lentiviral	  transduction	  has	  several	  advantages	  over	  traditional	  methods	  such	  as	  lipid-­‐mediated	  plasmid	  transfection	  or	  electroporation.	  They	  include	  high	  efficiency	  of	  infection	  of	  both	  dividing	  and	  non-­‐dividing	  cells,	  and	  long-­‐term	  stable	  expression	  of	  transgenes.	  The	  system	  used	  here	  is	  the	  pTRIPz	  lentivirus	  inducible	  shRNAmir	  system,	  which	  was	  developed	  by	  Open	  Biosystems	  and	  is	  engineered	  to	  be	  a	  Tet-­‐On	  system.	  Tet-­‐On	  technology	  allows	  the	  pTRIPz	  vector	  to	  provide	  for	  induced	  expression	  of	  shRNAmir	  in	  the	  presence	  of	  doxycycline.	  Two	  added	  features	  of	  pTRIPz	  are	  that	  the	  tetracycline-­‐inducible	  promoter	  drives	  the	  expression	  of	  a	  TurboRFP	  reporter	  gene	  in	  addition	  to	  the	  shRNAmir,	  and	  the	  vector	  contains	  a	  puromycin	  antibiotic	  resistance	  marker.	  The	  induced	  expression	  of	  TurboRFP	  allows	  for	  detection	  of	  expression	  from	  the	  TRE	  promoter,	  for	  quick	  assessment	  of	  factors	  such	  as	  basal	  expression,	  viral	  titre,	  transduction	  efficiency	  and	  overall	  technical	  success.	  In	  addition,	  stably	  transduced	  cells	  can	  be	  selected	  by	  the	  antibiotic	  puromycin.	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pTRIPz	  empty	  vector	  and	  pTRIPz	  shRNA	  Scramble	  vector	  were	  originally	  obtained	  from	  Open	  Biosystems.	  A	  pTRIPz-­‐shRNA	  H2A.Z	  vector	  had	  been	  constructed	  when	  creating	  pIND-­‐RFP-­‐shRNA	  H2A.Z	  (Figure	  4.6).	  To	  determine	  if	  the	  pTRIPz	  system	  functions	  in	  L929	  cells,	  the	  lentiviruses	  were	  produced	  and	  used	  to	  infect	  L929	  cells,	  as	  shown	  in	  Figure	  4.12.	  After	  stably	  transduced	  L929	  cell	  lines	  were	  generated,	  2	  µg/mL	  of	  doxycycline	  was	  added	  to	  the	  cells	  and	  TurboRFP	  expression	  was	  assessed	  at	  24–72	  h	  after	  induction	  by	  fluorescence	  microscopy.	  The	  highest	  induction	  efficiency,	  greater	  than	  80%,	  was	  observed	  at	  72	  h	  (Figure	  4.13).	  	  
4.2.4 Establishment of an inducible lentiviral system in 
mouse TSCs The	  same	  strategy	  as	  in	  Figure	  4.12	  was	  used	  to	  attempt	  to	  produce	  a	  doxycycline-­‐inducible	  lentiviral	  system	  in	  TSCs,	  but	  unfortunately	  it	  was	  not	  successful	  in	  TSCs.	  Few	  cells	  were	  TurboRFP-­‐positive	  after	  induction,	  and	  almost	  all	  the	  cells	  died	  during	  puromycin	  selection,	  indicating	  that	  TSCs	  were	  not	  successfully	  infected.	  There	  were	  two	  possibilities:	  low	  titre	  of	  lentivirus,	  which	  results	  in	  low	  transduction	  efficiency	  of	  TSCs;	  or	  low	  efficiency	  of	  the	  promoter	  in	  the	  vector,	  which	  may	  lead	  to	  very	  low	  levels	  of	  shRNA	  expression	  in	  TSCs.	  Experiments	  were	  performed	  to	  determine	  which	  of	  these	  possibilities	  was	  involved	  and	  to	  solve	  the	  problem.	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Figure 4.11 Strategy used to obtain an enriched population of inducer 
(L929-pVgRXR) cells.  First,	  pVgRXR	  was	  transfected	  into	  L929	  cells,	  followed	  by	  antibiotic	  selection	  for	  pVgRXR	  stably	  transfected	  cells	  using	  Zeocin.	  Then	  pIND-­‐GFP	  was	  transiently	  transfected	  into	  a	  polyclonal	  population	  of	  pVgRXR	  stably	  transfected	  cells,	  followed	  by	  induction	  using	  PonA.	  FACS	  sorting	  was	  used	  to	  select	  the	  GFP+	  cells,	  which	  indicated	  the	  cells	  with	  good	  transfection	  and	  induction.	  The	  cells	  were	  expanded	  and	  then	  sorted	  for	  GFP+	  cells	  two	  more	  times.	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Figure 4.12 Procedure for mouse L929 cell infection with lentivirus. 	  HEK293	  cells	  were	  transfected	  with	  pTRIPz-­‐shRNA	  Scramble	  or	  pTRIPz-­‐shRNA	  H2A.Z,	  in	  combination	  with	  pMD2.G	  and	  psPAX2,	  using	  Lipofectamine	  2000.	  The	  medium	  was	  changed	  6	  h	  later.	  Viral	  supernatants	  were	  harvested	  at	  48	  h	  post-­‐transfection	  and	  then	  used	  to	  infect	  mouse	  L929	  cells	  with	  polybrene	  (5	  µg/mL).	  Two	  days	  after	  infection,	  puromycin	  (2	  µg/mL)	  was	  used	  to	  select	  for	  transduced	  cells.	  Selection	  was	  complete	  after	  seven	  days	  of	  puromycin	  treatment.	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Figure 4.13 Analysis of L929 shRNA Scramble and L929 shRNA H2A.Z 
stable cell lines.  RFP+	  cells	  (expressing	  shRNA)	  were	  checked	  in	  the	  absence	  of	  doxycycline	  (−)	  and	  in	  presence	  of	  2	  µg/mL	  doxycycline	  (Dox)	  at	  24	  h,	  48	  h	  and	  72	  h	  after	  induction.	  Magnification:	  10X.	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Lentiviral	  titre	  can	  be	  increased	  by	  concentrating	  the	  lentiviral	  supernatants	  using	  ultracentrifugation.	  However,	  as	  the	  Tremethick	  laboratory	  has	  neither	  the	  approval	  nor	  the	  equipment	  to	  perform	  lentiviral	  ultracentrifugation,	  an	  alternative	  procedure	  was	  selected	  to	  concentrate	  viral	  supernatants,	  using	  Lenti-­‐X	  Concentrator.	  Since	  there	  are	  few	  studies	  reporting	  the	  use	  of	  this	  reagent,	  a	  trial	  viral	  concentration	  procedure	  using	  Lenti-­‐X	  Concentrator	  was	  performed	  in	  L929	  cells,	  as	  shown	  in	  Figure	  4.14.	  The	  lentiviral	  expression	  vector	  pLVTHM	  was	  used	  for	  producing	  virus,	  because	  it	  has	  constitutive	  GFP	  expression.	  The	  results	  demonstrated	  that	  most	  of	  the	  virus	  was	  functional,	  and	  transduction	  efficiency	  was	  substantially	  increased,	  to	  about	  90%,	  following	  concentration	  using	  Lenti-­‐X	  Concentrator	  (Figure	  4.15).	  	  As	  for	  the	  possibility	  of	  low	  transduction	  efficiency,	  there	  are	  conflicting	  reports	  about	  the	  activity	  of	  different	  promoters	  in	  different	  cells,	  while	  several	  studies	  have	  suggested	  that	  transcriptional	  inactivation	  of	  promoters	  occurs	  during	  selection	  of	  stably	  transfected	  cells	  (Chung	  et	  al.,	  2002,	  Lorenz	  et	  al.,	  2004,	  Ward	  and	  Stern,	  2002).	  To	  assess	  the	  transcriptional	  activities	  of	  different	  promoters	  using	  lentiviral	  vectors	  in	  TSCs,	  lentivirus	  was	  produced	  from	  pTRIPz	  and	  pLVTHM	  vectors	  (Figure	  4.16),	  concentrated	  with	  Lenti-­‐X	  Concentrator	  and	  used	  to	  infect	  TSCs.	  GFP	  expression	  was	  analysed	  48	  h	  post-­‐transduction	  with	  pLVTHM	  lentivirus,	  while	  TurboRFP	  expression	  was	  examined	  48	  h	  post-­‐transduction	  with	  pTRIPz	  lentivirus	  and	  induction	  with	  doxycycline.	  Although	  more	  RFP+	  cells	  were	  observed	  following	  Lenti-­‐X	  concentration	  for	  pTRIPz	  lentivirus	  (data	  not	  shown),	  the	  transduction	  efficiency	  of	  pLVTHM	  lentivirus	  was	  much	  higher	  than	  that	  of	  pTRIPz	  lentivirus	  (GFP+	  cells	  vs.	  RFP+	  cells;	  Figure	  4.17).	  This	  indicates	  that	  the	  elongation	  factor	  1α	  (EF1α)	  promoter	  in	  pLVTHM	  drove	  higher	  transgene	  expression	  than	  the	  cytomegalovirus	  (CMV)	  promoter	  in	  pTRIPz.	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Figure 4.14 Strategy used to assess the transduction efficiency after using 
Lenti-X Concentrator.  HEK293	  cells	  were	  transfected	  with	  pLVTHM	  in	  combination	  with	  pMD2.G	  and	  psPAX2,	  using	  Lipofectamine	  2000.	  The	  medium	  was	  changed	  after	  6	  h.	  Viral	  supernatant	  was	  harvested	  at	  48	  h	  post-­‐transfection,	  and	  concentrated	  from	  6	  mL	  down	  to	  60	  µL.	  Serial	  dilutions	  of	  concentrated	  viral	  pellet	  (10-­‐,	  50-­‐	  and	  400-­‐fold)	  were	  used	  to	  infect	  L929	  cells.	  As	  a	  control,	  unconcentrated	  viral	  supernatant,	  and	  10-­‐	  and	  50-­‐fold	  serial	  dilutions,	  were	  used	  to	  infect	  L929	  cells.	  Analysis	  for	  GFP+	  cells	  was	  performed	  24	  h	  and	  48	  h	  post-­‐transduction.	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Figure 4.15 Analysis of viral infection efficiency in L929 cells using Lenti-X 
Concentrator.  More	  GFP+	  cells	  were	  observed	  following	  viral	  concentration	  using	  Lenti-­‐X	  Concentrator	  (+Lenti-­‐X)	  than	  without	  it	  (−Lenti-­‐X).	  Images	  are	  shown	  post-­‐transduction	  (24	  h	  and	  48	  h).	  Magnification:	  10X.	  Phase,	  phase	  contrast.	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Figure 4.16 Detailed vector maps of pTRIPz and pLVTHM lentiviral vectors. (A)	  pTRIPz	  lentiviral	  vector,	  which	  produces	  a	  single	  transcript	  containing	  TurboRFP	  and	  shRNAmir	  from	  the	  CMV	  promoter	  (circled),	  and	  has	  a	  puromycin	  drug	  resistant	  marker	  for	  selecting	  stable	  cell	  lines.	  (B)	  pLVTHM	  lentiviral	  vector,	  which	  has	  GFP	  expressed	  from	  the	  EF1α	  promoter	  (circled),	  and	  a	  separate	  transcript	  for	  the	  shRNA,	  which	  is	  expressed	  from	  the	  H1	  promoter. 	   	  
Chapter	  4	  Establishment	  of	  a	  H2A.Z	  Knockdown	  System	  in	  Mouse	  L929	  and	  
Trophoblast	  Stem	  Cells	  
120	  
	  
Figure 4.17 Analysis of GFP and TurboRFP expression in TSCs. TSCs	  were	  transduced	  with	  concentrated	  pLVTHM	  or	  pTRIPz	  lentivirus,	  and	  analysed	  48	  h	  post-­‐transduction	  (and	  after	  induction	  with	  doxycycline	  (Dox)	  for	  pTRIPz).	  Magnification:	  20X.	  Phase,	  phase	  contrast.	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EGFP	  was	  shown	  to	  have	  highest	  expression	  when	  driven	  by	  the	  EF1α	  promoter	  in	  undifferentiated	  ESCs	  (Hong	  et	  al.,	  2007).	  As	  shown	  above,	  the	  EF1α	  promoter	  outperformed	  CMV	  in	  undifferentiated	  TSCs.	  In	  addition,	  the	  optimal	  concentration	  of	  puromycin	  selection	  for	  TSCs	  (1	  µg/mL)	  killed	  most	  cells	  following	  transduction	  with	  pTRIPz	  virus.	  As	  the	  selection	  process	  to	  produce	  stable	  cell	  lines	  can	  be	  problematic,	  the	  pLVTHM	  vector	  was	  selected	  to	  create	  the	  lentiviral	  constructs	  for	  H2A.Z	  knockdown	  in	  TSCs.	  	  Two	  different	  19	  nt	  shRNA	  H2A.Z	  target	  sequences	  were	  selected,	  shRNA	  H2A.Z-­‐1	  and	  shRNA	  H2A.Z-­‐2	  (Figure	  4.18C),	  which	  have	  been	  previously	  published	  (Rangasamy	  et	  al.,	  2004,	  Creyghton	  et	  al.,	  2008).	  To	  quickly	  and	  efficiently	  generate	  shRNA	  constructs,	  a	  strategy	  from	  the	  Wiznerowicz	  laboratory	  was	  used,	  to	  directly	  clone	  shRNA	  sequences	  into	  the	  pLVTHM	  vector	  by	  annealing	  two	  complementary	  shRNA	  oligonucleotides	  (Wiznerowicz	  et	  al.,	  2006)	  (Figure	  4.18A,	  B).	  The	  two	  lentiviral	  constructs	  harbouring	  different	  siRNAs	  (shRNA	  H2A.Z-­‐1	  and	  shRNA	  H2A.Z-­‐2)	  were	  used	  to	  infect	  L929	  cells.	  In	  parallel,	  a	  negative	  control	  non-­‐targeting	  shRNA	  (shRNA	  Control)	  was	  used.	  The	  infection	  efficiencies	  of	  these	  lentiviral	  vectors	  were	  all	  above	  80%,	  as	  shown	  by	  fluorescence	  microscopy	  (Figure	  4.19).	  Stably	  transduced	  L929	  cell	  lines	  were	  obtained	  by	  FACS	  sorting	  for	  GFP+	  cells	  (Figure	  4.20).	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Figure 4.18 H2A.Z shRNA design and cloning strategy for pLVTHM vector. (A)	  Schematic	  of	  the	  pLVTHM	  vector,	  showing	  the	  Cla	  I	  and	  Mlu	  I	  cloning	  sites	  for	  shRNA	  insertion.	  (B)	  Schematic	  of	  shRNA	  synthesis.	  The	  sense	  and	  antisense	  target	  sequences,	  (N)19,	  are	  shown	  in	  red	  and	  blue,	  respectively.	  (C)	  Schematic	  representation	  of	  two	  H2A.Z	  hairpin	  targeting	  sequences	  (red	  and	  blue).	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Figure 4.19 Fluorescence microscopy analysis of the infection efficiencies 
of different lentiviral vectors in L929 cells.  L929	  cells	  were	  infected	  with	  lentiviral	  particles	  harbouring	  a	  non-­‐targeting	  control	  shRNA	  (Scramble)	  and	  two	  different	  shRNAs	  against	  H2A.Z	  (H2A.Z-­‐1	  and	  H2A.Z-­‐2).	  (A–C)	  Phase-­‐contrast	  (Phase)	  images,	  and	  (D–F)	  GFP	  fluorescence	  images.	  Magnification:	  10X.	  Phase,	  phase	  contrast.	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Figure 4.20 FACS sorting strategy for establishing L929 cell lines stably 
transduced with pLVTHM-shRNA.  (A,	  B)	  Single-­‐cell	  gating	  criteria.	  (C,	  D)	  GFP+	  cell	  gating	  criteria.	  FSC,	  forward	  scatter;	  SSC,	  side	  scatter.	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Expression	  of	  the	  H2A.Z	  shRNAs	  resulted	  in	  the	  efficient	  and	  specific	  reduction	  of	  H2A.Z	  expression	  at	  both	  the	  mRNA	  and	  protein	  level	  in	  L929	  cells,	  compared	  to	  a	  control	  cell	  line	  expressing	  a	  non-­‐targeting	  shRNA,	  As	  reported	  previously,	  the	  knockdown	  of	  H2A.Z	  resulted	  in	  a	  small	  increase	  H2A	  expression	  (Figure	  4.21).	  shRNA	  H2A.Z-­‐1	  was	  selected	  for	  use	  in	  further	  experiments,	  because	  it	  had	  a	  higher	  knockdown	  efficiency,	  about	  70%	  knockdown	  in	  mRNA	  and	  protein	  level	  of	  H2A.Z	  compared	  to	  the	  control	  cells	  .	  This	  lentiviral	  construct	  was	  renamed	  pLVTHM-­‐shRNA	  H2A.Z-­‐1.	  	  Before	  pLVTHM-­‐shRNA	  H2A.Z-­‐1	  was	  used	  to	  transduce	  TSCs,	  the	  knockdown	  efficiency	  was	  first	  examined	  by	  transient	  transfection	  using	  the	  modified	  protocol	  outlined	  in	  section	  4.2.1	  (Figure	  4.22A).	  To	  investigate	  changes	  in	  endogenous	  H2A.Z	  levels,	  TSCs	  were	  transiently	  transfected	  with	  pLVTHM-­‐shRNA	  Control	  or	  pLVTHM-­‐shRNA	  H2A.Z-­‐1	  and	  analysed	  after	  48	  h	  by	  immunofluorescence	  staining.	  Single	  GFP+	  cells	  were	  selected	  for	  analysis	  of	  H2A.Z	  expression.	  Notably,	  H2A.Z	  expression	  was	  reduced	  in	  shRNA	  H2A.Z-­‐transfected	  cells	  compared	  to	  both	  shRNA	  Control-­‐transfected	  cells	  and	  untransfected	  cells	  (which	  are	  GFP−;	  Figure	  4.22B).	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Figure 4.21 shRNA-mediated H2A.Z depletion in L929 cells.  (A)	  H2A.Z	  protein	  abundance	  was	  determined	  by	  immunoblot	  analysis,	  showing	  its	  specific	  reduction	  in	  the	  stable	  shRNA	  H2A.Z-­‐1	  and	  H2A.Z-­‐2	  L929	  cells	  compared	  to	  the	  control	  cell	  line	  (Control),	  whereas	  no	  reduction	  in	  histone	  H2A	  or	  tubulin	  levels	  was	  observed.	  MemCode	  staining	  served	  as	  an	  internal	  control	  to	  show	  equal	  loading	  (Total	  protein).	  (B)	  H2A.Z	  mRNA	  levels	  were	  reduced	  in	  shRNA	  H2A.Z-­‐1	  L929	  cells,	  as	  measured	  by	  real-­‐time	  PCR	  relative	  to	  the	  control	  (shRNA	  Control)	  cell	  line.	  Data	  were	  normalised	  to	  Rplp0,	  and	  the	  error	  bars	  represent	  the	  standard	  deviation	  of	  three	  replicates.	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Figure 4.22 Immunofluorescence analysis of H2A.Z expression in TSCs 
following transfection with shRNA H2A.Z.  (A)	  Strategy	  for	  transient	  transfection	  of	  TSCs.	  (B)	  Knockdown	  of	  H2A.Z	  by	  transient	  transfection	  with	  pLVTHM-­‐shRNA	  Control	  or	  pLVTHM-­‐shRNA	  H2A.Z-­‐1.	  Cells	  were	  stained	  with	  an	  antibody	  against	  H2A.Z	  (grey),	  and	  nuclei	  were	  stained	  with	  DAPI	  (blue).	  Comparing	  GFP+	  cells	  expressing	  either	  shRNA	  Control	  or	  shRNA	  H2A.Z-­‐1	  (green	  arrows),	  H2A.Z	  staining	  was	  reduced	  in	  cells	  expressing	  shRNA	  H2A.Z-­‐1.	  Further,	  H2A.Z	  staining	  was	  lower	  in	  GFP+	  cells	  (green	  arrows)	  vs.	  GFP− 	  cells	  (grey	  arrows)	  in	  the	  shRNA	  H2A.Z-­‐1	  transfection,	  but	  not	  in	  the	  shRNA	  Control	  transfection.	  Magnification:	  60X.	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To	  establish	  an	  efficient	  and	  stable	  lentivirus-­‐mediated	  gene	  knockdown	  system	  in	  TSCs,	  TSCs	  were	  infected	  with	  pLVTHM-­‐shRNA	  Control	  or	  H2A.Z-­‐1	  by	  modifying	  a	  published	  protocol	  (Odiatis	  and	  Georgiades,	  2010)	  (Figure	  4.23).	  This	  protocol	  resulted	  in	  over	  40%	  of	  TSCs	  per	  well	  being	  transduced,	  as	  judged	  by	  the	  percentage	  of	  GFP-­‐expressing	  TSCs	  in	  70CM	  +	  F4H	  medium	  (undifferentiated	  cell	  medium)	  at	  three	  days	  after	  infection.	  Cells	  were	  sorted	  to	  enrich	  for	  GFP+	  cells	  by	  FACS	  sorting	  at	  five	  days	  post-­‐transduction,	  followed	  by	  culturing	  in	  70CM	  +	  F4H	  medium	  (Figure	  4.24).	  	  To	  examine	  whether	  lentiviral	  transduction	  and	  lentivirus-­‐mediated	  knockdown	  by	  themselves	  had	  any	  adverse	  effects	  on	  TSC	  self-­‐renewal	  and	  differentiation,	  gross	  cell	  morphology	  and	  marker	  gene	  expression	  profiles	  were	  compared	  between	  uninfected	  and	  shRNA	  Control-­‐infected	  TSCs	  cultured	  in	  either	  undifferentiated	  cell	  medium	  or	  differentiation	  medium.	  No	  appreciable	  differences	  were	  observed	  between	  uninfected	  and	  infected	  TSCs	  cultured	  in	  either	  undifferentiated	  cell	  medium	  or	  differentiation	  medium	  (Figure	  4.25).	  shRNA	  Control-­‐infected	  TSCs	  grown	  in	  differentiation	  medium	  for	  six	  days	  developed	  typical	  giant	  cell	  morphology,	  consisting	  of	  an	  enlarged	  nucleus	  with	  perinuclear	  granules	  (Figure	  4.25E–H).	  	  Moreover,	  undifferentiated	  TSC	  markers	  (Cdx2,	  Eomes)	  (Tanaka	  et	  al.,	  1998)	  were	  expressed	  at	  similar	  levels	  in	  both	  infected	  and	  uninfected	  cells	  grown	  in	  undifferentiated	  cell	  medium,	  and	  their	  expression	  was	  decreased	  upon	  culture	  in	  differentiation	  medium	  (Figure	  4.26A,	  B),	  while	  expression	  of	  the	  giant	  cell	  marker	  
PL-­‐1	  was	  increased	  (Figure	  4.26C).	  These	  results	  indicated	  that	  the	  pLVTHM	  lentiviral	  system	  can	  be	  used	  to	  transduce	  TSCs	  with	  high	  efficiency	  and	  has	  no	  detectable	  adverse	  effects	  on	  TSC	  behaviour.	  	  Importantly,	  TSC	  transduction	  with	  pLVTHM-­‐shRNA	  H2A.Z-­‐1resulted	  in	  efficient	  H2A.Z	  knockdown	  in	  cells	  cultured	  in	  undifferentiated	  cell	  medium,	  about	  60%	  knockdown	  at	  both	  the	  mRNA	  and	  protein	  level	  compared	  to	  control	  cells	  (Figure	  4.27).	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Figure 4.23 Strategy for TSC infection with lentivirus.  HEK293	  cells	  were	  transfected	  with	  pLVTHM-­‐shRNA	  Control	  or	  pLVTHM-­‐shRNA	  H2A.Z-­‐1	  in	  combination	  with	  pMD2.G	  and	  psPAX2	  using	  a	  calcium	  phosphate	  transfection	  method	  (see	  section	  2.3.3.1).	  Viral	  particles	  were	  concentrated	  with	  Lenti-­‐X	  Concentrator	  and	  used	  to	  infect	  TSCs.	  Five	  days	  post-­‐transduction,	  cells	  were	  FACS	  sorted	  for	  transduced	  GFP+	  cells.	  The	  gating	  criteria	  that	  were	  used	  are	  shown.	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Figure 4.24 Lentiviral-transduced TSCs after cell sorting.  TSCs	  were	  transduced	  with	  pLVTHM-­‐shRNA	  Control	  (A,	  B)	  or	  pLVTHM-­‐shRNA	  H2A.Z-­‐1	  (C,	  D).	  Cells	  were	  grown	  in	  undifferentiated	  cell	  medium	  and	  viewed	  using	  phase	  contrast	  (Phase;	  A,	  C)	  or	  GFP	  fluorescence	  (B,	  D)	  imaging.	  Magnification:	  20X.	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Figure 4.25 Maintenance of TSC differentiation characteristics following 
lentiviral transduction.  Both	  uninfected	  TSCs	  (A–D)	  and	  TSCs	  infected	  with	  shRNA	  Control	  (E–L)	  were	  cultured	  in	  differentiation	  medium	  for	  six	  days.	  Images	  were	  captured	  at	  day	  0	  (A,	  E,	  I),	  day	  2	  (B,	  F,	  J),	  day	  4	  (C,	  G,	  K)	  and	  day	  6	  (D,	  H,	  L),	  using	  both	  bright-­‐field	  (A–H)	  and	  GFP	  fluorescence	  (I–L)	  imaging.	  Magnification	  20X.	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Figure 4.26 Gene expression profiles of uninfected and pLVTHM-shRNA 
Control-infected TSCs and TGCs.  TSCs	  were	  cultured	  in	  differentiation	  medium	  for	  six	  days.	  Real-­‐time	  PCR	  analysis	  was	  used	  to	  assess	  (A)	  Cdx2,	  (B)	  Eomes	  and	  (C)	  PL-­‐I	  marker	  expression.	  No	  significant	  differences	  were	  seen	  for	  all	  genes	  assessed	  for	  a	  given	  day	  between	  uninfected	  (black	  columns)	  and	  infected	  (grey	  columns)	  cells.	  Data	  were	  normalised	  to	  Rplp0,	  and	  error	  bars	  represent	  the	  standard	  deviation	  of	  three	  experiments.	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Figure 4.27 H2A.Z expression was decreased in TSCs infected with 
pLVTHM-shRNA H2A.Z-1.  (A)	  H2A.Z	  protein	  abundance	  was	  determined	  by	  immunoblot	  analysis,	  showing	  that	  it	  was	  specifically	  reduced	  in	  TSCs	  transduced	  with	  shRNA	  H2A.Z-­‐1	  compared	  to	  the	  control	  cells.	  No	  changes	  in	  histone	  H2A	  or	  actin	  levels	  were	  observed.	  MemCode	  staining	  served	  as	  an	  internal	  control	  to	  show	  equal	  loading	  (Total	  protein)	  (B)	  H2A.Z	  mRNA	  levels	  were	  reduced	  upon	  shRNA	  H2A.Z-­‐1	  suppression	  of	  H2A.Z,	  as	  measured	  by	  real-­‐time	  PCR	  in	  H2A.Z-­‐depleted	  TSCs	  relative	  to	  the	  control	  cell	  line	  (shRNA	  Control).	  Data	  were	  normalised	  to	  Rplp0,	  and	  error	  bars	  represent	  the	  standard	  deviation	  of	  three	  experiments.	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4.3	  Discussion	  To	  establish	  a	  H2A.Z	  knockdown	  system	  in	  mouse	  L929	  cells	  and	  TSCs,	  three	  different	  shRNA	  expression	  systems	  were	  studied:	  the	  ecdysone-­‐inducible	  RNAi	  system,	  the	  pTRIPz	  lentivirus	  inducible	  RNAi	  system	  and	  the	  pLVTHM	  lentivirus	  constitutive	  RNAi	  expression	  system.	  Stable	  H2A.Z	  knockdown	  cell	  lines	  were	  created	  by	  using	  the	  tetracycline-­‐inducible	  lentiviral	  shRNA	  vector	  pTRIPz	  in	  L929	  cells,	  and	  the	  constitutive	  lentiviral	  shRNA	  vector	  pLVTHM	  in	  TSCs.	  The	  data	  demonstrated	  that	  each	  system	  has	  its	  advantages	  and	  drawbacks	  for	  shRNA	  expression	  in	  different	  mammalian	  cells.	  	  Previously,	  the	  efficacy	  of	  the	  ecdysone-­‐inducible	  RNAi	  system	  for	  H2A.Z	  was	  evaluated	  in	  both	  mouse	  and	  human	  cell	  lines	  (Rangasamy	  et	  al.,	  2004,	  Greaves	  et	  al.,	  2007).	  In	  this	  thesis,	  less	  than	  half	  of	  the	  clones	  responded	  to	  the	  ecdysone	  inducer	  (Figure	  4.7).	  Hence,	  it	  was	  necessary	  to	  test	  individual	  clones	  for	  their	  induction	  ability,	  which	  was	  further	  complicated	  by	  very	  low	  transfection	  efficiency	  in	  TSCs.	  To	  overcome	  this	  limitation,	  the	  conventional	  Lipofectamine	  transfection	  method	  was	  modified,	  which	  resulted	  in	  significantly	  increased	  TSC	  transfection	  efficiency.	  Next,	  a	  commercially	  available	  ecdysone-­‐inducible	  vector	  was	  modified	  by	  adding	  a	  feature	  of	  the	  pTRIPz	  vector,	  an	  RNA	  polymerase	  II	  promoter	  that	  drives	  the	  expression	  of	  a	  TurboRFP	  reporter	  gene	  in	  addition	  to	  shRNA	  (Figure	  4.6).	  This	  TurboRFP-­‐inducible	  expression	  enables	  the	  user	  to	  easily	  observe	  expression	  from	  the	  RNA	  polymerase	  II	  promoter,	  allowing	  quick	  assessment	  of	  overall	  technical	  success.	  	  This	  new	  vector	  with	  a	  fluorescent	  reporter	  for	  shRNA	  expression	  was	  tested	  for	  its	  knockdown	  capacity	  in	  L929	  cells	  and	  TSCs.	  Transient	  transfection	  of	  both	  cell	  lines	  with	  the	  modified	  ecdysone-­‐inducible	  vector	  did	  result	  in	  inducible	  expression	  of	  reporter	  protein	  (TurboRFP)	  (Figures	  4.7	  and	  4.10).	  Moreover,	  stable	  clones	  of	  L929	  cells	  and	  TSCs	  that	  gave	  the	  desired	  induction	  could	  not	  be	  obtained,	  even	  after	  antibiotic	  selection	  (Figure	  4.11).	  This	  may	  be	  explained	  by	  limitations	  of	  the	  heterodimerisation	  of	  the	  ecdysone	  receptor	  (EcR)	  with	  the	  retinoid	  X	  receptor	  (RXR)	  in	  mammalian	  cells.	  RXR	  (found	  in	  most	  mammalian	  cell	  types)	  is	  a	  reluctant	  dimer	  partner	  of	  EcR,	  and	  very	  high	  endogenous	  RXR	  levels	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are	  necessary	  for	  stimulation	  to	  occur.	  EcR	  is	  unable	  to	  support	  high-­‐level	  transactivation	  in	  the	  vast	  majority	  of	  mammalian	  cell	  types	  without	  high	  levels	  of	  the	  RXR	  dimer	  partner	  supplied	  by	  transfection	  (Yao	  et	  al.,	  1993,	  Yao	  et	  al.,	  1992,	  Suhr	  et	  al.,	  1998,	  Thomas	  et	  al.,	  1993).	  	  Despite	  having	  optimised	  the	  transfection	  conditions	  and	  included	  a	  reporter	  gene	  in	  the	  ecdysone	  system,	  stable	  clones	  could	  not	  be	  obtained	  in	  either	  L929	  cells	  or	  TSCs.	  Thus,	  a	  viral	  system	  for	  vector-­‐based	  expression	  of	  shRNAs	  was	  used	  instead.	  Two	  different	  lentiviral	  expression	  vectors	  were	  created	  for	  stable	  expression	  of	  H2A.Z	  shRNA	  in	  L929	  cells	  and	  TSCs	  (Figure	  4.16).	  pTRIPz	  was	  used	  as	  it	  would,	  in	  principle,	  result	  in	  the	  high	  transduction	  and	  induction	  efficiency	  in	  L929	  cells	  (Figure	  4.13).	  	  	  In	  contrast,	  it	  was	  not	  possible	  to	  create	  TSC	  pTRIPz-­‐shRNA	  stable	  clones.	  Aside	  from	  the	  need	  to	  concentrate	  the	  virus,	  reduced	  efficiency	  of	  the	  promoter	  in	  this	  vector	  may	  have	  caused	  shRNA	  expression	  problems	  in	  TSCs	  (C.	  Odiatis	  and	  P.	  Georgiades,	  personal	  communication).	  Studies	  have	  shown	  that	  promoter	  choice	  directly	  affects	  target	  gene	  knockdown	  efficiency,	  and	  hence	  could	  determine	  the	  success	  of	  an	  experiment.	  The	  CMV	  promoter	  has	  been	  reported	  to	  be	  much	  less	  active	  in	  lymphohematopoietic	  cells	  such	  as	  T	  cells,	  B	  cells	  and	  monocytes,	  although	  it	  provides	  very	  efficient	  expression	  in	  many	  cancer	  cell	  lines	  of	  fibroblastic	  and	  epithelial	  origin	  (An	  et	  al.,	  2000,	  Salmon	  et	  al.,	  2000).	  It	  was	  demonstrated	  that	  lentiviral	  vector-­‐mediated	  transgene	  expression	  in	  endothelial	  progenitor	  cells	  was	  dependent	  on	  the	  appropriate	  gene	  promoter	  (Hong	  et	  al.,	  2007).	  	  Indeed,	  the	  EF1α	  promoter	  in	  the	  pLVTHM	  vector	  drove	  higher	  expression	  of	  a	  fluorescent	  protein	  reporter	  than	  the	  CMV	  promoter	  of	  pTRIPz	  (Figure	  4.17).	  Consistent	  with	  this	  result,	  it	  was	  shown	  that	  the	  EF1α	  promoter	  directed	  the	  highest	  level	  of	  transgene	  expression	  among	  all	  the	  promoters	  tested	  (the	  composite	  CAG	  promoter,	  the	  human	  PGK-­‐1	  promoter,	  the	  murine	  stem	  cell	  virus	  (MSCV)	  LTR,	  and	  the	  gibbon	  ape	  leukaemia	  virus	  (GALV)	  LTR),	  and	  the	  CMV	  promoter	  was	  the	  weakest	  in	  undifferentiated	  ESCs	  and	  embryoid	  body	  cells	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(Hong	  et	  al.,	  2007).	  It	  is	  still	  unclear	  whether	  promoter	  activities	  change	  during	  the	  differentiation	  of	  TSCs.	  Future	  experiments	  could	  focus	  on	  the	  expression	  of	  shRNAs	  and	  GFP	  at	  different	  stages	  of	  TSC	  differentiation.	  	  Finally,	  the	  lentiviral	  pLVTHM	  vector	  was	  used	  to	  establish	  TSCs	  stably	  transduced	  with	  shRNA	  H2A.Z,	  as	  it	  mediated	  gene	  knockdown	  in	  a	  large	  proportion	  of	  TSCs	  due	  to	  its	  high	  transduction	  efficiency	  (Figure	  4.24).	  However,	  only	  about	  50%	  of	  TSCs	  were	  transduced,	  despite	  using	  a	  similar	  protocol	  to	  that	  used	  in	  the	  Georgiades	  laboratory,	  which	  they	  reported	  gave	  a	  90%	  transduction	  efficacy	  (Odiatis	  and	  Georgiades,	  2010).	  The	  only	  two	  differences	  between	  the	  protocols	  are	  that	  12-­‐well	  plates	  (Corning)	  were	  used	  for	  transduction	  and	  a	  chemical	  reagent	  (Lenti-­‐X	  Concentrator)	  was	  used	  to	  concentrate	  virus	  in	  the	  current	  study,	  instead	  of	  IVF	  4-­‐well	  dishes	  (Nunc)	  and	  ultracentrifugation	  used	  in	  their	  study,	  due	  to	  limited	  resources	  in	  the	  Tremethick	  laboratory.	  It	  is	  unknown	  whether	  these	  differences	  affected	  the	  transduction	  efficiency.	  However,	  a	  similar	  transduction	  efficiency	  to	  that	  observed	  in	  this	  thesis	  was	  obtained	  even	  when	  using	  the	  IVF	  4-­‐well	  dishes	  and	  ultracentrifugation	  (Abell	  et	  al.,	  2011).	  	  To	  establish	  pure	  transduced	  stable	  cell	  lines,	  additional	  steps	  were	  employed	  to	  enrich	  for	  transduced	  cells,	  based	  on	  GFP	  expression.	  Although	  strict	  gating	  criteria	  were	  used	  to	  exclude	  cell	  doublets	  (Figure	  4.23),	  due	  to	  the	  tight	  epithelial	  morphology	  of	  TSCs	  it	  is	  still	  not	  possible	  to	  select	  a	  completely	  pure	  transduced	  cell	  population.	  For	  this	  reason,	  the	  addition	  of	  antibiotic	  selection	  could	  be	  used	  to	  eliminate	  this	  problem	  in	  future	  experiments.	  	  The	  advantages	  and	  drawbacks	  of	  the	  three	  RNAi	  systems	  that	  were	  used	  in	  this	  thesis	  are	  summarised	  in	  Table	  4.1,	  based	  on	  the	  results	  observed	  in	  L929	  cells	  and	  TSCs.	  In	  conclusion,	  a	  method	  for	  knocking	  down	  H2A.Z	  in	  TSCs	  was	  identified	  and	  validated.	  Moreover,	  the	  results	  demonstrated	  that	  the	  value	  of	  the	  system	  to	  be	  used	  for	  shRNA	  expression	  is	  determined	  by	  the	  specific	  aims	  of	  the	  study.	  Most	  importantly,	  it	  should	  be	  considered	  that	  the	  success	  of	  a	  given	  expression	  system	  mainly	  depends	  on	  the	  cell	  type	  used.	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Table 4.1 Comparison of H2A.Z knockdown systems in L929 cells and 
TSCs 
	   Type	  of	  
system	  








• Control	  the	  level	  of	  H2A.Z	  knockdown	  
• Tightly	  regulated	  
• A	  lipophilic	  inducer,	  which	  is	  efficient	  in	  all	  mammalian	  cells	  
o Clonal	  variation:	  not	  all	  clones	  respond	  to	  inducer	  
o Restricted	  to	  certain	  cell	  type	  
o Time-­‐consuming	  to	  establish	  stable	  cell	  line	  
pTRIPz	  
System	  
Lentivirus	  system	   • Efficiently	  deliver	  shRNA	  
• Stable	  shRNA	  expression	  
• Antibiotic	  resistant	  
• Control	  the	  level	  of	  H2A.Z	  knockdown	  
o CMV-­‐based	  promoter	  inefficiently	  drives	  shRNA	  expression	  in	  certain	  cells.	  E.g.	  TSCs	  
pLVTHM	  
System	  
Lentivirus	  system	   • Efficiently	  deliver	  shRNA	  
• Stable	  shRNA	  expression	  
• GFP	  marker	  
• EF1α	  promoter	  works	  efficiently	  in	  TSCs	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5.1	  Introduction	  There	  are	  ~7,000	  full-­‐length	  LINE-­‐1s	  in	  the	  human	  genome(Rangwala	  et	  al.,	  2009),	  whereas	  the	  mouse	  genome	  has	  almost	  16,000.	  Although	  the	  majority	  of	  LINE-­‐1	  copies	  in	  the	  mammalian	  genome	  are	  truncated	  at	  their	  5ʹ′	  ends	  and	  are	  transcriptionally	  and	  retrotranspositionally	  incompetent,	  a	  number	  of	  potentially	  active	  elements	  exist	  in	  both	  human	  and	  mouse	  genomes	  (80-­‐100	  and	  3000,	  respectively)	  (Cordaux	  and	  Batzer,	  2009).	  The	  functional	  properties	  of	  LINE-­‐1s	  are	  of	  significant	  biological	  interest.	  The	  activity	  of	  intact	  elements	  can	  cause	  mutation,	  disrupt	  regulatory	  elements,	  induce	  genomic	  instability	  and	  even	  drive	  genome	  evolution	  (Burns	  and	  Boeke,	  2012,	  Cordaux	  and	  Batzer,	  2009).	  Some	  mobility	  of	  young,	  active	  LINE-­‐1s	  is	  observed	  during	  early	  embryogenesis	  (Kano	  et	  al.,	  2009),	  in	  neuronal	  precursor	  cells	  (Coufal	  et	  al.,	  2009)	  and	  cancer	  cells	  (Belancio	  et	  al.,	  2008).	  LINE-­‐1s	  can	  induce	  ectopic	  gene	  expression	  in	  embryonic	  and	  cancer	  tissues,	  which	  demonstrates	  their	  potential	  roles	  in	  both	  development	  and	  tumorigenesis	  (Faulkner	  et	  al.,	  2009).	  	  Given	  the	  potential	  danger	  of	  LINE-­‐1	  retrotransposition	  causing	  genomic	  damage,	  host	  cells	  use	  a	  variety	  of	  defences	  against	  retrotransposons	  to	  prevent	  deleterious	  insertions,	  including	  epigenetic	  mechanisms	  mediated	  by	  CpG	  promoter	  DNA	  methylation	  (Richardson,	  2003,	  Yu	  et	  al.,	  2001,	  Hata	  and	  Sakaki,	  1997),	  piRNAs	  (Aravin	  et	  al.,	  2007a),	  endogenous	  siRNAs	  (Kawamura	  et	  al.,	  2008,	  Hock	  and	  Meister,	  2008,	  Czech	  et	  al.,	  2008)	  and	  chromatin	  modifications.	  	  Several	  chromatin	  modifications	  are	  believed	  to	  have	  evolved	  to	  regulate	  and	  restrict	  LINE-­‐1	  expression	  in	  both	  germline	  and	  somatic	  cells.	  For	  example,	  H3K9me2,	  a	  repressive	  chromatin	  modification,	  contributed	  to	  LINE-­‐1	  silencing	  during	  spermatogenesis,	  along	  with	  DNA	  methylation	  and	  a	  piRNA	  mechanism	  (Di	  Giacomo	  et	  al.,	  2013).	  A	  high	  level	  of	  H3K9me3,	  another	  repressive	  chromatin	  modification,	  was	  found	  at	  several	  LTR	  and	  LINE	  families	  in	  both	  somatic	  and	  germ	  cells	  (Pezic	  et	  al.,	  2014).	  In	  mouse	  ESCs,	  a	  function	  of	  Suv39h-­‐dependent	  H3K9me3	  chromatin	  methylation	  was	  to	  specifically	  repress	  intact	  LINE-­‐1s	  in	  the	  ESC	  epigenome	  (Bulut-­‐Karslioglu	  et	  al.,	  2014).	  However,	  in	  committed	  cells	  (neural	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progenitor	  cells,	  induced	  MEFs),	  Suv39h-­‐dependent	  H3K9me3	  methylation	  was	  progressively	  lost	  from	  LINE-­‐1s,	  and	  this	  decline	  was	  compensated	  by	  an	  increase	  in	  DNA	  methylation	  (Bulut-­‐Karslioglu	  et	  al.,	  2014).	  However,	  the	  role	  of	  histone	  variants	  in	  this	  process	  has	  been	  poorly	  investigated.	  	  Several	  lines	  of	  evidence	  have	  hinted	  at	  a	  role	  for	  H2A.Z	  in	  controlling	  LINE-­‐1s.	  H2A.Z	  plays	  an	  essential	  role	  in	  maintaining	  the	  integrity	  of	  mammalian	  constitutive	  heterochromatin,	  a	  domain	  enriched	  in	  DNA	  satellite	  repeats	  (Greaves	  et	  al.,	  2007).	  The	  abundance	  of	  H2A.Z	  relative	  to	  H2A	  at	  heterochromatin	  can	  vary	  dramatically	  in	  a	  differentiation	  state-­‐dependent,	  cell-­‐specific	  and	  chromosome-­‐specific	  manner.	  Furthermore,	  H2A.Z	  is	  localised	  to	  the	  promoters	  of	  genes	  in	  various	  systems,	  suggesting	  a	  role	  in	  gene	  regulation	  (Valdes-­‐Mora	  et	  al.,	  2012,	  Conerly	  et	  al.,	  2010,	  Cui	  et	  al.,	  2009).	  However,	  the	  direct	  function	  of	  H2A.Z	  in	  LINE-­‐1	  expression	  had	  not	  been	  explored.	  	  It	  was	  shown	  in	  Chapter	  3	  that	  cell	  type	  differences	  observed	  in	  H2A.Z	  enrichment	  at	  LINE-­‐1s	  had	  an	  inverse	  relationship	  with	  LINE-­‐1	  expression	  (Figure	  3.3).	  Moreover,	  LINE-­‐1	  expression	  was	  reduced	  during	  TSC	  differentiation,	  also	  corresponding	  with	  an	  increase	  in	  H2A.Z	  deposition	  at	  LINE-­‐1s.	  It	  is	  not	  clear	  however,	  if	  the	  gain	  of	  H2A.Z	  is	  a	  cause	  of	  this	  repression	  or	  its	  deposition	  at	  these	  elements	  is	  a	  consequence	  of	  them	  becoming	  silenced.	  Having	  successfully	  introduced	  a	  lentiviral-­‐based	  H2A.Z	  knockdown	  system	  into	  L929	  cells	  and	  TSCs	  (see	  Chapter	  4),	  the	  hypothesis	  that	  H2A.Z	  may	  be	  directly	  responsible	  for	  the	  transcriptional	  silencing	  of	  LINE-­‐1s	  could	  be	  rigoursly	  tested.	  	  
5.2	  Results	  
5.2.1 LINE-1 transcript levels were increased by H2A.Z 
silencing in L929 cells To	  examine	  whether	  H2A.Z	  plays	  a	  role	  in	  suppressing	  the	  expression	  of	  LINE-­‐1s,	  mouse	  L929	  cells	  were	  transduced	  with	  lentivirus	  from	  which	  H2A.Z	  shRNA	  is	  constitutively	  produced,	  then	  cellular	  RNA	  was	  isolated	  to	  assess	  LINE-­‐1	  expression	  by	  real-­‐time	  PCR.	  The	  results	  showed	  that	  loss	  of	  H2A.Z	  produced	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significant	  upregulation	  in	  the	  level	  of	  LINE-­‐1	  transcripts	  (Figure	  5.1).	  Moreover,	  increased	  expression	  was	  not	  evenly	  distributed	  along	  LINE-­‐1.	  Instead,	  the	  upregulation	  was	  relatively	  high	  at	  the	  LINE-­‐1	  5ʹ′	  end,	  in	  the	  region	  that	  corresponds	  to	  several	  copies	  of	  the	  ~200	  bp	  monomers	  that	  function	  as	  a	  promoter,	  and	  at	  ORF1,	  but	  dropped	  towards	  LINE-­‐1	  ORF2.	  This	  transcript	  level	  difference	  across	  LINE-­‐1	  was	  associated	  with	  the	  asymmetric	  distribution	  of	  H2A.Z	  along	  these	  elements	  (Figure	  3.1A),	  as	  H2A.Z	  levels	  on	  the	  5ʹ′	  UTR	  and	  ORF1	  of	  LINE-­‐1s	  were	  higher	  on	  average	  than	  H2A.Z	  levels	  on	  ORF2.	  	  It	  is	  possible	  that	  the	  expression	  of	  silenced	  genes	  flanking	  LINE-­‐1s	  may	  also	  be	  regulated	  by	  H2A.Z,	  given	  that	  the	  heterochromatin	  formed	  at	  LINE-­‐1s	  may	  be	  able	  to	  spread	  (Chow	  et	  al.,	  2010).	  To	  test	  this,	  different	  sets	  of	  primers,	  either	  spanning	  or	  not	  spanning	  intron–exon	  junctions,	  were	  designed	  to	  detect	  the	  silent	  genes	  
Mbd3l1	  and	  Muc16.	  As	  described	  in	  Chapter	  3,	  Mbd3l1	  is	  embedded	  between	  a	  full-­‐length	  LINE-­‐1	  (L1Md_F2)	  and	  several	  non-­‐functional	  LINE-­‐1s,	  while	  Muc16	  is	  only	  6.5	  kb	  from	  L1Md_F2	  (Figure	  3.2A).	  Mbd3l1	  is	  predominantly	  expressed	  in	  the	  testis,	  specifically	  in	  round	  spermatids	  (Jiang	  et	  al.,	  2002)	  while	  Muc16	  may	  have	  a	  role	  in	  the	  metastasis	  of	  ovarian	  cancer	  cells	  (Scholler	  et	  al.,	  2007,	  Gubbels	  et	  al.,	  2006,	  Rump	  et	  al.,	  2004).	  Real-­‐time	  PCR	  failed	  to	  detect	  any	  transcripts	  for	  these	  two	  genes	  (data	  not	  shown),	  either	  in	  shRNA	  Control	  or	  H2A.Z-­‐depleted	  cells,	  showing	  that	  H2A.Z	  by	  itself	  is	  not	  required	  for	  the	  silencing	  of	  these	  genes.	  	  To	  determine	  whether	  H2A.Z	  knockdown	  altered	  the	  expression	  of	  active	  gene	  neighbouring	  a	  LINE-­‐1,	  the	  transcription	  of	  DNA	  polymerase	  I	  (Pol	  I)	  was	  examined	  in	  H2A.Z-­‐depleted	  L929	  cells.	  Pol	  I	  is	  only	  5	  kb	  away	  from	  LINE-­‐1s	  and	  is	  expressed	  in	  L929	  cells.	  There	  was	  no	  significant	  upregulation	  of	  Pol	  I	  mRNA	  when	  H2A.Z	  was	  depleted	  (Figure	  5.1).	  Taken	  together,	  the	  results	  showed	  that	  LINE-­‐1	  transcripts	  are	  elevated	  in	  cells	  depleted	  of	  H2A.Z.	  In	  contrast,	  the	  expression	  of	  genes	  neighbouring	  LINE-­‐1s	  is	  not	  affected,	  suggesting	  that	  H2A.Z	  may	  selectively	  repress	  LINE-­‐1s	  while	  other	  potentally	  redundant	  mechanisms	  act	  to	  regulate	  neighbouring	  genes.	  	  	   	  




Figure 5.1 Depletion of H2A.Z in L929 cells leads to increased levels of 
LINE-1 transcripts.  The	  relative	  levels	  of	  LINE-­‐1	  (L1)	  and	  DNA	  polymerase	  I	  (Pol	  I)	  mRNA	  were	  determined	  by	  real-­‐time	  PCR.	  Data	  were	  normalised	  to	  the	  reference	  gene	  Rplp0	  and	  are	  shown	  relative	  to	  control	  L929	  cells	  (shRNA	  Control),	  which	  had	  transcript	  levels	  set	  to	  1.	  Error	  bars	  represent	  the	  standard	  deviation	  of	  three	  experiments.	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5.2.2 Differential regulation of LINE-1s by H2A.Z between 
undifferentiated and differentiated trophoblast cells To	  test	  the	  hypothesis	  that	  H2A.Z	  plays	  a	  direct	  role	  in	  the	  repression	  of	  LINE-­‐1	  expression	  during	  TSC	  differentiation,	  mouse	  TSCs	  were	  transduced	  with	  lentivirus	  that	  has	  constitutive	  H2A.Z	  shRNA	  production.	  Cells	  were	  sorted	  by	  flow	  cytometry	  to	  enrich	  for	  transduced	  cells,	  and	  both	  shRNA	  Control	  and	  H2A.Z-­‐depleted	  TSCs	  were	  differentiated	  to	  TGCs.	  LINE-­‐1	  transcript	  levels	  were	  determined	  using	  real-­‐time	  PCR	  (Figure	  5.2A).	  	  First,	  we	  wondered,	  even	  though	  H2A.Z	  is	  already	  depleted	  on	  active	  LINE-­‐1s	  in	  TSCs,	  what	  would	  be	  the	  consequence	  of	  further	  depleting	  H2A.Z.	  Surprisingly,	  LINE-­‐1	  transcript	  levels	  were	  considerably	  reduced	  in	  H2A.Z-­‐depleted	  TSCs	  compared	  to	  control	  TSCs	  (Figure	  5.2B).	  To	  confirm	  that	  this	  reduction	  in	  TSC	  LINE-­‐1	  expression	  was	  not	  due	  to	  the	  cells	  having	  differentiated	  into	  TGCs	  (in	  which	  LINE-­‐1	  expression	  is	  lower;	  see	  Figure	  3.6),	  it	  was	  determined	  whether	  H2A.Z	  knockdown	  in	  TSCs	  affected	  maintenance	  of	  their	  stem	  cell	  state	  but	  this	  was	  not	  the	  case.	  Notably,	  H2A.Z-­‐depleted	  TSCs	  showed	  typical	  colony	  morphology	  (Figure	  5.3I,	  M),	  and	  expressed	  the	  TSC	  markers	  Cdx2,	  Esrrb	  and	  Fgfr2	  at	  levels	  similar	  to	  control	  cells	  (Figure	  5.4A–C).	  Moreover,	  removal	  of	  FGF4	  from	  the	  culture	  medium	  promoted	  the	  differentiation	  of	  H2A.Z-­‐depleted	  TSCs	  into	  trophoblast	  lineages	  similar	  to	  control	  TSCs,	  as	  showed	  by	  morphology	  (Figure	  5.3D,	  H,	  L,	  P),	  and	  by	  the	  loss	  of	  stem	  cell	  marker	  expression	  and	  the	  increased	  expression	  of	  the	  PL-­‐I	  differentiation	  marker	  (Figure	  5.4).	  How,	  then,	  does	  the	  reduction	  in	  H2A.Z	  levels	  lead	  to	  a	  reduction	  in	  LINE-­‐1	  transcript	  levels	  in	  TSCs,	  instead	  of	  increased	  levels?	  In	  considering	  this	  question,	  it	  must	  be	  remembered	  that	  H2A.Z	  can	  be	  present	  in	  different	  forms	  due	  to	  post-­‐translational	  modifications,	  as	  outlined	  in	  section	  1.2.3,	  and	  the	  H2A.Z	  modification	  state	  can	  be	  as	  important	  as	  the	  presence	  or	  absence	  of	  H2A.Z	  at	  a	  particularly	  genomic	  location.	  Acetylated	  H2A.Z	  (acH2A.Z)	  is	  a	  good	  candidate	  to	  investigate,	  as	  it	  is	  enriched	  at	  the	  promoters	  of	  active	  genes	  (Bruce	  et	  al.,	  2005,	  Hu	  et	  al.,	  2013,	  Ku	  et	  al.,	  2012,	  Valdes-­‐Mora	  et	  al.,	  2012).	  The	  relationship	  between	  acH2A.Z	  and	  LINE-­‐1	  expression	  was	  determined	  by	  comparing	  the	  profiles	  of	  this	  mark	  in	  TSCs	  and	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TGCs	  using	  ChIP	  and	  real-­‐time	  PCR	  analysis.	  The	  TSS	  of	  Cdx2	  was	  used	  as	  a	  positive	  control,	  because	  this	  gene	  is	  only	  expressed	  in	  TSCs.	  Whereas	  total	  H2A.Z	  levels	  at	  LINE-­‐1s	  was	  lower	  in	  TSCs	  than	  in	  TGCs	  (Figure	  3.6),	  the	  reverse	  was	  true	  for	  acH2A.Z;	  its	  levels	  were	  higher	  in	  TSCs	  than	  in	  TGCs,	  especially	  at	  the	  5ʹ′	  UTR	  (Figure	  5.5).	  The	  results	  suggest	  that	  promoter-­‐associated	  H2A.Z	  is	  predominately	  acetylated	  in	  activate	  LINE-­‐1s	  in	  TSCs.	  	  Next,	  the	  effect	  of	  the	  loss	  of	  H2A.Z	  on	  LINE-­‐1s	  expression	  was	  examined	  in	  TGCs.	  Interestingly,	  increased	  expression	  of	  LINE-­‐1s	  was	  observed	  in	  H2A.Z-­‐depleted	  TGCs	  compared	  to	  control	  TGCs	  (Figure	  5.6).	  Detailed	  analysis	  of	  different	  LINE-­‐1	  regions	  revealed	  that	  the	  expression	  of	  ORF2	  was	  largely	  unaltered	  in	  H2A.Z-­‐depleted	  TGCs	  compared	  to	  either	  control	  TGCs	  or	  H2A.Z-­‐depleted	  TSCs	  (Figure	  5.6).	  Together,	  these	  results	  suggested	  that	  during	  TSC	  differentiation,	  acH2A.Z	  is	  lost	  from	  LINE-­‐1s	  while	  the	  total	  level	  of	  H2A.Z	  occupancy	  of	  LINE-­‐1s	  increases,	  especially	  at	  the	  5ʹ′	  UTR	  and	  in	  ORF1,	  to	  silence	  LINE-­‐1	  transcription.	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Figure 5.2 Depletion of H2A.Z in TSCs decreases LINE-1 transcript levels.  (A)	  Strategy	  to	  knock	  down	  H2A.Z	  in	  TSCs	  and	  to	  induce	  differentiation.	  TSCs	  were	  transduced	  with	  lentivirus	  and	  sorted	  by	  flow	  cytometry	  to	  enrich	  for	  transduced	  cells,	  followed	  by	  differentiation	  in	  TS	  medium	  (without	  FGF4	  and	  heparin)	  for	  six	  days.	  (B)	  Real-­‐time	  PCR	  analysis	  for	  LINE-­‐1	  transcript	  levels	  in	  TSCs.	  Data	  were	  normalised	  to	  Rplp0	  and	  are	  shown	  relative	  to	  control	  TSCs	  (transduced	  with	  shRNA	  Control	  lentivirus).	  Experiments	  were	  performed	  three	  times	  and	  error	  bars	  represent	  the	  standard	  deviation.	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Figure 5.3 Trophoblast morphology during differentiation is similar 
between control and H2A.Z-deficient TSCs.  Both	  shRNA	  Control	  (a–h)	  and	  shRNA	  H2A.Z-­‐1	  (i–p)	  TSCs	  were	  cultured	  in	  differentiation	  medium	  for	  six	  days.	  Images	  were	  captures	  at	  day	  0	  (a,	  e,	  i,	  m),	  day	  2	  (b,	  f,	  j,	  n),	  day	  4	  (c,	  g,	  k,	  o)	  and	  day	  6	  (d,	  h,	  l,	  p),	  using	  bright-­‐field	  (a–d,	  i–l)	  or	  GFP	  fluorescence	  (e–h,	  m–p)	  imaging.	  Magnification:	  20X.	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Figure 5.4 Expression of TSC stemness genes in control and H2A.Z-
depleted TSCs and TGCs.  TSCs	  were	  cultured	  in	  differentiation	  medium	  for	  six	  days,	  and	  the	  cells	  were	  analysed	  by	  real-­‐time	  PCR.	  No	  significant	  differences	  were	  found	  for	  all	  genes	  assessed	  (Cdx-­‐2,	  Esrrb,	  Fgfr2,	  PL-­‐I)	  between	  shRNA	  Control	  (black	  columns)	  and	  shRNA-­‐H2A.Z-­‐1	  (grey	  columns)	  TSCs	  and	  TGCs.	  Data	  were	  normalised	  to	  Rplp0.	  Experiments	  were	  performed	  three	  times	  and	  error	  bars	  represent	  the	  standard	  deviation.	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Figure 5.5 Enrichment of acH2A.Z on LINE-1s in TSCs and TGCs. 	  ChIP–PCR	  analysis	  of	  acH2A.Z	  enrichment	  was	  performed	  on	  all	  LINE-­‐1s.	  Signal	  was	  normalised	  to	  input.	  The	  dashed	  line	  represents	  the	  threshold	  signal,	  which	  was	  set	  at	  the	  enrichment	  of	  acH2A.Z	  on	  an	  inactive	  gene	  in	  TGCs	  (Cdx2).	  ChIP–PCR	  experiments	  were	  performed	  three	  times	  and	  error	  bars	  indicate	  the	  standard	  deviation.	  Student’s	  t-­‐tests	  showed	  that	  the	  acH2A.Z	  levels	  on	  5ʹ′	  UTR	  were	  significantly	  different	  between	  TSCs	  and	  TGCs	  (P	  <	  0.05).	  	   	  
Chapter	  5	  Regulation	  of	  Histone	  H2A.Z	  on	  LINE-­‐1s	  
151	  
	  	  
Figure 5.6 Expression of LINE-1s in control and H2A.Z-depleted TSCs and 
TGCs.  TSCs	  were	  cultured	  in	  differentiation	  medium	  for	  six	  days.	  Real-­‐time	  PCR	  was	  used	  to	  determine	  the	  expression	  for	  all	  LINE-­‐1	  regions	  in	  shRNA	  Control	  (black	  columns)	  and	  shRNA	  H2A.Z-­‐1	  (grey	  columns)	  TSCs	  and	  TGCs.	  Data	  were	  normalised	  to	  Rplp0,	  and	  error	  bars	  represent	  the	  standard	  deviation	  of	  three	  replicate/experiments.	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5.3	  Discussion	  Although	  TEs	  and	  other	  repetitive	  regions	  occupy	  almost	  half	  of	  the	  genome,	  they	  have	  received	  surprisingly	  little	  attention	  with	  regards	  to	  the	  role	  of	  their	  regulation.	  In	  this	  chapter,	  the	  role	  of	  H2A.Z	  in	  controlling	  LINE-­‐1	  expression	  was	  investigated	  in	  L929	  cells,	  TSCs	  and	  TGCs.	  The	  data	  unequivocally	  shows	  that	  H2A.Z	  plays	  a	  role	  in	  the	  repression	  of	  LINE-­‐1s	  expression	  in	  L929	  cells	  and	  TGCs,	  while	  in	  TSCs	  it	  has	  an	  activating	  role.	  Where	  H2A.Z	  is	  located	  on	  the	  LINE-­‐1s	  and	  its	  modification	  status	  appears	  to	  determine	  whether	  it	  activates	  or	  represses	  LINE-­‐1s	  expression.	  	  TEs	  can	  be	  targeted	  for	  silencing,	  and	  this	  silencing	  can	  spread	  to	  affect	  neighbouring	  sequences,	  including	  endogenous	  genes	  or	  regulatory	  elements	  (Richards,	  2006,	  Weil	  and	  Martienssen,	  2008,	  Lisch,	  2009).	  A	  similar	  amount	  of	  H2A.Z	  was	  found	  on	  the	  LINE-­‐1-­‐neighbouring	  genes	  Mbd3l1	  and	  Muc16	  as	  on	  LINE-­‐1s	  (Figure	  3.2),	  but	  there	  was	  no	  change	  in	  the	  expression	  of	  these	  two	  genes	  in	  H2A.Z-­‐depleted	  cells	  compared	  with	  control	  cells.	  However,	  the	  level	  of	  H2A.Z	  occupancy	  of	  these	  genes	  in	  shRNA	  H2A.Z	  versus	  shRNA	  control	  cells	  was	  not	  examined	  and	  therefore	  it	  cannot	  be	  concluded	  that	  H2A.Z	  does	  not	  have	  a	  role	  in	  the	  silencing	  of	  these	  genes.	  H2A.Z	  protein	  is	  present	  in	  H2A.Z-­‐depleted	  cells	  and	  therefore	  H2A.Z	  may	  be	  preferentially	  maintained	  at	  LINE-­‐1-­‐neighbouring	  genes	  but	  be	  more	  dynamic	  and	  readily	  lost	  from	  LINE-­‐1s	  when	  H2A.Z	  is	  limiting.	  Further	  experiments	  are	  required	  to	  investigate	  the	  H2A.Z	  levels	  on	  LINE-­‐1s	  and	  on	  these	  two	  genes	  (as	  well	  as	  on	  other	  genes	  at	  a	  genome-­‐wide	  level)	  in	  both	  H2A.Z-­‐depleted	  and	  control	  L929	  cells.	  	  Previously,	  the	  Tremethick	  laboratory	  demonstrated	  that	  the	  loss	  of	  histone	  H2A.Z	  at	  promoters	  is	  coincident	  with	  its	  gain	  at	  centromeric	  and	  subtelomeric	  regions	  as	  TSCs	  pass	  from	  G1	  phase	  to	  M	  phase,	  suggesting	  that	  there	  is	  a	  dynamic	  net	  movement	  of	  H2A.Z	  from	  promoters	  to	  these	  repetitive	  DNA	  elements	  when	  they	  become	  functionally	  important	  (Nekrasov	  et	  al.,	  2012).	  Important	  future	  experiments	  will	  be	  to	  examine	  whether	  the	  expression	  and	  level	  of	  H2A.Z	  at	  LINE-­‐1s	  in	  TSCs	  changes	  during	  the	  cell	  cycle.	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Strikingly,	  in	  contrast	  to	  the	  effect	  of	  depleting	  H2A.Z	  in	  TGCs,	  LINE-­‐1	  expression	  was	  decreased	  in	  H2A.Z-­‐depleted	  TSCs	  (Figure	  5.2).	  Previously,	  it	  was	  shown	  that	  H2A.Z	  facilitates	  the	  expression	  of	  many	  pluripotency	  genes	  and	  the	  repression	  of	  developmental	  genes	  in	  ES	  cells.	  (Hu	  et	  al.,	  2013).	  As	  a	  regulation	  of	  LINE-­‐1	  expression	  was	  not	  due	  to	  cell	  differentiation,	  it	  was	  possible	  that	  acetylated	  H2A.Z,	  rather	  than	  total	  H2A.Z,	  was	  involved	  in	  LINE-­‐1	  regulation	  in	  TSCs.	  Comparing	  the	  level	  of	  acH2A.Z	  enrichment	  at	  LINE-­‐1s	  between	  TSCs	  and	  TGCs	  showed	  a	  significantly	  higher	  level	  of	  acH2A.Z	  at	  LINE-­‐1s	  in	  TSCs,	  especially	  at	  the	  5ʹ′	  UTR	  (Figure	  5.5).	  Overall,	  it	  was	  shown	  that	  decreased	  acH2A.Z	  at	  the	  TSS	  and	  an	  overall	  increase	  of	  H2A.Z	  occupancy	  levels	  take	  place	  in	  concert	  with	  LINE-­‐1	  repression	  during	  TSC	  differentiation.	  The	  data	  suggests	  that	  an	  inverse	  relationship	  between	  acH2A.Z	  and	  total	  H2A.Z	  occupancy	  may	  regulate	  LINE-­‐1	  expression.	  A	  similar	  relationship	  between	  gene	  expression	  and	  H2A.Z/acH2A.Z	  occupancy	  was	  observed	  in	  human	  cancer	  (Valdes-­‐Mora	  et	  al.,	  2012).	  	  In	  summary,	  LINE-­‐1	  expression	  was	  induced	  by	  H2A.Z	  knockdown	  in	  two	  different	  cell	  types,	  L929	  cells	  and	  TGCs,	  arguing	  that	  H2A.Z	  has	  a	  direct	  role	  in	  repressing	  LINE-­‐1	  expression.	  Notably,	  this	  study	  also	  shows	  for	  the	  first	  time	  that	  H2A.Z	  regulation	  of	  LINE-­‐1s	  may	  require	  a	  change	  in	  the	  level	  of	  total	  H2A.Z	  to	  acH2A.Z	  occupancy.	  This	  also	  may	  explain	  the	  conflicting	  reports	  of	  H2A.Z	  having	  both	  positive	  and	  negative	  effects	  on	  gene	  regulation	  (Adam	  et	  al.,	  2001,	  Gallant-­‐Behm	  et	  al.,	  2012,	  Gevry	  et	  al.,	  2007,	  Hardy	  et	  al.,	  2009).	  However,	  the	  results	  do	  not	  show	  that	  H2A.Z	  is	  the	  sole	  factor	  required	  for	  LINE-­‐1s	  repression	  and	  indeed	  based	  on	  others	  studies	  (Pezic	  et	  al.,	  2014,	  Bulut-­‐Karslioglu	  et	  al.,	  2014,	  Karimi	  et	  al.,	  2011),	  it	  is	  most	  likely	  that	  H2A.Z	  works	  in	  concert	  with	  other	  repressive	  marks	  such	  H3K9me3.	  On	  the	  other	  hand,	  H2A.Z	  and	  DNA	  methylation	  are	  mutually	  exclusive	  marks	  (Zilberman	  et	  al.,	  2008).	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6.1	  Introduction	  Studies	  have	  shown	  that	  chromatin	  structure,	  resulting	  from	  post-­‐translational	  modification	  of	  histones,	  chromatin	  remodelling	  and	  histone	  eviction,	  has	  significant	  effects	  on	  all	  aspects	  of	  transcription	  that	  is	  mediated	  by	  RNA	  polymerase	  II	  (Guenther	  et	  al.,	  2007).	  Histone	  variant	  incorporation	  within	  chromatin	  regions	  is	  also	  a	  key	  way	  for	  cells	  to	  modulate	  gene	  transcription.	  Differences	  between	  variant	  and	  canonical	  histones	  are	  found	  in	  the	  histone	  tails	  (Doyen	  et	  al.,	  2006a),	  the	  histone	  fold	  domains	  (Doyen	  et	  al.,	  2006b),	  or	  even	  in	  just	  a	  few	  key	  amino	  acids	  (Henikoff	  and	  Ahmad,	  2005)	  which	  can	  affect	  how	  they	  are	  deposited	  into	  chromatin.	  The	  differences	  can	  affect	  both	  the	  physical	  properties	  of	  the	  nucleosome	  and	  nucleosome	  dynamics,	  enabling	  them	  to	  participate	  in	  gene	  activation	  or	  repression	  (Korber	  and	  Horz,	  2004,	  Ladurner,	  2003,	  McKittrick	  et	  al.,	  2004).	  	  There	  are	  two	  general	  models	  of	  gene	  transcription	  regulatory	  mechanisms.	  In	  one	  model,	  transcription	  is	  primarily	  regulated	  at	  the	  initiation	  step,	  when	  DNA-­‐binding	  transcription	  factors	  recruit	  the	  transcriptional	  machinery.	  In	  the	  other	  model,	  the	  critical	  regulatory	  steps	  involve	  transcript	  elongation	  or	  stability	  after	  transcriptional	  initiation	  (Krumm	  et	  al.,	  1993,	  Kuras	  and	  Struhl,	  1999,	  Saunders	  et	  al.,	  2006).	  These	  two	  models	  are	  not	  mutually	  exclusive,	  and	  they	  indicate	  that	  distinct	  mechanisms	  have	  evolved	  to	  regulate	  the	  association	  between	  chromatin	  and	  transcription	  factors,	  to	  orchestrate	  RNA	  polymerase	  II	  (RNAPII)	  translocation	  across	  a	  nucleosomal	  template	  during	  transcription.	  	  As	  described	  in	  section	  1.2.3,	  H2A.Z	  has	  been	  implicated	  in	  the	  regulation	  of	  transcription	  in	  many	  studies;	  however,	  these	  studies	  have	  led	  to	  contradictory	  views	  as	  to	  whether	  H2A.Z	  promotes	  or	  inhibits	  transcription.	  H2A.Z	  may	  affect	  either	  initiation	  or	  elongation	  to	  promote	  or	  inhibit	  transcription.	  Several	  studies	  reported	  that	  H2A.Z	  can	  change	  the	  local	  chromatin	  structure	  to	  recruit	  transcriptional	  machinery	  and	  activators	  at	  poised	  promoters,	  which	  stimulates	  transcription	  (Hardy	  et	  al.,	  2009,	  Adam	  et	  al.,	  2001,	  Gligoris	  et	  al.,	  2007,	  Lemieux	  et	  al.,	  2008).	  Importantly,	  there	  was	  a	  positive	  correlation	  between	  the	  levels	  of	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H2A.Z	  and	  RNAPII	  at	  promoters	  in	  human	  cells	  (Hardy	  et	  al.,	  2009),	  whether	  or	  not	  the	  latter	  was	  engaged	  in	  transcription.	  Besides	  its	  roles	  in	  transcriptional	  activation	  and	  initiation,	  H2A.Z	  was	  also	  found	  to	  promote	  elongation	  in	  yeast	  (Santisteban	  et	  al.,	  2000)	  or	  the	  other	  hand,	  the	  DREM	  complex	  (DP,	  Retinoblastoma	  [Rb]-­‐like,	  E2F,	  and	  MuvB)	  targets	  H2A.Z	  to	  gene	  bodies	  for	  repression	  in	  C.elegans	  (Latorre	  et	  al.,	  2015).	  	  Similarly,	  other	  studies	  showed	  that	  H2A.Z	  enrichment	  was	  negatively	  correlated	  with	  the	  transcription	  of	  genes	  in	  yeast	  (Zhang	  et	  al.,	  2005,	  Millar	  et	  al.,	  2006,	  Guillemette	  et	  al.,	  2005,	  Li	  et	  al.,	  2005)	  and	  in	  mammals.	  For	  example,	  H2A.Z	  negatively	  regulated	  transcription	  of	  p21	  and	  other	  targets	  of	  p53,	  and	  occupied	  the	  promoters	  of	  genes	  that	  were	  silenced	  during	  mitosis	  (Gallant-­‐Behm	  et	  al.,	  2012,	  Kelly	  et	  al.,	  2010,	  Gevry	  et	  al.,	  2007).	  Therefore,	  the	  specific	  function	  of	  H2A.Z	  in	  transcriptional	  regulation	  remains	  unclear,	  but	  could	  relate	  to	  where	  H2A.Z	  is	  deposited	  within	  a	  gene	  (e.g.	  the	  promoter	  versus	  the	  TSS	  versus	  the	  gene	  body)	  (Soboleva	  et	  al.,	  2014).	  Further,	  genome-­‐wide	  studies	  have	  provided	  a	  static	  picture	  of	  H2A.Z	  distribution	  with	  few	  studies	  examing	  the	  temporal	  changes	  in	  its	  distribution	  on	  gene	  regulatory	  regions	  during	  the	  transition	  between	  a	  poised	  and	  an	  active	  state.	  To	  gain	  new	  insights	  into	  how	  H2A.Z	  regulates	  gene	  transcription,	  and	  its	  relationship	  with	  RNAPII	  recruitment,	  T	  lymphocyte	  (T	  cell)	  development	  was	  used	  here	  as	  an	  in	  vivo	  model	  system.	  	  For	  many	  years,	  thymocytes	  have	  served	  as	  a	  good	  model	  for	  studying	  developmental	  regulation	  because	  cells	  at	  specific	  developmental	  stages	  are	  relatively	  easy	  to	  isolate.	  T	  cell	  development	  in	  the	  thymus	  is	  a	  stepwise	  process,	  and	  involves	  cell	  differentiation,	  proliferation	  and	  selection	  to	  form	  mature	  T	  cell	  subsets.	  During	  this	  process,	  genes	  are	  programmed	  to	  be	  either	  “on”	  or	  “off”,	  which	  offers	  an	  ideal	  developmental	  system	  to	  study	  how	  dynamic	  changes	  in	  chromatin	  structure	  are	  associated	  with	  transcription.	  Epigenetic	  chromatin	  modifications	  during	  T	  cell	  development	  and	  lineage	  commitment	  have	  also	  been	  described	  (Chi	  et	  al.,	  2002,	  Bilic	  et	  al.,	  2006,	  Kioussis	  and	  Ellmeier,	  2002,	  Naito	  et	  al.,	  2007,	  Schoenborn	  et	  al.,	  2007,	  Ansel	  et	  al.,	  2006).	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T	  cell	  development	  begins	  with	  the	  migration	  of	  thymocytes,	  which	  are	  committed	  lymphoid	  progenitor	  cells,	  from	  adult	  bone	  marrow	  or	  foetal	  liver	  into	  the	  thymus,	  where	  they	  undergo	  cellular	  maturation	  and	  T	  cell	  receptor-­‐based	  selection.	  Distinct	  developmental	  compartments	  have	  been	  defined	  according	  to	  the	  expression	  of	  the	  CD4	  and	  CD8	  co-­‐receptors	  on	  differentiating	  thymocytes.	  Early	  committed	  T	  cells	  express	  neither	  CD4	  nor	  CD8,	  and	  are	  termed	  double	  negative	  (DN;	  CD4−CD8−),	  which	  give	  rise	  to	  CD4+	  CD8+	  double-­‐positive	  (DP)	  intermediates,	  which	  in	  turn	  yield	  mature	  CD4+	  CD8− 	  (CD4)	  or	  CD4− 	  CD8+	  (CD8)	  single-­‐positive	  mature	  progeny.	  Double-­‐negative	  thymocytes	  can	  be	  further	  subdivided	  into	  four	  stages	  of	  differentiation	  (DN1,	  CD44+	  CD25−;	  DN2,	  CD44+	  CD25+;	  DN3,	  CD44− 	  CD25+;	  and	  DN4,	  CD44− 	  CD25−)	  (Li	  et	  al.,	  2005,	  Guillemette	  et	  al.,	  2005,	  Adam	  et	  al.,	  2001)	  (Figure	  6.1).	  	  Through	  this	  process,	  both	  transcriptional	  activation	  and	  repression	  of	  numerous	  genes	  occurs.	  One	  such	  gene	  is	  Cd69,	  which	  is	  useful	  for	  studying	  transcriptional	  regulation	  during	  T	  cell	  development	  (Sant'Angelo	  et	  al.,	  1998),	  as	  its	  expression	  is	  associated	  with	  the	  stimulation	  of	  T	  cell	  receptors	  (Barthlott	  et	  al.,	  1997).	  In	  the	  thymus,	  immature	  CD4+	  CD8+	  thymocytes	  that	  are	  undergoing	  positive	  or	  negative	  selection	  transiently	  express	  cell-­‐surface	  protein	  CD69	  (Brandle	  et	  al.,	  1994,	  Hare	  et	  al.,	  1999,	  Swat	  et	  al.,	  1993,	  Yamashita	  et	  al.,	  1993).	  In	  T	  cells,	  the	  Cd69	  promoter	  adopts	  an	  open	  chromatin	  conformation,	  which	  can	  direct	  gene	  transcription	  (Vazquez	  et	  al.,	  2009).	  	  In	  this	  chapter,	  to	  identify	  the	  timing	  of	  recruitment	  of	  H2A.Z	  and	  RNAPII	  to	  the	  
Cd69	  promoter	  at	  defined	  stages	  of	  thymocyte	  development,	  cells	  were	  sorted	  for	  each	  developmental	  stage	  and	  then	  ChIP–PCR	  was	  performed.	  Changes	  in	  the	  association	  of	  H2A.Z	  and	  RNAPII	  with	  different	  regions	  of	  Cd69	  were	  compared	  with	  Cd69	  expression	  during	  T	  cell	  development.	  This	  enabled	  a	  determination	  of	  whether	  the	  recruitment	  of	  H2A.Z	  to	  inducible	  promoters	  during	  T	  cell	  development	  was	  part	  of	  the	  activation	  process,	  and	  if	  so,	  whether	  this	  recruitment	  preceded	  or	  was	  concurrent	  with	  the	  recruitment	  of	  RNAPII.	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6.2	  Results	  
6.2.1 Cell-surface marker CD69 and the isolation of thymic 
subsets To	  confirm	  that	  sufficient	  material	  from	  each	  thymocyte	  development	  stage	  was	  available	  to	  perform	  ChIP,	  a	  sorting	  strategy	  was	  used	  as	  shown	  in	  Figure	  6.2.	  Cells	  were	  stained	  for	  the	  presence	  of	  the	  cell-­‐surface	  markers	  CD4,	  CD8	  and	  CD69,	  with	  cells	  characterised	  by	  high	  levels	  of	  CD4,	  CD69	  and	  CD8	  expression,	  or	  no	  or	  low	  levels	  of	  CD4,	  CD8	  and	  CD69	  expression.	  Cells	  from	  the	  thymuses	  of	  4–6-­‐week-­‐old	  C57BL/6	  mice	  were	  sorted	  into	  double-­‐negative,	  double-­‐positive	  and	  single-­‐positive	  thymic	  T	  cells	  with	  >	  98%	  purity	  by	  flow	  cytometry	  (Figure	  6.3).	  Indeed,	  high	  levels	  of	  CD4	  and	  CD8	  were	  observed	  in	  more	  than	  80%	  of	  the	  cells,	  and	  no	  or	  low	  levels	  of	  CD4	  and	  CD8	  expression	  in	  a	  small	  fraction	  (<	  2%)	  of	  the	  cells.	  	  CD69	  marks	  T	  cells	  that	  have	  been	  activated	  by	  encountering	  their	  cognate	  antigen,	  whether	  in	  the	  periphery	  or	  during	  positive	  selection	  in	  the	  thymus	  (Hara	  et	  al.,	  1986,	  Cosulich	  et	  al.,	  1987,	  Testi	  et	  al.,	  1989).	  Previous	  studies	  also	  observed	  that	  CD69+	  cells	  present	  in	  vivo	  appeared	  to	  represent	  a	  transitional	  cell	  population	  that	  was	  between	  immature	  double-­‐positive	  cells	  and	  mature	  single-­‐positive	  cells	  (Yamashita	  et	  al.,	  1993).	  As	  shown	  in	  Figure	  6.3,	  most	  of	  the	  freshly	  prepared	  mouse	  thymocytes	  were	  CD69− ,	  while	  only	  ~10%	  expressed	  significant	  levels	  of	  CD69.	  The	  highest	  level	  of	  CD69	  expression	  occurs	  in	  double	  positive	  cells	  and	  drops	  in	  single	  positive	  cells	  (Lopez-­‐Cabrera	  et	  al.,	  1993).	  Altogether,	  these	  results	  suggest	  that	  the	  staining	  and	  sorting	  strategy	  used	  successfully	  isolated	  the	  cell	  populations	  of	  interest.	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Figure 6.1 A simple model of T cell development in the thymus.  Several	  stages	  of	  thymocyte	  differentiation	  can	  be	  distinguished	  based	  on	  the	  expression	  of	  CD4	  and	  CD8	  co-­‐receptors.	  Double-­‐negative	  (DN)	  cells	  can	  be	  subdivided	  further	  into	  four	  subsets	  (DN1–DN4)	  based	  on	  the	  expression	  of	  CD25	  and	  CD44.	  With	  the	  expression	  of	  both	  CD4	  and	  CD8,	  the	  cells	  enter	  the	  double-­‐positive	  (DP)	  stage.	  During	  the	  transition	  from	  DP	  to	  single-­‐positive	  (SP)	  cells,	  the	  T	  cell	  repertoire	  is	  formed	  by	  a	  process	  known	  as	  positive	  selection.	  DP	  cells	  that	  express	  potentially	  harmful	  (autoreactive)	  T	  cell	  receptors	  are	  deleted	  by	  negative	  selection	  at	  this	  stage,	  whereas	  DP	  thymocytes	  expressing	  T	  cell	  receptors	  that	  do	  not	  recognise	  self-­‐peptide–MHC	  complexes	  are	  eliminated	  in	  a	  process	  that	  is	  known	  as	  “death	  by	  neglect”.	  Positive	  selection	  results	  in	  commitment	  to	  either	  CD4+	  or	  CD8+	  SP	  cells.	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Figure 6.2 Strategy used to select cells from each stage of T cell 
development.  Cells	  were	  isolated	  from	  C57BL/6	  (B6)	  mice,	  and	  sorted	  as	  shown.	  The	  sorted	  cells	  were	  used	  in	  ChIP–PCR	  experiments.	  The	  mouse	  Cd69	  gene	  is	  shown	  with	  the	  location	  of	  the	  PCR	  primer	  sets	  used.	  Primer	  positions	  indicate	  the	  distance	  from	  the	  TSS	  (red	  arrow).	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Figure 6.3 Sorting strategy used to select cells from different stages of T 
cell development by flow cytometry.  Cells	  were	  sorted	  for	  PE	  (CD69),	  Alexa	  Fluor	  488	  (FITC;	  CD8)	  and	  APC	  (CD4)	  expression.	  The	  gating	  strategy	  used	  is	  shown.	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6.2.2 Dynamic change in RNA polymerase II enrichment in 
the Cd69 promoter during thymocyte development To	  determine	  the	  pattern	  of	  RNAPII	  enrichment	  at	  different	  stages	  of	  T	  cell	  development,	  ChIP–PCR	  was	  performed	  on	  cells	  isolated	  from	  each	  stage	  described	  in	  section	  6.2.1.	  ChIP	  experiments	  were	  carried	  out	  using	  an	  antibody	  directed	  against	  RNAPII	  (8WG16),	  which	  recognizes	  the	  tandem	  seven	  residues	  repeats	  in	  the	  C-­‐terminal	  domain	  (CTD)	  (Phatnani	  and	  Greenleaf,	  2006).	  Real-­‐time	  PCR	  experiments	  were	  performed	  using	  primers	  directed	  to	  different	  regions	  of	  promoter	  across	  Cd69.	  In	  considering	  where	  to	  locate	  primers,	  the	  location	  of	  different	  exons	  of	  Cd69	  was	  taken	  into	  account.	  CD69	  is	  a	  type	  II	  transmembrane	  C-­‐type	  lectin	  encoded	  in	  the	  NK	  gene	  complex	  on	  mouse	  chromosome	  6.	  The	  gene	  spans	  ~7.5	  kb	  and	  contains	  five	  exons.	  The	  first	  two	  exons	  encode	  the	  cytoplasmic	  and	  transmembrane	  domains,	  and	  exons	  III,	  IV	  and	  V	  encode	  the	  extracellular	  region	  of	  the	  protein.	  The	  defined	  murine	  Cd69	  promoter	  (–650	  bp	  to	  +1	  bp	  relative	  to	  the	  transcription	  start	  site)	  is	  a	  cis-­‐acting	  element	  known	  to	  regulate	  gene	  expression	  (Ziegler	  et	  al.,	  1994).	  The	  primers	  used	  in	  this	  thesis	  covered	  the	  
−2	  kb	  to	  +500	  bp	  region	  of	  Cd69	  (Figure	  6.2),	  which	  includes	  the	  promoter	  region	  and	  the	  first	  exon.	  	  As	  RNAPII	  recruitment	  is	  an	  obvious	  step	  in	  the	  induction	  of	  transcription,	  ChIP–PCR	  was	  used	  to	  examine	  RNAPII	  recruitment	  to	  the	  Cd69	  promoter	  region.	  RNAPII	  levels	  increased	  at	  the	  TSS	  (primer	  set	  −I,	  150bp	  upstream	  from	  the	  TSS)	  from	  the	  double-­‐negative	  cell	  stage	  to	  the	  double-­‐positive	  stage	  (Figure	  6.4A),	  consistent	  with	  the	  induction	  of	  Cd69	  transcription.	  In	  the	  transition	  from	  double-­‐positive	  cells,	  CD4+CD8+,	  at	  which	  expression	  of	  CD69	  is	  high,	  to	  mature	  single-­‐positive	  cells,	  CD4-­‐CD8+	  or	  CD4+CD8-­‐,	  at	  which	  the	  expression	  of	  CD69	  drops,	  downregulation	  of	  Cd69	  transcription	  was	  associated	  with	  the	  loss	  of	  RNAPII	  at	  the	  
Cd69	  TSS	  (Figure	  6.4A).	  	  	  Next,	  RNAPII	  was	  mapped	  across	  the	  entire	  promoter	  region	  (Figure	  6.4B).	  As	  expected,	  RNAPII	  was	  most	  enriched	  at	  or	  near	  the	  TSS.	  Given	  that	  the	  maximal	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loading	  of	  RNAPII	  occurs	  at	  the	  same	  time	  when	  CD69	  transcription	  begins	  in	  CD4+CD8+CD69+	  cells	  and	  not	  before	  in	  CD4-­‐CD8-­‐CD69-­‐	  cells	  or	  CD4+CD8+CD69-­‐	  cells,	  this	  suggests	  that	  the	  Cd69	  promoter	  is	  not	  first	  assembled	  into	  a	  RNAPII-­‐containing	  poised	  promoter	  as	  reported	  previously	  (Muse	  et	  al.,	  2007).	  	  
6.2.3 Dynamic change in H2A.Z enrichment in the Cd69 
gene during thymocyte development To	  determine	  the	  dynamics	  of	  H2A.Z	  enrichment	  at	  the	  Cd69	  gene	  during	  T	  cell	  development,	  ChIP–PCR	  assays	  were	  performed	  using	  a	  H2A.Z	  affinity	  purified	  antibodies	  at	  different	  stages	  of	  development,	  identical	  to	  that	  done	  for	  RNAPII.	  In	  contrast	  to	  RNAPII,	  H2A.Z	  was	  enriched	  at	  the	  Cd69	  gene	  in	  CD4− 	  CD8− 	  CD69− 	  cells,	  at	  the	  TSS	  (−I).	  On	  the	  other	  hand,	  H2A.Z	  was	  lost	  before	  the	  induction	  of	  CD69	  transcription	  in	  CD4+	  CD8+	  CD69+	  cells	  (Figure	  6.5A).	  	  To	  determine	  the	  change	  in	  H2A.Z	  occupancy	  across	  the	  promoter	  during	  the	  activation	  of	  Cd69,	  H2A.Z	  enrichment	  was	  investigated	  using	  primers	  spanning	  the	  entire	  promoter	  region.	  This	  confirmed	  that	  the	  occupancy	  of	  H2A.Z	  was	  inversely	  correlated	  with	  RNAPII	  recruitment.	  H2A.Z	  was	  enriched	  at	  the	  TSS	  and	  flanking	  upstream	  and	  downstream	  regions	  in	  CD4− 	  CD8− 	  CD69− 	  cells.	  On	  the	  other	  hand,	  H2A.Z	  is	  removed	  prior	  to	  the	  binding	  of	  RNAPII	  and	  the	  activation	  of	  Cd69	  transcription.	  This	  data	  strongly	  suggests	  that	  the	  recruitment	  of	  RNAPII	  requires	  the	  removal	  of	  H2A.Z	  in	  CD4+	  CD8+	  CD69− .	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Figure 6.4 Dynamic changes in RNAPII recruitment to the Cd69 gene. 
RNAPII	  ChIP–PCR	  assays	  were	  performed	  with	  mouse	  CD4−	  CD8− 	  CD69− ,	  CD4+	  CD8+	  CD69− ,	  CD4+	  CD8+	  CD69+,	  CD4+	  CD8− 	  CD69+,	  CD4+	  CD8− 	  CD69− ,	  CD4− 	  CD8+	  CD69+,	  and	  CD4− 	  CD8+	  CD69− 	  cells.	  Data	  are	  shown	  for	  (A)	  150bp	  upstream	  of	  the	  TSS	  (promoter	  –I)	  and	  (B)	  the	  entire	  Cd69	  promoter	  (promoter	  –IV	  to	  +II).	  The	  location	  of	  the	  primer	  sets	  used	  is	  shown	  beneath	  the	  graphs.	  The	  results	  represent	  the	  mean	  and	  standard	  deviation	  (A)	  or	  mean	  (B)	  of	  two	  independent	  experiments.	  Gapdh	  was	  used	  as	  a	  reference	  gene.	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Figure 6.5 Dynamic changes in H2A.Z recruitment to the Cd69 gene.  
H2A.Z	  ChIP–PCR	  assays	  were	  performed	  with	  mouse	  CD4−	  CD8− 	  CD69− ,	  CD4+	  CD8+	  CD69− ,	  CD4+	  CD8+	  CD69+,	  CD4+	  CD8− 	  CD69+,	  CD4+	  CD8− 	  CD69− ,	  CD4− 	  CD8+	  CD69+,	  and	  CD4− 	  CD8+	  CD69− 	  cells.	  Data	  are	  shown	  for	  (A)	  150bp	  upstream	  of	  the	  TSS	  (promoter	  –I)	  and	  (B)	  the	  entire	  Cd69	  promoter	  (promoter	  –IV	  to	  +II).	  The	  location	  of	  the	  primer	  sets	  used	  is	  shown	  beneath	  the	  graphs.	  The	  results	  represent	  the	  mean	  and	  standard	  deviation	  (A)	  or	  mean	  (B)	  of	  two	  independent	  experiments.	  Gapdh	  was	  used	  as	  a	  reference	  gene.	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6.3	  Discussion	  To	  try	  to	  clarify	  contradictory	  data	  concerning	  the	  relationship	  between	  histone	  variant	  H2A.Z	  enrichment	  at	  the	  promoter	  and	  gene	  expression,	  changes	  in	  the	  distribution	  of	  H2A.Z	  and	  RNAPII	  were	  investigated	  in	  vivo	  by	  studying	  mouse	  T	  cell	  development.	  H2A.Z	  and	  RNAPII	  enrichment	  were	  examined	  at	  the	  Cd69	  promoter,	  a	  classic	  (supposedly)	  poised	  gene	  that	  is	  rapidly	  induced	  following	  T	  cell	  receptor	  activation	  in	  double-­‐positive	  thymocytes.	  This	  gene	  is	  turned	  off	  again	  as	  cells	  differentiate	  into	  mature	  single-­‐positive	  thymocytes.	  The	  data	  demonstrated	  that	  H2A.Z	  was	  inversely	  associated	  with	  RNAPII	  on	  the	  Cd69	  promoter,	  and	  the	  chromatin	  occupancy	  of	  both	  H2A.Z	  and	  RNAPII	  changed	  with	  the	  dynamic	  expression	  of	  Cd69	  during	  T	  cell	  development.	  This	  result	  was	  consistent	  with	  observations	  in	  Jurkat	  T	  cells,	  in	  which	  induction	  of	  CD69	  expression	  was	  paralleled	  by	  depletion	  of	  H2A.Z	  and	  concomitant	  deposition	  of	  RNAPII	  (and	  H3.3)	  (Sutcliffe	  et	  al.,	  2009).	  	  This	  negative	  correlation	  between	  the	  presence	  of	  H2A.Z	  and	  gene	  expression	  has	  also	  been	  observed	  in	  other	  studies	  (Barski	  et	  al.,	  2007,	  Guillemette	  et	  al.,	  2005,	  Li	  et	  al.,	  2005,	  Raisner	  et	  al.,	  2005,	  Zhang	  et	  al.,	  2005).	  Interestingly,	  H2A.Z	  was	  present	  both	  upstream	  and	  downstream	  of	  the	  Cd69	  TSS	  to	  assemble	  this	  repressive	  chromatin	  structure	  but	  was	  most	  enriched	  around	  the	  TSS	  in	  double-­‐negative	  cells	  (Figure	  6.5B).	  This	  observation	  is	  also	  supported	  by	  results	  in	  yeast	  (Santisteban	  et	  al.,	  2011).	  Notably,	  H2A.Z	  is	  lost	  from	  the	  Cd69	  promoter	  in	  CD4+	  CD8+	  CD69−  cells,	  a	  developmental	  stage	  prior	  to	  the	  induction	  of	  Cd69	  expression,	  showing	  that	  the	  loss	  of	  H2A.Z	  by	  itself	  is	  not	  sufficient	  for	  gene	  activation.	  This	  may	  not	  be	  surprising	  given	  that	  cell	  type	  specific	  transcription	  factors	  are	  the	  driving	  force	  for	  the	  activation	  of	  transcription.	  	  	  One	  final	  note	  is	  that	  the	  Cd69	  promoter	  has	  been	  described	  as	  a	  poised-­‐promoter	  with	  RNAPII	  sitting	  at	  the	  TSS	  prior	  to	  the	  induction	  of	  transcription	  (Guenther	  et	  al.,	  2007,	  Lorincz	  and	  Schubeler,	  2007,	  Schones	  et	  al.,	  2008).	  However,	  the	  results	  presented	  in	  Figure	  6.4	  show	  that	  this	  is	  not	  the	  case.	  The	  studies	  that	  describe	  the	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Cd69	  promoter	  as	  a	  poised	  promoter	  were	  all	  performed	  with	  T	  cells	  cultured	  in	  
vitro.	  Therefore,	  perhaps	  care	  must	  be	  taken	  when	  extrapolating	  results	  from	  tissue	  culture	  cells	  to	  the	  in	  vivo	  situation.	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H2A.Z	  has	  been	  associated	  with	  both	  activation	  and	  repression	  of	  gene	  transcription	  (Albert	  et	  al.,	  2007,	  Flaus	  et	  al.,	  2004,	  Fan	  et	  al.,	  2002),	  yet	  how	  H2A.Z	  affects	  gene	  expression	  in	  these	  opposing	  ways	  has	  been	  an	  enigma.	  Possible	  explanations	  for	  this	  may	  be	  the	  nature	  of	  the	  underlying	  DNA	  sequence,	  the	  physiological	  context	  of	  the	  promoter,	  where	  H2A.Z-­‐containing	  nucleosome	  are	  located	  within	  a	  gene	  and	  the	  modification	  status	  of	  the	  incorporated	  H2A.Z.	  To	  gain	  new	  insights	  into	  the	  mechanism	  by	  which	  H2A.Z	  regulates	  gene	  transcription,	  this	  thesis	  has	  examined	  the	  transcriptional	  role	  of	  H2A.Z	  in	  regulating	  two	  different	  types	  of	  RNAPII	  transcribed	  elements:	  a	  coding	  gene,	  Cd69,	  and	  a	  retrotransposon	  LINE-­‐1.	  	  
7.1	  H2A.Z	  –	  a	  new	  repressor	  of	  LINE-­‐1	  transcription	  Given	  the	  knowledge	  that	  H2A.Z	  is	  targeted	  to	  repetitive	  DNA	  sequences	  found	  at	  mouse	  heterochromatin	  and	  the	  centromere	  (Greaves	  et	  al.,	  2007),	  this	  thesis	  started	  by	  examining	  whether	  H2A.Z	  is	  also	  directed	  to	  another	  type	  of	  repetitive	  element,	  LINE-­‐1s.	  The	  following	  data	  unequivocally	  shows	  that	  H2A.Z	  is	  an	  important	  repressor	  of	  LINE-­‐1	  expression	  in	  mouse	  cell	  lines:	  (1)	  The	  occupancy	  of	  H2A.Z	  relative	  to	  H2A	  varies	  in	  cell-­‐type	  specific	  manner	  with	  LINE-­‐1s	  that	  are	  repressed	  containing	  more	  H2A.Z	  in	  their	  5’UTR	  and	  ORF1	  compared	  to	  LINE-­‐1s	  that	  are	  active.	  (2)	  During	  the	  differentiation	  of	  TSCs	  to	  TGCs,	  LINE-­‐1s	  become	  silenced	  and	  this	  is	  directly	  correlated	  with	  an	  increase	  in	  the	  occupancy	  of	  H2A.Z	  and	  most	  significantly	  (3)	  knocking	  down	  H2A.Z	  expression	  activates	  LINE-­‐1s	  expression	  in	  two	  different	  cell	  lines,	  L929	  cells	  and	  TGCs.	  Therefore,	  in	  addition	  to	  assembling	  major	  and	  minor	  satellites	  into	  a	  heterochromatic	  structure	  (Greaves	  et	  al.,	  2007),	  it	  also	  assembles	  LINE-­‐1s	  into	  a	  repressed	  chromatin	  state.	  This	  suggests	  that	  H2A.Z	  may	  have	  evolved	  to	  keep	  repetitive	  elements	  silenced.	  Supporting	  this	  notion,	  a	  previous	  study	  in	  Drosophila	  showed	  that	  H2A.Z	  was	  essential	  for	  the	  targeted	  formation	  of	  ectopic	  heterochromatin	  and	  gene	  silencing	  when	  transgene	  arrays	  were	  integrated	  into	  the	  Drosophila	  genome	  (Swaminathan	  et	  al.,	  2005).	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On	  the	  other	  hand,	  a	  previous	  study	  in	  human	  cancer	  revealed	  that	  the	  activation	  of	  LINE-­‐1s	  correlated	  with	  the	  acquisition	  of	  H2A.Z	  at	  the	  TSS	  (Wolff	  et	  al.,	  2010).	  However,	  as	  shown	  here	  H2A.Z	  also	  has	  a	  role	  in	  the	  activation	  of	  LINE-­‐1s	  in	  TSCs	  showing	  that	  H2A.Z	  can	  have	  opposing	  roles	  even	  on	  the	  same	  transcribed	  element.	  The	  ability	  of	  H2A.Z	  to	  either	  repress	  or	  activate	  LINE-­‐1s	  was	  dependent	  upon	  whether	  H2A.Z	  was	  acetylated	  or	  not,	  and	  the	  location	  of	  H2A.Z	  within	  the	  LINE-­‐1s.	  High	  occupancy	  of	  acH2A.Z	  was	  observed	  at	  the	  5’UTR	  of	  active	  LINE-­‐1s	  in	  TSCs,	  but	  not	  when	  they	  were	  repressed	  in	  TGCs.	  In	  addition,	  a	  repressed	  LINE-­‐1	  was	  characterised	  by	  having	  a	  higher	  abundance	  of	  unacetylated	  H2A.Z	  both	  at	  the	  5’UTR	  but	  also	  downstream	  into	  the	  coding	  region	  (ORF1).	  This	  data	  is	  consistent	  with	  other	  studies,	  which	  also	  showed	  that	  acH2A.Z	  was	  strongly	  enriched	  at	  the	  TSS	  of	  active	  genes	  (Bruce	  et	  al.,	  2005,	  Hu	  et	  al.,	  2013,	  Ku	  et	  al.,	  2012,	  Valdes-­‐Mora	  et	  al.,	  2012).	  More	  interestingly,	  study	  in	  human	  embryonic	  carcinoma-­‐derived	  cell	  lines	  demonstrated	  treating	  cells	  with	  histone	  decetylase	  inhibitors	  rapidly	  reverses	  the	  silencing	  of	  LINE-­‐1	  retrotransposition(Garcia-­‐Perez	  et	  al.,	  2010).	  	  	  H2A.Z	  is	  deposited	  at	  promoters	  by	  two	  remodelling	  complexes,	  P400	  and	  SRCAP	  (Kobor	  et	  al.,	  2004).	  In	  addition,	  the	  TIP60	  histone	  acetyl	  transferase	  component	  of	  P400	  is	  responsible	  for	  acetylating	  H2A.Z	  (Park	  et	  al.,	  2010).	  Therefore,	  the	  data	  suggests	  that	  the	  action	  of	  these	  remodelling	  complexes	  underpin	  whether	  H2A.Z	  activates	  or	  represses	  LINE-­‐1	  transcription.	  For	  example,	  an	  attractive	  hypothesis	  to	  be	  tested	  in	  the	  future	  is	  that	  during	  the	  differentiation	  of	  TSCs	  to	  TGCs,	  P400	  is	  no	  longer	  recruited	  to	  the	  5’UTR	  of	  LINE-­‐1s	  to	  acetylate	  H2A.Z.	  	  Taken	  together,	  a	  model	  can	  be	  proposed	  where	  acH2A.Z	  is	  targeted	  to	  active	  LINE-­‐1s	  in	  undifferentiated	  cells	  (TSCs),	  while	  in	  differentiated	  	  cells	  (L929	  cells	  and	  TGCs),	  this	  acetylation	  is	  lost	  with	  an	  overall	  gain	  of	  non-­‐acetylated	  H2A.Z	  to	  repress	  LINE-­‐1s	  transcription	  (Figure	  7.1).	  	  However,	  it	  is	  unlikely	  that	  H2A.Z	  is	  solely	  responsible	  for	  the	  repression	  of	  LINE-­‐1s	  transcription	  and	  future	  studies	  would	  examine	  the	  histone	  code	  of	  these	  repressive	  H2A.Z-­‐containing	  nucleosomes	  (for	  example,	  H2A.Z	  has	  been	  linked	  with	  the	  repressive	  H3K27me3	  mark	  (Creyghton	  et	  al.,	  2008)).	  Concerning	  DNA	  methylation,	  H2A.Z	  and	  DNA	  methylation	  are	  mutually	  exclusive	  marks	  (Zilberman	  et	  al.,	  2008).	  Genome-­‐wide	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analyses	  have	  shown	  that	  TSCs	  have	  low	  global	  levels	  of	  DNA	  methylation	  compared	  to	  mouse	  embryonic	  stem	  cells	  particularly	  in	  repeated	  DNA	  sequences	  (Farthing	  et	  al.,	  2008).	  It	  is	  therefore	  attractive	  to	  suggest	  that	  in	  the	  absence	  of	  LINE-­‐1	  methylation,	  H2A.Z	  assumes	  an	  even	  more	  important	  role:	  functionally	  replaces	  DNA	  methylation	  to	  keep	  these	  retrotransposons	  in	  a	  repressed	  state.	  	  	  
7.2	  H2A.Z	  –	  a	  modulator	  of	  RNAPII	  recruitment	  
during	  development	  As	  both	  a	  positive	  and	  negative	  association	  was	  observed	  between	  H2A.Z	  enrichment	  on	  LINE-­‐1s	  and	  the	  level	  of	  LINE-­‐1s	  transcription	  during	  TSC	  differentiation,	  it	  was	  decided	  to	  further	  investigate	  H2A.Z	  function	  on	  transcription	  in	  a	  cell	  differentiation	  system,	  where	  genes	  are	  programmed	  to	  be	  either	  activated	  or	  repressed	  during	  development	  in	  vivo.	  Specifically,	  while	  many	  studies	  have	  observed	  an	  association	  between	  H2A.Z	  and	  RNAPII	  recruitment	  in	  S.	  
cerevisiae	  (Mizuguchi	  et	  al.,	  2004,	  Kobor	  et	  al.,	  2004,	  Krogan	  et	  al.,	  2003),	  mammals	  (Papamichos-­‐Chronakis	  et	  al.,	  2011)	  and	  plants	  (Dryhurst	  et	  al.,	  2009),	  few	  studies	  have	  examined	  the	  temporal	  relationship	  between	  the	  recruitment	  of	  H2A.Z	  and	  RNAPII	  when	  a	  promoter	  becomes	  activated	  during	  development.	  	  To	  investigate	  these	  sequences	  of	  events,	  the	  occupancy	  of	  H2A.Z	  and	  RNAPII	  on	  the	  Cd69	  promoter	  was	  examined	  during	  thymocyte	  development,	  where	  the	  Cd69	  gene	  is	  transiently	  expressed.	  Unexpectedly,	  H2A.Z	  was	  present	  on	  the	  Cd69	  promoter	  early	  in	  development	  in	  CD4-­‐	  CD8-­‐	  CD69-­‐	  prior	  to	  the	  recruitment	  of	  RNAPII	  and	  activation	  of	  the	  Cd69	  promoter.	  Moreover,	  H2A.Z	  was	  subsequently	  lost	  prior	  to	  the	  recruitment	  of	  RNAPII	  (Figure	  6.5B).	  Therefore,	  rather	  than	  facilitating	  RNAPII	  recruitment,	  this	  data	  suggests	  that	  H2A.Z	  keeps	  the	  Cd69	  promoter	  in	  a	  repressed	  state	  and	  its	  specific	  and	  targeted	  removal	  alters	  the	  promoter	  chromatin	  architecture	  to	  facilitate	  the	  subsequent	  recruitment	  of	  RNAPII.	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Figure 7.1 Model of LINE-1 transcriptional regulation, dependent on H2A.Z 
occupancy and its acetylation state in undifferentiated and differentiated 
cells.  In	  undifferentiated	  cells	  (e.g.	  TSCs),	  LINE-­‐1s	  that	  are	  actively	  transcribed	  have	  acH2A.Z	  at	  their	  5ʹ′	  UTR.	  In	  differentiated	  cells	  (e.g.	  TGCs	  and	  L929	  cells),	  non-­‐acetylated	  H2A.Z	  is	  enriched	  at	  the	  5ʹ′	  UTR	  of	  LINE-­‐1s	  and	  represses	  their	  transcription,	  either	  through	  active	  deacetylation	  of	  acH2A.Z	  or	  by	  exchange	  with	  a	  non-­‐acetylated	  H2A.Z	  nucleosome	  (shown	  as	  “?”).	  	  	  This	  observation	  is	  consistent	  with	  studies	  examining	  signalling	  induced	  transcription	  where	  H2A.Z	  is	  present	  near	  the	  TSS	  in	  the	  repressed/poised	  state	  and	  upon	  induction,	  H2A.Z	  is	  removed	  concurrent	  with	  or	  prior	  to	  the	  recruitment	  of	  RNAPII	  (Sutcliffe	  et	  al.,	  2009).	  On	  the	  other	  hand,	  this	  finding	  is	  not	  consistent	  with	  other	  studies	  showing	  that	  H2A.Z	  is	  involved	  in	  recruiting	  RNAPII	  (Weber	  et	  al.,	  2014).	  The	  most	  likely	  explanation	  for	  these	  differences	  is	  that	  H2A.Z	  does	  not	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have	  a	  simple	  universal	  role	  but	  acts	  differently	  on	  different	  promoters	  perhaps	  again	  determined	  by	  the	  action	  of	  P400	  and	  /or	  SRCAP,	  the	  promoter	  specific	  transcription	  factors	  involved	  and	  the	  positioning	  of	  the	  H2A.Z	  containing	  nucleosome.	  Future	  experiments	  using	  next-­‐generation	  sequencing	  techniques	  such	  as	  ChIP-­‐sequencing	  (H2A.Z,	  acH2A.Z	  and	  RNAPII	  ChIP-­‐seq)	  at	  the	  different	  stages	  of	  development	  will	  determine	  the	  degree	  and	  nature	  of	  those	  promoters	  that	  are	  repressed	  versus	  those	  that	  are	  activated	  by	  H2A.Z.	  	  
7.3	  Insights	  into	  different	  gene	  knockdown	  systems	  To	  understand	  H2A.Z	  function,	  the	  gold	  standard	  is	  to	  disrupt	  its	  normal	  expression	  and	  study	  the	  resulting	  phenotypes.	  With	  the	  increasing	  variety	  of	  tools	  available	  for	  modulating	  gene	  expression,	  particularly	  for	  knockdown	  experiments,	  it	  was	  difficult	  to	  select	  the	  most	  appropriate	  system.	  As	  each	  system	  has	  its	  own	  advantages	  and	  limitations	  (see	  section	  4.1),	  choosing	  the	  right	  one	  for	  a	  project	  mainly	  depends	  on	  the	  specific	  experimental	  design.	  Before	  commencing	  experiments,	  the	  most	  common	  factors	  to	  consider	  are	  the	  loss-­‐of-­‐function	  type	  (reversible	  or	  irreversible),	  the	  time	  required	  to	  establish	  stable	  clones,	  the	  cost	  of	  the	  experiment	  and	  the	  ease	  of	  performing	  the	  experiment.	  	  Considering	  these	  factors,	  it	  is	  reasonable	  to	  say	  that	  pTRIPz	  was	  a	  better	  system	  than	  the	  other	  two	  explored	  (the	  ecdysone-­‐inducible	  system	  and	  pLVTHM;	  Figure	  7.2).	  However,	  it	  was	  somewhat	  surprising	  that	  pTRIPz	  did	  not	  work	  in	  TSCs.	  Therefore,	  other	  major	  factors	  that	  needed	  to	  be	  considered	  in	  this	  thesis	  were	  the	  promoter	  driving	  shRNA	  expression	  and	  the	  target	  cells	  used.	  In	  one	  study,	  the	  EF1α	  promoter	  directed	  the	  highest	  level	  of	  transgene	  expression	  and	  the	  CMV	  promoter	  the	  weakest	  in	  undifferentiated	  ESCs	  and	  embryoid	  bodies	  (Hong	  et	  al.,	  2007).	  A	  different	  lentiviral	  system	  used	  in	  this	  thesis,	  pLVTHM,	  which	  has	  an	  EF1α	  promoter,	  resulted	  in	  a	  higher	  knockdown	  efficiency	  than	  pTRIPz	  in	  TSCs.	  By	  comparing	  the	  advantages	  and	  drawbacks	  of	  all	  the	  knockdown	  systems,	  it	  was	  concluded	  that	  the	  combination	  of	  cell	  line	  type	  and	  promoter	  are	  critical	  for	  the	  success	  of	  a	  given	  knock	  down	  expression	  system.	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Figure 7.2 Factors to consider when choosing a gene knockdown system. (a)	  Loss-­‐of-­‐function	  type.	  While	  ecdysone-­‐inducible	  shRNA	  and	  pTRIPz	  can	  induce	  reversible	  gene	  knockdown,	  pLVTHM	  induces	  permanent	  knockdown.	  (b)	  Time	  to	  produce	  stable	  clones.	  Transduction	  of	  lentivirus	  (pLVTHM	  and	  pTRIPz)	  is	  the	  most	  direct	  and	  quickest	  route,	  while	  ecdysone-­‐inducible	  shRNA	  requires	  more	  time	  to	  establish	  stable	  clones.	  (c)	  Cost	  of	  the	  experiment.	  Ecdysone-­‐inducible	  shRNA	  requires	  PonA	  for	  induction,	  which	  makes	  the	  experiments	  cost	  more,	  while	  pTRIPz	  requires	  doxycycline,	  which	  costs	  less	  than	  PonA.	  (d)	  Ease	  of	  the	  experiment.	  pTRIPz	  and	  pLVTHM	  lentiviral	  systems	  require	  simple	  transfection	  and	  then	  infection	  of	  target	  cells,	  especially	  for	  L929	  cells.	  For	  TSCs,	  these	  viral	  approaches	  only	  need	  to	  be	  additionally	  optimised	  for	  the	  concentration	  of	  virus.	  However,	  the	  ecdysone-­‐inducible	  system	  has	  two	  vectors	  and	  the	  problem	  of	  low	  induction	  efficiency,	  making	  it	  more	  complicated.	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7.4	  Future	  directions	  To	  understand	  all	  aspects	  of	  H2A.Z	  function	  on	  LINE-­‐1s	  transcription,	  as	  outlined	  above,	  the	  role	  of	  the	  remodelling	  complexes	  P400	  (including	  TIP60)	  and	  SRCAP	  will	  need	  to	  be	  explored	  by	  performing	  ChIP	  and	  knockdown	  experiments.	  It	  is	  attractive	  to	  speculate	  that	  by	  inhibiting	  P400	  and/or	  SCARP	  expression,	  this	  may	  overcome	  H2A.Z	  mediated	  repression	  of	  LINE-­‐1s	  expression	  during	  TSCs	  differentiation.	  Conversely,	  by	  inhibiting	  TIP60	  expression	  in	  TSCs,	  LINE-­‐1s	  expression	  may	  be	  inhibited	  by	  preventing	  H2A.Z	  acetylation.	  However,	  such	  experiment	  might	  be	  more	  difficult	  to	  conduct	  than	  anticipated.	  Since	  the	  P400	  complex	  consists	  of	  at	  least	  two	  independent	  and	  functionally	  distinct	  sub-­‐complexes:	  YL-­‐1,	  a	  histone	  chaperone	  that	  deposites	  H2A.Z	  on	  chromatin	  (Latrick	  et	  al.,	  2016),	  and	  ANP32E,	  a	  histone	  chaperone	  that	  removes	  H2A.Z	  from	  chromatin	  (Obri	  et	  al.,	  2014).	  In	  addition,	  the	  role	  of	  other	  epigenetic	  modifications	  in	  the	  silencing	  of	  LINE-­‐1s	  need	  to	  be	  explored	  by	  performing	  LINE-­‐1s	  specific	  and	  genome-­‐wide	  ChIP-­‐Seq	  experiments	  and	  other	  histone	  modifications.	  	  Other	  interesting	  questions	  that	  need	  to	  be	  addressed	  are:	  (1)	  when,	  during	  the	  TSC	  differentiation	  process,	  do	  LINE-­‐1s	  become	  repressed	  by	  H2A.Z,	  i.e.	  does	  it	  occur	  before	  or	  when	  TGCs	  arise;	  (2)	  identify	  the	  histone	  deacetylase	  involved	  in	  deacetylating	  H2A.Z	  and	  whether	  histone	  deacetylase	  inhibitors	  affect	  LINE-­‐1s	  transcription	  in	  TGCs;	  (3)	  perform	  H2A.Z	  ChIP-­‐Seq	  experiments	  and	  DNA	  methylation	  bisulphite	  analysis	  to	  investigate	  the	  relationship	  between	  H2A.Z	  and	  DNA	  methylation	  at	  LINE-­‐1s	  and	  other	  regions	  of	  the	  genome;	  (4)	  whether	  the	  loss	  of	  H2A.Z	  increase	  the	  retrotransposition	  frequency,	  and	  particularly	  interesting,	  use	  a	  LINE-­‐1	  plasmid-­‐based	  strategy	  (Ostertag	  et	  al.,	  2000)	  to	  determine	  whether	  H2A.Z	  is	  deposited	  at	  new	  sites	  of	  LINE-­‐1s	  insertion	  to	  support	  the	  hypothesis	  that	  H2A.Z	  has	  evolved	  to	  keep	  repetitive	  elements	  silenced;	  (5)	  whether	  H2A.Z	  has	  a	  similar	  role	  in	  repressing	  human	  LINE-­‐1s	  and	  the	  link	  with	  DNA	  methylation	  and	  (6)	  whether	  H2A.Z.2,	  another	  H2A.Z	  isoform	  (Horikoshi	  et	  al.,	  2013),	  has	  same	  role	  as	  H2A.Z.1	  in	  repressing	  LINE-­‐1	  since	  this	  study	  focused	  solely	  on	  H2A.Z.1.	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Supplementary Table shows the genomic location of H2A.Z (Table S1) and 
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